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To My Parents 
ABSTRACT 
Precise in vitro fusion of DNA fragments, in the vector system 
devised by McKenney and colleagues, has been used to investigate 
transcriptional terminators (present in the 17 genome) for the 
E.coli RNA polymerase. 	Three terminator-containing fragments 
have been studied, allowing estimation of the efficiency of each 
signal in vivo in isolation from the T7 genome. 	The best character- 
ised of these is the tecl terminator at the end of the "early" 
region. 	My estimates of a 76-78% termination of transcription at 
tecl are in good agreement with the previous estimate, of Millette 
and colleagues, for this terminator in T7 itself. 	The second 
terminator, designated tec2 and previously studied in vitro, 
appears to be inactive in vivo in the tec2-fusion I have constructed. 
I have also identified a new transcriptional terminator of unknown 
physiological importance, designated tec3, from the late region of 
the T7 genome. 	I estimate a 95% efficiency of termination for this 
signal and have determined the DNA sequence (179 bp) of the tec3-
containing T7 Alul fragment. 
Several of these fragments stimulate termination when transcribed 
in the opposite direction to natural transcription of the phage 
genome during infection. 	The significance of this, and the possible 
involvement of a cofactor(s) interaction with E.coli RNA polymerase 
during termination at tecl are discussed. 
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ABBREVIATIONS 
bp 	 base pair 
Kbp 	 Kilobase pair 
moi 	 multiplicity of infection 
Rpol 	 RNA polymerase 
nM 	 nanometres 
pX 	 protein product of qene X 
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Chl 	 Chloramphenicol resistant or sensitive 
Amp R/S 
	
Ampicillin resistant or sensitive 
att 	 attenuator 
Pgal 	promoter for e.g. the qal operon 
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CHAPTER 1 - INTRODUCTION 
It is an essential requirement of all living organisms that 
they should be able to respond, both in the short and long term, to 
environmental change. 	The bacterium Escherichia coli can achieve 
this both at the primary level of gene expression, namely trans- 
cription, and at stages beyond. 	Here, structural genes are 
delineated by regulatory sequences (promoters, attenuators and 
terminators), and transcription is the responsibility of a single 
DNA-dependent RNA polymerase (Rpol). 	Regulation is achieved by 
modulating the efficiency with which E.coli Rpol can recognise and 
respond to these regulatory sequences. 
The studies described in this thesis are an attempt to increase 
our knowledge of the interactions between [.coli Rpol and one type 
of transcriptional signal, the terminator. 
COMPONENTS OF THE TRANSCRIPTION MACHINERY 
Transcriptional activity in E.coli can vary drastically with 
physiological conditions. 	In accordance with this, we find that 
components of the system exhibit a degree of structural complexity 
and variability. 
Rpol 
A complex oligomeric protein whose properties have been 
extensively reviewed, for example by Losick and Chamberlin (1976), 
and by Lathe (1978). 	It consists of a catalytically competent core 
which interacts with a number of cofactors involved in a specific 
initiation or termination activities. 	The minimal enzyme, known 
as "CORE ENZYME" is composed of three distinct polypeptide subunits 
alpha, beta and beta-prime. 	These exist in the molar ratio 
2. 
and the active form in vivo would appear to be monomeric 
(Zarudnaya et al, 1976). 	This pattern of a288' in core enzyme is 
repeated in other prokaryotes studied (Fukuda et al, 1977; Burgess, 
1976). 
The cr-subunit: 	This has a molecular weight of 3000 daltons 
(Ovchinnikov et al, 1977) and is encoded by the rpoA gene. 	No 
clear function has yet been ascribed to a, but reconstitution of 
the active enzyme from purified subunits absolutely requires it (Heil 
and Zillig, 1970) and mutations in rpoA can alter transcriptional 
specificity (Fujiki et al, 1976). 
The B-subunit: This is encoded by the rppB gene and is a 
protein of 1,342 amino acid residues (Ovchinnikov et al, 1981). Beta 
has been implicated in substrate (NIP) binding (Armstrong et al, 
1976) and genetic studies have suggested a role for it in the 
specificity of transcriptional initiation and termination (Wozny 
et al, 1975; Tessman and Peterson, 1976; Yarnamori et ml, 1977; 
Lecocq and Dambly, 1976; Guarente and Beckwith, 1977) 
The B'-subunit: This is encoded by the rpoC gene and is a 
protein of 1,407 amino acid residues (Ovchinnikov et al, 1982). 
Beta-prime is a particularly basic protein (Zillig et ml, 1970) and 
has been implicated in the primary binding of Rpol to DNA (Fukada 
and Ishihama, 1974). 	Other authors have suggested a role for B' 
in promoter selection (Gros et ml, 1976; Coppo et ml, 1975) 
although it is not predominantly determinant in this as will be 
seen later. 
Core enzyme binds to the DNA template in vitro (Hinkle and 
Chamberlin, 1972), and catalyses the 5'+3' polymerisation of 
ribonucleoside 5'-triphosphates complementary to the template. 
precursor complex can achieve the former but not the latter step. 
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The reaction is effectively irreversible due to the hydrolysis and 
release of pyrophosphate. 	Efficient polymerisation by core enzyme 
requires the presence of a single-stranded DNA-template, a double-
stranded nicked DNA-template, or a double-stranded linear DNA-template 
(Vogt, 1969; Burgess et al, 1969; Berg et al, 1971; Ishihama et al, 
1971). 	Any nick can serve as a transcriptional initiation site 
for core enzyme (Hinkle et al, 1972). 	Presumably, this explains 
the observation that such transcription shows little or no strand 
specificity and initiates at random sites on the nicked templates 
(Hinkle and Chamberlin, 1972). 
More specific Rpol activity is observed when core enzyme is 
complexed with another Rpol subunit, sigma (o). 
The sigma-subunit: This is an acidic protein, has a molecular 
weight of 82,800 daltons (Lowe et al, 1979) and is encoded by the 
rpoD gene. 	The core enzyme-sigma complex has the structure 
and is known as "HOLOENZYME". 	It is this form of the 
enzyme that will faithfully transcribe templates using true promoter 
sequences as transcription initiation sites. 	Sigma is present in 
the call in less than stoichiometric amounts compared with other 
Rpol subunits (Ishihama et al, 1976), has a rapid turnover during 
transcription, dissociating from Rpol after initiation (Travers 
and Burgess, 1969), and appears to bind to DNA only in the 
complex (Hillel and Wu, 1978). 	Sigma binding to core-enzyme 
produces a conformational change in the enzyme structure (Wu et al, 
1976) that is presumably related to the observed differences 
between core and holoenzyme, i.e.: 
1) An altered DNA binding affinity. 	Core enzyme binds to many 
-1 
sites on DNA with an intermediate affinity, K assoc 
	
11 
2x10 M 	on 
the T7 genome. 	Holoenzyme binds to the same template resulting 
4. 
in two types of complex (i) Kassoc 	i012 to 1014M, thought to 
be true E.coli Rpol promoters, (ii) K350  = 
10  
to 109M 1, thought 
to reflect a reduced general affinity of holoenzyme for DNA 
(Hinkle and Chamberlin, 1972). 
An ability to melt regions of the helix in promoter:holoenzyme 
complexes (Chamberlin, 1976). 
An increase in the rate of transcriptional initiation 
(Chamberlin, 1976). 
A decrease in non-specific initiation at nicks. 	This is 
accompanied by an inhibition of transcription by holoenzyme due to 
nicks serving as tight binding sites for holoenzyme however few 
allow transcriptional initiation (Hinkle et ml, 1972). 
Sigma factor, therefore, confers transcriptional initiation 
specificity on the non-specific core-enzyme complex and is an 
essential requirement for the correct initiation of RNA synthesis. 
The omega-subunit: Highly purified preparations of Rpol 
sometimes contain another weakly associated subunit, W. 	This has 
a molecular weight of 8p00-12JJ00 daltons, is not essential for full 
activity of reconstituted Rpo]. (Burgess, 1976) and may, in fact, be 
three distinct polypeptides (Lathe, 1978). 
Rpol ASSOCIATED POLYPEPTIDES OF E.coli. 
Rpol may associate with a number of other cofactors during its 
transcriptional activities, with effects on initiation and/or 
termination. 	Although some cannot be considered true Rpol subunits, 
others deserve such consideration in the light of current thoughts 
on their activities. 	This discussion primarily concerns termination, 
but of some relevance are such associations at initiation sites. 
These will be mentioned briefly in the context of Rpol/cofactor 
interactions: 
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Catabolite gene activator protein (CAP) 
This positive effector binds to cyclic AMP (cAMP) when the 
intracellular levels of the latter are high, i.e. in the absence 
of glucose. 	The resulting complex exhibits pleiotropic effects 
on initiation (not all positive) by binding to sequences in the 
promoter region of a number of operons: In the lac and ara operons, 
CAP-cAMP complex potentiates transcription (de Crombrugghe et al, 
1971; Ogden et al, 1980). 	In the y,j  operon, however, CAP-cAMP 
complex stimulates initiation from one and inhibits initiation 
from the other of two overlapping promoters (Musso et al, 1977). 
These dual promoters allow a form of cellular regulation reacting 
to CAP-cAMP levels based on differential translation efficiency 
(Queen and Rosenberg, 1981). 	The relative efficiency of trans- 
lation of the 5'-proximal and distal genes of the operon varies 
with the promoter used, and is therefore regulated by the CAP-cAMP 
complex. 	Sequences important for CAP-cAMP function will be 
discussed later, as will those relevant to other cofactors mentioned. 
Repressor proteins 
A number of transcription units are under negative control, 
two of the best understood of these are the bc and trp operons. 
In the former, when intracellular concentration of lactose is low, 
initiation is inhibited by the product of the lacI gene, the lao 
repressor. 	In this situation, repressor binds to a region over- 
lapping the lac promoter, sterioally preventing Rpol from initiating 
transcription (Majors, 1975a). 	When intracellular concentrations 
of lactose are high, repressor binds instead to the sugar molecule 
and this complex no longer interferes with initiation at the lac 
promoter. 	In the trpcontrol region, a similar but distinct 
situation prevails. 	When intracellular concentrations of 
L-tryptophan are high, the product of the trpR gene, the trp 
aporepressor (a 47 kdal homodimer), binds the amino acid to form an 
active repressor complex. 	This sterically blocks Rpol initiation 
by binding to a region overlapping the trp promoter. 	Aporepressor 
alone has a low affinity for this region and does not prevent 
initiation. 
Repressor control of transcription also occurs in A gene 
expression and the reader is referred to the review by Ptashne et al 
(1980). 	Bacteriophage A encodes two proteins that play contrasting 
roles in determining its mode of growth (see Fig. 1.1). 	One, the 
A repressor, is the product of the ci gene and is required for 
lysogeny. 	The other, Cro, is the product of the cro gene and is 
required for lytic phage growth. 	To maintain lysogeny, repressor 
turns off early gene expression, including that of cro, and turns 
on transcription of ci. 	It therefore functions as both a positive 
and negative regulator of gene transcription. 	To encourage lytic 
growth, Cro performs two negative functions: it prevents repressor-
stimulated transcription of ci; and it reduces expression (following 
and early burst) of early genes including cro. 	The effects of 
repressor and Cro result from their binding to two operators on 
the phage chromosome. 	The situation at the right operator is most 
relevant and will be described briefly. 	Two promoters overlap the 
82 bp region defined as 	One of these, P 
R' 
 directs rightward 
transcription of a set of early genes including cro, the other, PRM, 
directs leftward transcription of CI in a lysogen. 	Repressor and 
Cro bind to three similar 17 bp sequences in 
0R °R1' 0R2' 0R3) and 
sterically block transcriptional initiation at P 
R 
 or P RM 
Binding of repressor occurs from right to left (O-O 3) whereas 
binding of Cro occurs from left to right 0R3°R1 
	
It is the 
Fig. 1.1 
A Partial genetic map of X. 
Promoters and terminators are boxed. 	The dashed arrows represent 
the termini and orientations of various transcripts discussed in 
the text. 	Transcripts terminate at tLl  and tRI (and as a result 
of readthrough, t[2  and tR2) unless pN antagonises termination at 
the four terminators shown. 	In the case of tL2 the termination 
is rho-independent. 	The sequences of the nutL and nutR regions 
are shown (for the DNA strancig equivalent to the mRNA). 
4— Dn 
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occupancy of these binding sites by repressor or Cro that deter- 
mines which promoter is active and hence, which genes are transcribed. 
Rho Protein 
Rho (p) is a hexameric protein (Oda and Takanami, 1972; 
Fingel and Richardson, 1979) with a monomer weight of 50,000 daltons 
(Roberts, 1969; Oda and Takanami, 1972) and is the product of the 
rho gene (Ratner, 1976a). 	It exhibits two activities: (1) the 
termination of transcription and release of RNA at specific sites 
(Roberts, 1969), (2) an RNA-dependent hydrolysis of ATP and other 
ribonucleoside triphosphates to nucleoside diphosphates, liberating 
inorganic phosphate. 	The former activity is dependent upon the 
latter (Howard and de Crombrugghe, 1976). 	It is present in E.coli 
in approximately a two-fold molar excess over Rpol core complex 
(Blumental et a1, 1976) and appears to act catalytically (Richardson, 
1970) although it has been suggested that it may act stoichiometrically 
(Richardson and Conaway, 1980). 	The mechanism by which rho promotes 
termination remains obscure, but two lines of evidence suggest that 
rho and Rpol may interact. 	Das et al (1978) have observed that 
mutations in the rpoB gene restore polarity which had been relieved 
by a rho mutation. 	Moreover, the mutant Rpol terminates at the 
rho-dependent sites in A only in the presence of the defective rho. 
This suggests a functional relationship between rho and the 
s-subunit of Rpol during termination. 	Similarly, a completed, 
accurate termination event at Xtr2  and 	t' requires the presence 
of both pnusA and rho (Platt, 1981; Greenblatt, 1981). 	Greenblatt 
and Li (1981) have demonstrated the binding of the acidic pnusA to 
Rpol in vitro and proposed its association with Rpol during elongation. 
Rho is 2 basic protein and, hence, pnusA may mediate rho binding to 
a paused Rpoi molecule, whereupon rho would stimulate termination, 
possibly by causing a conformational change in the paused complex. 
Other observations suggest how rho may achieve its contact 
with Rpoi. 	Darlix (1973) observed that rho requires nascent RNA 
in order to act, termination being abolished if the RNA chain is 
destroyed by ribonuclease action. 	There is also evidence that rho 
binds to a specific region on the Xcro mRNA in vitro (Bektesh and 
Richardson, 1980). 	Once attached, rho appears to entwine itself 
in RNA in an ATP-dependent style and can, therefore, "move" along 
RNA in either direction (Gallupi and Richardson, 1980). 	These 
observations led Gallupi and Richardson (op.cit.) to propose a 
model by which rho may achieve contact with transcribing Rpol 
molecules: each subunit of the rho hexamer has two binding sites 
for RNA and one for a nucleotide. 	One RNA binding site on each 
subunit is aligned to form a major RNA binding sites on the hexamer. 
The second RNA binding site on each subunit remains independent 
but has its affinity for RNA modulated by the state of occupancy of 
the nucleotide binding site in the same subunit. 	When ATP is bound 
at the nucleotide site, RNA is retained strongly by the secondary 
site. 	ATP hydrolysis causes the release of the RNA chain from 
this site but does not affect binding at the major site. 	Hence, 
they propose a primary binding of rho to RNA via the major site, 
possibly at a preferred sequence, and subsequent attachments to 
more distal regions via the six secondary sites. 	ATP hydrolysis 
at the nucleotide sites results in the release of RNA from 
secondary attachments. 	Subsequent ATP binding and hydrolysis 
allows the attachment of more distal segments of the RNA molecule 
to rho in either a 5' or 3' direction. 	In this way, rho can "wrap" 
RNA around itself and "migrate" along the chain in either direction 
until it induces termination upon contact with an Rpol molule. 
This event probably occurs at paused Rpol molecules in a site 
specific fashion (Shigesada and Wu, 1980) although there is evidence 
that rho, having contacted Rpol, may cause termination anywhere 
(Richardson and Conaway, 1980). 
Finally, rho may, in general, act alone to mediate termination 
but it has recently become evident that in some cases its activities 
are manifested in conjunction with other cofactors (Greenblatt and 
Li, 1981; Ward and Gottesman, 1981). 	These interactions will be 
discussed in further detail later. 	However, it is presumed that 
some rho activity is required for cell viability as only partial 
rho mutants have been isolated to date. 
nusA •protein 
This is a 69,000 dalton, acidic protein and is the product of 
the nusA gene located at 68' on the E.coli chromosome (Greenblatt 
et al, 1981). 	It was initially defined genetically by a mutation 
affecting transcription termination in bacteriophage X (Friedman, 
1971) and is identical to the 'L-factor' require for -galactosidase 
synthesis in vitro (Kung et al, 1975; Greenblatt et al, 1980). 
Greenblatt has demonstrated the equimolar stoichiometric binding of nusA 
protein to Rpol core enzyme in vitro. 	pnusA does not bind to Rpol 
holoenzyme, and o is able to displace it from the 8'-c 2-nusA 
complex (Greenblatt and Li, 1981). 	Greenblatt proposes that pnusA 
associates with Rpol during elongation and that there are inter-
changeable, complementary forms of the enzyme as follows: 
nusA 
Cy 







Greenblatt has also demonstrated the binding of pnusA to the anti-
termination factor pN of X in vitro, but has been unable to show 
binding of N protein to Rpol in vitro (Greenblatt et al, 1980). 
Observations in vivo and in vitro suggest that pnusA serves to 
mediate the interaction of Rpol with termination and antitermination 
factors: (i) nusA mutations relieve polarity to some degree in vivo; 
(ii) they prevent the growth of bacteriophage X, as the products 
of both nusA and a further gene, nusB, are required for the phage N 
function to act (Ward and Gottesman, 1981). 	The requirement for 
nusA protein to permit N protein activity has also been demonstrated 
in vitro (Greenblatt et al, 1981), assayed as readthrough at the 
xt R1 and AtLI  terminators; (iii) nusA protein antitermination 
activity has been shown to be necessary for readthrough at the 
attenuator of the rpoBC operon in vitro (Barry et 21, 1979; 
Greenblatt et al, 1980); (iv) termination activity of nusA protein 
has been demonstrated at the bacteriophage At R2 terminator in vitro, 
where it causes Rpol to pause for 10-15 minutes, and at the 
terminator in vitro, where it confers specificity on the termination 
event. 	A full termination event requires the presence of rho 
protein (Platt, 1981). 
It can clearly be seen that Rpol is influenced by several 
accessory proteins, probably many more than have come to light so 
far. 	Indeed, as mentioned earlier, one of those described might 
justifiably be promoted to the ranks of Rpol subunits, namely pnusA. 
NUCLEOTIDE SEQUENCES INVOLVED IN TRANSCRIPTIONAL REGULATION 
An obvious place to regulate gene expression is at the primary 
level of interaction between Rpol and the DNA template. 	Two basic 
mechanisms exist to achieve this 	(i) variation of the nucleotide 
sequences involved, (ii) the use of other proteins to influence 
these interactions. 	In this section, sequences important in 
initiation and termination will be discussed with a bias towards 
the latter. 
Transcriptional units in E.coli are defined by specific 
nucleotide sequences involved in the initiation and termination of 
transcription. 	These have been the subject of major reviews by 
Gilbert (1976) and Rosenberg and Court (1979). 	Transcription 
termination has been discussed more specifically by other authors 
(Roberts, 1976; Adhya and Gottesman, 1978a; Platt, 1981; 
Yanofsky, 1981). 
A wide range of promoter sequences of varying efficiencies 
and cofactor dependencies have now been determined. 	Despite their 
functional differences, a degree of structural uniformity has 
emerged. 	The first of these is a relatively conserved 7 bp sequence 
centred about 10 bp upstream of the mRNA start-point (Pribnow, 1975; 
Schaller et al, 1975). 	The consensus sequence is TATPuATPu and has 
become known as the 'Pribnow Box' or -10 region. 	Promoters 
studied so far have at least 5 positions in agreement with this 
consensus sequence. 	Although I in the sixth position of the 
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heptamer is present in every case, other positions vary. 	Positions 
1, 2 and 6 are strongly conserved, the remaining four positions 
being only weakly so, with A and G favoured at positions 4 and 7 
respectively. 	The 6 bp immediately upstream of the heptamer are 
also conserved, but less stringently so. 	Here,the consensus 
suggested by sequence comparisons is ATTTGT, and its involvement in 
promoter function is supported by chemical modification contact 
studies (Rosenberg and Court, 1979). 	Hence, the conserved -10 
region clearly extends for some 13 bp and the extent to which 
particularly positions are conserved appears to vary widely. 
Sequence similarity is also notable in a region about 35 bp 
upstream of the mRNA start-point, known as the -35 or recognition 
region (Takanami et al, 1976). 	A highly conserved trinucleotide, 
JIG, occurs adjacent to and upstream of a less stringently conserved 
ACA sequence. 	This hexanucleotide occurs within a region of weaker 
homology resulting in a consensus sequence of TGTTGACA-TTT where 
positions 1, 2, 10,11 and 12 are only weakly conserved. 	Position 9 
has no tendency to be conserved. 	The -35 region is thought to be 
involved in the initial recognition of the promoter by Rpol 
(Schaller et al, 1975). 	DNA protection studies using mild DNAase I 
digestion of Rpol:promoter complexes (footprinting) indicate that 
the enzyme covers some 60-70 bp upstream of the mRNA initiation site 
(Schmitz and Galas, 1979). 	Further similar studies using chemical 
and physical DNA modifying agents suggested that Rpol interacts 
most strongly with the Pribnow box and the -35 regior emphasising 
their importance in promoter function (Siebenlist et al, 1980). 
Nucleotide sequences upstream of the -35 region are generally A/I 
rich, but show no other homologies. 
A further sequence homology might be expected between promoters 
13. 
regulated by cAMP-CAP complex. 	DNA binding and protection studies 
on three such promoter regions demonstrate that cAMP-CAP complex 
binds: 1) lac operon DNA at a symmetrical sequence lying -55 to 
-70 bp upstream of the mRNA start site (Majors, 1976b; Simpson, 1980), 
2) ara operon DNA at two sites, -78 to -107 bp and -121 to -146 bp 
upstream of the araBAD mRNA start site (Ogden et al, 1980), 3) 
operon DNA at a site -24 to -50 bp upstream of the P1 initiated mRNA 
start site (Taniguchi et 21, 1979; Galas and Schmitz, 1978). 	The 
gal promoter possesses an analogous sequence to the lac binding site 
but DNA from this region has been shown to be non-essential for 
cAMP-CAP dependent 	-transcription (Taniguchi et al, op.cit.). 
The araBAD promoter has no such homology around the -55 to -70 
region. 	A computer search of sequences around these binding sites 
reveals a consensus sequence, TGTCACACTTT, which may be important in 
cAMP-CAP binding. 	The ara and gal binding sites conform well to 
this sequence, but the lac binding site is less consistent 
(Tanaguchi et al, op.cit.). 
How can we reconcile the different locations of the binding 
sites observed? 	Clearly, the means by which cAMP-CAP influences 
Rpol at these sites may differ. 	For example, if we assume a 
cAMP-CAP-Rpol interaction, then in the gal operon the binding sites 
for these proteins are close enough for such contact to occur. On 
the other hand, in the ara operon, the binding sites are well 
separated and such contact would be unlikely to occur. 	Ogden et al 
(op.cit.) have proposed a model for ara by which cAMP-CAP binding 
could influence Rpol. 	This utilises the araC protein (inducer form, 
paraC md) as a "bridging" protein between Rpol initiating trans-
cription at the araBAD promoter and cAMP-CAP bound at -78 to -107 bp. 
They demonstrate the binding of paraC' 	to the region between 
14. 
cAMP-CAP and Rpol protected sequences and suggest the sequential 
binding of cAMP-CAP, paracmnd, and Rpol to enhance initiation at 
the araBAD promoter. 	Events at the lac promoter may be more 
complicated. 	The binding site here does not conform well to the 
consensus sequence and exhibits a dyad symmetry. 	Contact between 
cAMP-CAP, bound at -70 to -55, and Rpol has been suggested by 
Simpson (op.cit.) following his observations that cAMP-CAP protects 
DNA up to -47 bp and Rpol protects DNA down to -43 bp. 	However, 
there is evidence that cAMP-CAP binding may involve another region 
(-17 to -30) which overlaps a subset of the consensus sequence, 
ACACTTT (-28 to -34) (Dickson et 21, 1977). Co-operative binding 
of cAMP-CAP to these two regions may compensate for their deviation 
from the consensus sequence and allow direct contact between 
cAMP-CAP and Rpol. 
Alternatively, cAMP-CAP binding may destabilise the helix 
allowing Rpol to initiate transcription more easily. 	This has been 
called "telestability" and would remove the requirement for 
protein-protein interactions. 	McKay and Steitz (1981) proposed 
that cAMP-CAP may destabilise the promoter region by binding to a 
left-handed, B-DNA conformation. 	This predicts a reduction in the 
winding number of closed circular DNA following cAMP-CAP binding. 
However, Kolb and Buc (1982) attempted to measure this parameter at 
cAMP-CAP-bound lac and gal promoters on small covalently closed 
DNAs, but were unable to observe a reduction in winding. 	Finally, 
the reader is referred to the mini-review by Adhya and Garges (1982) 
for a more detailed discussion of how cAMP-CAP may act at these 
sequences. 
Mutant promoter sequences supplement information gained from 
wild-type sequence comparisons. 	Most promoter point mutations 
15. 
affect promoter function adversely (i.e. promoter down mutations) 
and cluster in either the -10 or -35 region. 	Of those in the 
-10 region, almost all occur within the three most highly conserved 
positions of the heptamer. 	Mutations which enhance the activity 
of promoters ("promoter up" mutations) are also concentrated in 
the -10 or -35 regions. 	These are generally found to increase 
homology to the consensus sequence (Rosenberg and Court, 1979). 
Termination essentially consists of three steps: the 
elongation process ceases; the RNA transcript is released; and 
the Rpol:DNA complex dissociates. 	The relative order of the last 
two steps is unclear but with T7 tecl in vitro, the given order 
appears to be correct (O'Hare, 1978). 
The growing number of terminator sequences characterised 
allows similar speculation concerning sequences important in the 
termination event. 	I have compiled a list of a number of these 
sequences (Fig. 1.3). 	Three common features become evident: 
1) a region of hyphenated dyad symmetry (i.e. an inverted repeat 
sequence) generally precedes the termination site, 2) the 3'-
terminus of the RNA transcript frequently contains a series of 
U-residues, 3) the region preceding the termination site is usually, 
but not invariably, G/C-rich. 	There is substantial variation 
among these terminators both in the length of the sequence repeated 
(i.e. stem length) and distance between the repeats (i.e. loop size). 
Termination generally occurs 20(±4) nucleotides downstream of the 
centre of dyad-symmetry, ending rarely at a unique residue, but 
rather "stuttering" over two or more adjacent nucleotides 
(Rosenberg and Court, 1979). 
These sites exhibit a wide range of overall efficiency (measured 
in different systems, and therefore possibly not simply comparable) 
Fig. 1.3 	Terminator sequences. 
The strand with the same nucleotide sequence as the messenger is 
indicated, 5' to 31 , left to right. 	The region of hyphenated 
dyad symmetry is underlined where present. 	The mark (') shown in 
some sequences indicates site(s) where termination has been shown 
to occur in vivo and/or in vitro. 
References for these sequences and mRNA endpoints are as follows: 
X65, in vitro and in vivo; Xoop, in vitro and in vivo; Xt R11 
in vitro and in vivo; 021 oop, in vitro; P22 oop, in vitro; 
080M3, in vivo; fd, in vitro; 0X174; G4; trp att, in vitro and 
in vivo; thratt, in vitro; his att, in vitro; .aatt, in vitro; 
SlO; 5-65, in vivo; tRNATyr, in vitro (see review by Rosenberg 
and Court, 1979); At L1 (Drahos and Sybaiski, 1981); xt, in vitro 
(Calva and Burgess, 1980); 17 ted, in vitro (Dunn and Studier, 
1980); ilvaE(Lawther and Hatfield, 1980); rpoBC att, in vivo (Barry 
et al, 1960); Ltrkt, in vitro and in vivo; !p.t',  in vitro and 
in vivo (Wu et al, 1981; Platt, 1981); 	2C att, in vitro (Jaurin 
et al, 1981). 
Fig. 	1.3 Phage Terminators 
x6S CGCAGGTAATAGTTAGAGCCTGCATAACGGTTTCGCGATTTTTTATATCT 
Aoop 





















hisatt - AACTCATGAGAAAGCCCCCCCAAGATCACCTTCCGflGGICTTTATATAAT 
pflatt CCAAGACTAACAATAAAEGCCTCCAAA1CGGGG1GCCTTTT]JATTGATA 












Si 0 	TCTCTCAATACGAATAAAGCJAGAAATAflCCGTTTATTTTTTCTAC 
5-6S 	TCAATATTTTAGFCGCFCCAGTCAGTAATGATTGGGGCCTTTTTA' 
Tyr 	 i 
tRNA - TTCAAAA1TCCCTGAACTCTCAAGCGAATCE1CAATCAAATATTCTflCCC 
4- 
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and of dependence or rho factor for termination. 	The structure 
of those that function efficiently in vitro in the absence of 
cofactors, and current thoughts on the termination process, led 
Farnham and Platt (1980) to propose a model for rho-independent 
termination. 	They propose that Rpol, in the absence of additional 
factors, requires both a hairpin structure and a 3'-terminal stretch 
of uridine residues in the transcript in order to terminate 
efficiently in vitro. 
The inverted-repeat sequence could be involved in base pairing 
in DNA, RNA or DNA:RNA structures. 	The former and the latter 
seem unlikely in the light of several observations: 
If CTP is replaced by lIP in the transcript of the tLrp attenuator, 
termination does not occur. 	I/C base pairs are weaker than 
0/C base pairs. 	This implicates the involvement of the 
transcript in the termination event (Lee and Yanofsky, 1977). 
Mutations in the 	-attenuator that decrease termination 
(CC to AT) could destabilise RNA: RNA or RNA:DNA structures 
(Stauffer et ml, 1978). 
Mutations in the trp attenuator (CC to CC) and At R1 (AT to CC) 
exist that decrease the efficiency of termination and should 
not disrupt RNA:DNA structures (Stauffer et ml, 1978; Rosenberg 
et al, 1978). 
Stem-loop formation in the transcript, therefore, seems to be 
a requirement for termination. 	Its contribution to the termination 
event may be revealed by indications that RNA hairpins elicit pausing 
by Rpol (Rosenberg et ml, 1978; Farnham and Platt, 1981). 	Pausing 
occurs at the XtR1  terminator (Rosenberg et ml, 1978), at two 
potential hairpin structures in the !-attenuator (Farnham and Platt, 
1981), and at the At R2 terminator in the presence of nusA protein 
4 
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(Greenblatt et al, 1981). 	The importance of the hairpin is 
emphasised by the large number of mutations affecting termination 
that are found to affect its sequence (Wulff, 1976; McDermit et al, 
1976; Rosenberg et al, 1978; Stauffer et al, 1978; Yanofsky, 1981; 
Hong eta]., 1971; 	Gardner, 1979). 
Whether or not RNA-release occurs following pausing may be 
determined by RNA:DNA interactions immediately following the hairpin. 
rtin and Tinoco (1980) suggest that a run of uridine residues down-
stream of the hairpin would facilitate dissociation of the transcript 
from the template, since a poly rU-dA hybrid of this type is 
particularly unstable. 	Should no such run of uridines be present, 
Rpol might merely resume elongation after a pause at the hairpin 
structure. 	Indeed, the deletion of the terminal 4 TA base pairs 
in the run of 8 present in the trp attenuator 	1419) abolishes 
termination in vitro and reduces it in vivo (Bertrand et al, 1977). 
However, termination does occur at this mutant sequence if a mutant 
(203) polymerase is used, which is presumably less demanding than 
wild-type enzyme regarding the number of uridine residues present 
(Farnham and Platt, 1980). 	Furthermore, the use of base analogues 
such as Br-UTP and allylamine-UTP which form stronger base pairs 
with A than does UTP, elevates readthrough at the ! -attenuator. 
The above observations suggest a mechanism for termination in 
the absence of other cofactors that involves both RNA:RNA and RNA:DNA 
pairing. 	Termination of transcription would depend positively on 
the rate of formation or stability of the RNA hairpin, and negatively on 
the stability of the distal rU:dA hybrid region. 	These ideas have 
been further supported by the study of synthetic, functional, 
termination sites possessing the two features discussed here (Platt, 
1981). 
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Examination of terminator sequences reveals a class that do 
not possess a series of uridine residues at the 3' end of the 
transcript. 	These terminators (AtRi, 	t', tRNATYr and xtRo) 
all exhibit an absolute dependence on rho factor for termination 
(Rosenberg etal, 1978; Platt, 1981; Upper et al, 1978; Calva 
and Burgess, 1980). 	This justifies their classification as fully 
rho-dependent terminators, the distinction between rho dependence 
and independence being a hazy one. 	[For example, rho does not 
affect the cessation of RNA elongation at the jj attenuator in vitro, 
but may stimulate the release of the leader transcript (Fuller and 
Platt, 1978). 	It may, therefore, merely enhance termination 
without increasing it.] 
The structure Of rho-dependent terminators is interesting, but 
somewhat confusing. 	A comparison of the XtRt 	
Tyr 
tRNA 	and 
terminators at the sequence level reveals: 1) a weak dyad symmetry 
preceding the termination point, 2) an A/I-rich sequence spanning 
the RNA terminus, 3) the common sequence CAATCAA in At RI and tRNATYF 
with the subset ATCAA in AtRO just preceding the stop site. 	Rho 
may act to confer instability at this site. 	Indeed, an unusual 
feature of the tRNATYr terminator is the triple repeat of a near 
identical 178 bp sequence (Upper et al, 1978). 	Termination 
in vitro occurs not in the first repeat but in the second and could 
potentially occur in the third. 	The base differences between these 
repeats may reveal important sequences for rho-dependent termination. 
The most likely important difference lies within the common sequence 
ATCAA mentioned earlier. 	The second and third repeats conform to 
this sequence whereas the first exhibits the sequence ATTAA. 	This 
C/T base change is the closest to the termination region and 
supports the suggestion that this sequence is important in rho-
dependent termination. 
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The 	t' sequence has none of these features, but is AlT-rich 
and causes heterologous termination over a stretch of 50 nucleotides 
in the presence of rho. 	Inclusion of nusA protein in this trans- 
cription reaction yields only one major RNA product suggesting a 
number of cofactors maybe required for termination here. 	The 
lack of similarity between LEt' and other transcription terminators 
may also suggest a distinct termination event at this site. Indeed, 
two functional termination sites exist at the end of the Lr2 operon: 
1) a weak rho-independent terminator with a dyad-symmetry, followed 
by a series of uridine residues, (t); 2) the above strong, 
rho-dependent terminator, 280 nucleotides downstream, (fl2t'). 
The 3' terminus of mRNA isolated in vivo exhibits a sequence corres- 
ponding to 1Mt (Wu and Platt, 1978). 	This could be the result of 
a rho-dependent interaction between the two terminators in vivo or 
termination at both sites followed by a processing of the longer 
transcript. 	If we can extend observations in vitro to the situation 
in vivo, then the former possibility seems unlikely. 	Wuetal (1981) 
have shown that when cloned individually next to the trp promoter, 
in vitro transcripts do not differ from those obtained with the 
terminators in tandem configuration. 	This would rule out an inter- 
action in vitro and presumably in vivo. 	Hence, the explanation of 
their behaviour and importance requires further study. 
Concluding this section, it should be emphasised that it is not, 
as yet, possible to recognise promoters or terminators merely from 
nucleotide sequence. 	Their existence and an estimation of their 
efficiencies requires the use of gene fusions utilising e.g. 
lac or trp genes to monitor their activities. 	Experimental results 
have implicated RNA:RNA and RNA:DNA interactions in the termination 
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event. 	Despite this, several questions remain to be answered: 
How does Rpol recognise the RNA hairpin presumably behind it? 
How does the hairpin promote pausing? 	3) Is this pausing 
involved in a mechanism for regulating the elongation rate of Rpol? 
4) Do ribosomes have an influence on this and/or other steps of 
termination? 	5) What is the significance of the multiple 
terminators at the ends of the fl 	
Tyr 
and tRNA 	operons? 6) How 
do rho-dependent and rho-independent termination differ? 7) How 
does commitment to RNA release arise, following pausing? 	8) Do 
other cofactors influence these events besides those discussed? 
The probing of molecular interactions between proteins involved 
in recognising transcription terminators and the sequences they 
recognise may provide some answers to the above questions. 	Mean- 
while, our ignorance is still great. 
TERMINATION AS A CONTROL MECHANISM FOR GENE EXPRESSION 
Efficient transcriptional termination is essential at the ends 
of operons to prevent transcriptional interference affecting 
expression of genetic information downstream. 	The terminators 
role in the transcription cycle has in the past, as its name 
implies, been confined purely to this. 	The discovery of terminators 
proximal to, within, and between coding sequences has led to a 
reappraisal of termination as an important means of controlling gene 
expression in E.coli. 	This section will discuss three instances 
of terminator-modulated transcription: 
Attenuation 
Early studies on the control of expression of the trp operon 
concentrated on the effects of the 47 kdal homodimer product of the 
unlinked trpfl gene, the aporepressor (Gunsalus et al, 1979). 	When 
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complexed with tryptophan, this prevents initiation at the trp 
promoter by binding to the overlapping operator site. 	But several 
early observations suggested that this was not the sole means of 
trp regulation: 1) tryptophanyl-tRNA synthetase mutants display 
regulatory anomalies; addition of tryptophan to these causes only 
partial repression of trp operon expression (Hiraga et al, 1967; 
Kano et al, 1968; Ito, 1972). 	2) the addition of tryptophan to 
Irp-starved cells inhibits transcriptional initiation and elongation 
in the early region of the operon (Imamoto, 1968). 	3) mutants 
lacking a functional repressor are still able to exhibit some 
degree of regulation over the 	-operon (Baker and Yanofsky, 1972; 
Morse and Morse, 1976). 	4) öertain 	2-deletions, contained 
wholly within the transcribed region, display an unexpected six-fold 
stimulation of the distal genes of the operon (Jackson and Yanofsky, 
1973; Bertrand et al, 1976). 	5) the first 140 nucleotides of the 
trp mRNA are more abundant than more distal segments, presumably due 
to "premature" termination of some transcripts (Bronson et al, 1973; 
Bertrand et al, 1976; Squires et al, 1976). 	These observations 
imply a complex mechanism of control for trp expression involving 
tryptophan, aporepressor, !E.-tRNA synthetase or its product, and 
a site of transcriptional discontinuity in the early region of 
the operon. 
The nucleotide sequence of the region proximal to the first 
structural gene (trpE) has several interesting features (Squires 
et al, 1976; Lee et al, 1978) (see Fig. 1.4). 	The 162 nucleotides 
lying between the 5'-end of the trp mRNA and the AUG of trpE are 
known as the leader transcript. 	It potentially encodes a 14 amino- 
acid peptide, with tandem tryptophan re9idues at positions 10 and 
11, and a UGA stop codon at +69 to +71. 	Between here and the end 
Fig. 1.4 
The nucleotide sequence of the 5'-end of jp messenger RNA and 
the proposed secondary structures in the trp leader transcript. 
The sequence shows: the boxed AUGs where translation starts and 
the boxed UGA where it stops; the predicted amino acid sequence 
of the jjtrp leader peptide; the 3'-terminus of the paused trans-
cript at nucleotide 90 (underlined); the 3'-terminus of the Lra 
leader transcript at nucleotide 140-141 (arrowed). 	Beneath this, 
the line diagram represents the trp leader transcript with the 
coordinates of regions of interest given as nucleotides from the 
mRNA start point. 	Inverted repeat sequences are represented by 
arrows and referred to as 1, 2, 3 and 4 for simplicity. 	To the 
right are shown the proposed secondary structures in the trp  
leader transcript together with their calculated free energies of 
formation (in Kcal mol ) (from Oxender et al, 1979). 
1 	 20 	 40 	 60 
p ppAAGU U CACGUAAAAAGGUUAUCGACAAA3CAAUUUUCGUACUGAAAGGUUGGUGGCGCAc1JUCJ 
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of the leader is a CC-rich region of dyad-symmetry (3:4, +114 to +121 
and +126 to +134) followed by a run of 8 TA base pairs (+134 to +141), 
similar to the rho-independent transcription terminators discussed 
earlier. 	Ribosomes bind tightly around the AUG of the potential 
14 amino-acid peptide (Platt et al, 1976) and although leader peptide 
synthesis in vivo has not been demonstrated, studies of fusions of 
the initial section of the fla leader directly to trpE have shown 
that translation can begin at this point in vivo (Miozzara and 
Yanofsky, 1978). 	Furthermore, the possible terminator functions 
in vitro and in vivo in the absence of rho. 	Transcription in vitro 
yields products ending with 7 or 8 U-residues at positions +140 and 
+141 (Lee and Yanofsky, 1977). 	Similarly, transcription in vivo 
produces transcripts ending in 4 to 8 U-residues, due to stopping 
between +137 and +141. 	At early times of transcription in vitro, 
some RNA products end at position +90, distal to a second possible 
dyad.-symmetry (1:2, +52 to +70 and +74 to +94). 	Kinetic studies 
indicate that this is not the result of a true termination event, 
but is caused by Rpol pausing at this point. 	The paused trans- 
cript resumes elongation to become the terminated leader transcript 
or the readthrough transcript (Yanofsky, 1981). 	A third, 
dyad-symmetry, is observed between the first two symmetries 
(2:3, +74 to +85 and +108 to +119). 	Formation of this hairpin 
would exclude the formation of both hairpins described earlier. 
Termination does not occur after this symmetry. 	Finally, a fourth 
possible RNA hairpin structure exists involving an early segment, 
containing the leader ribosome binding site, and a distal segment of 
the transcript. 	If this pairing were to occur it would exclude 
ribosome-binding and hence translation of the leader (Yanofsky, 1981). 
Free energy calculations suggest that all of the possible hairpins 
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are plausible. 	Moreover, assessment of leader RNA structure by 
hydrolysis with the structure-sensitive T1-RNAase indicate that at 
least the first three possible structures are involved in base 
pairing (Lee and Yanofsky, 1977; Oxender et al, 1979). 	Further- 
more, the importance of the 3:4 hairpin is emphasised by the 
properties of a number of deletions: 	one, whose promoter-proximal 
end-point is in the centre of the potential stem-loop, completely 
abolishes termination; one, which shortens the run of TA base pairs 
from B to 4, reduces termination efficiency (1419); and one, 
whose nearer end-point is 11 nucleotides beyond the normal RNA 
stop-site, has no detectable effect on termination (Bertrand et al, 1977). 
Efficient termination is observed in vitro, when translation 
is absent, or upon starvation for amino acids located early in the 
leader peptide. 	Similarly, a mutation (!L29)  which changes the 
leader region AUG initiated codon to AUA, reducing ribosome 
initiation, leads to increased termination in vivo as well as a 
reduced response to starvation (Zurawski et al, 1978). 	Furthermore, 
mutations in trpS, leading to defective charging of tRNATrP,  and 
tryptophan (or arginine) starvation lead to relief of termination 
at this site (Morse and Morse, 1976; Bertrand and Yanofsky, 1976; 
Zurawski et al, 1978), 	This suggests that charging of tRNATrP  is 
involved in trp operon expression although other mutants exist 
which suggest that defective tRNA-ribosome interactions are 
influential in this (Yanofsky and Soil, 1977). 	Nevertheless, these 
findings imply strongly that translational effects (clearly involving 
the leader peptide) are important in trp operon expression. 
Current thoughts on the events regulating flj operon expression 
are based on a model proposed by Oxender et al (1979). 	The mechanism 
has been designated "attenuation" and occurs when an Rpol molecule 
24. 
escapes repressor control at the trp promoter. 	Transcription of 
the leader region is accompanied by ribosome attachment at the 
leader polypeptide ribosome binding site. 	Transcription and trans- 
lation continue until Rpol reaches the first dyad-symmetry, pausing 
at position +90. 	This may allow the following ribosome to approach 
the polymerase molecule and so facilitate the synchronisation of 
ribosome with Rpol movement. 	When transcription resumes, the 
translating ribosome may stall at one of the adjacent tryptophan 
codons (if the cell is deficient in tryptophan), or move to the 
translation stop codon (if tryptophan is plentiful). 	The position 
of the ribosome on the transcript determines which alternative RNA 
secondary structure forms, and hence the decision to terminate 
or continue transcription. 	Stalling of the ribosome on the LrR- 
codons allows stem-loop 2:3 to form, excluding stem-loop 3:4 
formation, and allows Rpol to extend transcription into the trp 
structural genes. 	Termination of translation at the translation 
stop codon prevents stem-loop 2:3 formation, thus allowing stem-loop 
3:4 formation and so promoting transcriptional termination. 	Total 
absence of translation has a similar effect, allowing formation of 
stem-loops 1:2, and 3:4, the latter being essential for trans- 
cription termination. 	Whether termination occurs or not, the 
leader ribosome-binding site may be blocked by pairing with the 
distal transcript segment, which would prevent further (redundant) 
leader translation. 
This model explains the observation that starvation for 
arginine is also able to relieve trp attenuation in vivo (Zurawski 
et al, 1978), since stalling at the arg codon distal to the trp 
codons should allow stem-loop 2:3 formation as before. 	Similarly, 
mutations that relieve or enhance attenuation disrupt or promote 
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(respectively) the formation of stem-loop 3:4 (for review see 
Yanofsky, 1981). 	The exploitation of transcriptional termination 
and transcription-translation coupling provides an elegant control 
system for 	-operon expression. 	The effect of repression exerts 
the greatest quantitative effect in viva, reducing transcription 
by up to 70-fold, and responding to tryptophan levels exclusively. 
Attenuation, on the other hand, reduces transcription in vivo by 
up to 10-fold and is influenced by the activity of tryptophanyl-tRNA 
synthetase, the amount of tRNA 
Trp
, and the overall rate of protein 
synthesis. 	Tryptophan starvation affects both repression and 
attenuation and can, therefore, reduce transcription of the 
operon by up to 700-fold. 	The combined action of the two 
mechanisms allows E.coli to respond to both external and internal 
constraints relevant to expression of the 	-operon. 	Finally, 
several other amino-acid biosynthesis pathways in gram-negative 
bacteria utilise very similar mechanisms to regulate expression of 
relevant enzymes (e.g. his; thr; ile; 	j) (Yanofsky, 1981). 
Antiterrnination 
Transcriptional termination has a major influence on the 
regulation of expression of the bacteriophage x genome (Hershey, 
1971; Roberts, 1976; Das et al, 1976). 	Following phaqe 
infection, the host Rpol transcribes the "early" genes of X 
initiating transcription of two major promoters, P L and P R' within 
the immunity region (see Fig. 1.1). 	Leftward and rightward 
transcription is limited by rho-dependent transcription terminators, 
tLl 	and t R11 flanking the immunity region. 	N is the first gene of 
the major leftward operon (transcribed from 	and its product, 
N protein, is required to antagonise termination at tLl  and  tRi  and, 
hence, to permit efficient transcription of distal genes (Taylor 
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et al, 1967; Salstrom and Sybalski, 1978a). 
Readthrough is also stimulated at the AtL2 termination site, 
which is apparently rho-independent, thus pN is truly an anti-
termination factor and not merely an anti-rho factor (Gottesman 
et al, 1978). 	This antitermination is phage specific (the N-gene 
product of the lambda-like phage 21 will not complement XN-mutants), 
suggesting a specific interaction with site(s) on the phage genome 
(Friedman et al, 1973). 	Deletions have defined such sites to the 
left of P (nut L, for N-utilisation) and to the right of the cro 
gene (nut R) (Adhya et al, 1974; Salstrom and Szybalski, 1976). 
Furthermore, the nucleotide sequences of these regions reveal two 
sites of near identical two-fold rotational symmetry (16 of 17 bp) 
appropriately positioned to be nutL and nutR. 	The occurrence of 
nutL mutations within this 17 bp sequence suggests that these two 
sequences are indeed involved in N protein activity (Rosenberg et al, 
1978; Salstrom and Szybalski, 1978b) . 	Interestingly, these sites 
exhibit a potential for hairpin formation and possess distal sequences 
similar to the CAATCAA noted in some rho-dependent terminators. 
Transcription termination does not appear to occur here, but the 
stem-loop might be involved in Rpol pausing to facilitate pN-Rpol 
interaction (assuming that pausing is a general effect of hairpin 
structures). The antitermination effect of pN can be observed at 
nearly all terminators downstream of a nut site. 	This has been 
demonstrated, for example, at trpt in A/np fusions, and by 
suppression of a variety of polar mutations (Segawa and Imamoto, 
1976; Adhya et al, 1974). 
Evidence for an N protein-Rpol interaction comes from the 
observations of Greenblatt and suggests a mechanism by which this 
may occur. 	The interactions he has shown between nusA protein, 
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Rpol, and N protein (discussed earlier) suggest that nusA protein 
may mediate binding of N protein to Rpol, thereby creating the 
transcriptional juggernaut proposed by Adhya (1974). 	This 
suggestion is supported by the demonstration that the products of 
the nusA and nusB genes are required for phage N function to act 
in viva (Ward and Gottesman, 1981). 	Should this be the case, we 
can speculate that pnusA may act in a similar way to bind other 
cofactors to Rpol, e.g. rho (as discussed earlier) and other 
undiscovered cofactors. 
N protein also stimulates transcription from P and P 2-4 fold 
(Hu etal, 1979; Hu and Szybalski, 1979) and from other promoters 
derived from both X and pBR322 (Drahos and Szybalski, 1981). 	This 
has yet to be demonstrated to be a general effect of N protein and 
its mechanism is obscure. 
Drahos and Szybalski (1981) have investigated the nucleotide 
sequences involved in pN action by studying each module separately 
and in various combinations. 	They have utilised the galK-fusion 
system for monitoring transcription signals developed by McKenney 
et al (to be described later in this thesis) to examine the 
relationship between their structure and function. 	They demonstrate: 
1) the termination activity of At L1, galactokinase activity being 
reduced by 80%; 2) N protein stimulation of transcription from 
(pBR322) and PR'  (x); 3) a 25 bp sequence carrying the 17 bp 
dyad-symmetry termed nutL restores 60% of pN-stimulated transcription 
if inserted in the correct orientation. 	Such antitermination will 
only occur at terminators downstream of a correctly orientated nutL 
sequence and no effect on transcription is observed in the absence 
of pN-function. 	The overall results strongly support the proposal 
that the 17 bp dyad-symmetry constitutes a site required for pN 
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activity and clearly demonstrate the interactions between various 
components of the A antitermination system. 
Nevertheless, the mechanism of pN-mediated antitermination 
remains open to speculation. 	Adhya and Gottesman (1978a) proposed 
a number of mechanisms for pN action, variations of these are: 
1) pN interacts with Rpol (possibly via pnusA and pnusB) producing 
a conformational change in the polymerase such as to disfavour 
termination. 2) pN may interact with Rpol as above, but mediate 
antitermination by antagonising ribosome dischar ge at stop codons 
in such a way that rho can no longer gain access to Rpol (via 
nascent RNA) to catalyse termination. 	The ability of pN to 
antagonise termination even at rho-independent sites (e.g. At L2) 
would require further explanation. 	We can speculate, for example, 
that undischarged ribosomes might prevent formation or function of 
RNA stem-loops required for termination. 	3) pN may affect the 
structure of nascent RNA directly so as to prevent termination. 
Evidence supporting the involvement of ribosomes in antitermination 
comes from the observation that some ribosomal protein mutants 
affect N protein function (Friedman et al, 1981). 	Such mutations 
lie in the nusE gene which codes for the ribosomal protein 510. 
Friedman et al have suggested that pN prevents transcription 
termination by coupling Rpol to the ribosome. 	Alternatively they 
suggest 510 may have an indirect role in antitermination by regulating 
the synthesis of a protein that is directly involved e.g. pnusA, 
pnusB or pN. 	However, the observation that N protein appears to 
function in the absence of ribosomes in vitro argues against their 
involvement in the antitermination event (Ishii et 21, 1980). 
The available evidence does not exclude any of these suggestions. 
The affinities of Rpol, pnusA, and pN for each other do, however, 
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suggest the formation of a tripartite complex and a continuous 
association during subsequent transcriptional activities. 	At all 
events, the balance between termination and antitermination by pN 
plays a subtle and evidently important role in the regulation of 
X gene expression. 
Polarity 
The final means by which termination affects gene expression 
to be discussed is the phenomenon of polarity. 	Some mutations in 
structural genes affect not only the product of the mutated gene, 
but also reduce or abolish the expression of other, distal genes 
within the same operon (Jacob and Monad, 1962). 	Such mutations are 
of two types: 1) the generation of an in-phase nonsense codon by 
point mutation, insertion, or deletion of DNA (nonsense polarity); 
2) the insertion/deletion of DNA creating a new translation frame 
with a stop codon either within an insertion, or distal to the 
site of mutation (frame-shift polarity). 	Translation will cease 
at the newly created site, in the absence of nonsense suppressors, 
and RNA sequences distal to it will not be translated, unless 
reinitiation of translation occurs (Platt et al, 1972). 
Adhya and Gottesman (1978b) proposed a model to account for 
polarity based on two major features: there are cryptic rho-
dependent transcription terminators within operans; and these sites 
are immune to rho-activity whilst the nascent mRNA is being trans- 
lated. 	The model requires a tight coupling of transcription and 
translation and is supported by the existence of secondary mutations 
that relieve polarity without restoring translation of the mutant 
gene (Morse and Primakoff, 1970). 	Several such mutations have been 
shown to affect the termination factor rho, suggesting that 
rho-dependent transcriptional termination is involved in polarity 
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(Richardson et al, 1975 ; Korn and Yanofsky, 1976; Ratner, 1976b). 
Polarity relief by many different rho mutants also suggests that 
mRNA degradation does not play a major role as this should be 
unaffected by defective rho. 	Furthermore, the demonstration of 
rho-dependent terminators within the trp, lac and gal operons and 
the Acro gene provides evidence for the existence of termination 
sites required by the model. 	Similarly, the relief of polarity 
by pN-mediated antitermination supports the suggestion that polarity 
is primarily due to premature termination of transcription (Adhya 
et al, 1974; Franklin, 1974). 
Their model proposes that when an operon is being expressed, 
the nascent mRNA is normally covered with ribosomes. 	Potential 
rho-dependent transcription termination sites may be present within 
the nascent mRNA, but are prevented from functioning because rho 
cannot gain access to the RNA. 	Creation of a nonsense codon within 
the transcript leads to loss of ribosomes and exposure of distal 
mRNA. 	Rho attaches to the latter transcript, possibly at preferred 
sites, and by "diffusing" along the chain,it contacts an Rpol 
molecule paused at the next potential rho-dependent terminator. 
Rho subsequently induces termination here, leading to release of the 
mRNA chain and dissociation of the Rpol molecule. 	In the light 	of 
present knowledge we might extend this model to permit rho-independent 
termination sites a potential role in polarity: ribosomes may 
prevent stem-loop formation in the nascent mRNA and so oppose rho-
independent termination and possibly even pausing. 
Polarity can prevent the wasteful synthesis of large regions 
of untranslatable mRNA, or the expression of distal gene products 
which are often useless in the absence of the mutated gene product. 
Thus, there may be a selective pressure for the retention of cryptic 
transcription terminators within genes. 
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A SUMMARY OF THE TRANSCRIPTIONAL BEHAVIOUR OF COLIPHAGE T7 
The original aim of these studies required the cloning of a 
fully rho-independent terminator for E.coli RNA polymerase, from 
the genome of bacteriophage 17. 	This parasite of E.coli has been 
well studied genetically and biochemically (for reviews see Studier, 
1972; Hausmann, 1976; Studier et al, 1979; KrUger and 
Schr8der. 1981). In the following section1l shall summarise what 
is known about the transcriptional properties of coliphage T7. 
Coliphage T7 
17 has a genome of linear, double-stranded DNA which is not 
circularly permuted (Studier, 1972) but has a 160 bp direct-repeat 
at each end (Dunn and Studier, 1981). 	The genome comprises some 
40,000 bp (McDonell et al, 1977; Dunn and Studier, 1981) and 
codes for about 30 identified gene products, 20 of which are known 
to be essential for laboratory growth on a wild-type host 
(Studier, 1972). 	Some 15 additional, putative genes have been 
identified solely by nucleotide sequencing of the genome (Boothroyd 
and Hayward, 1979; Dunn and Studier, 1981; Dunn and Studier, 1982). 
Identified genes of T7 are conventionally numbered according to 
their relative positions on the 17 genetic map, those more recently 
discovered being given decimal numbers to indicate their relative 
positions. 	Co-ordinates of regions of interest may be expressed in 
base pairs or, more usually, 11T7 units", each of which is 400 bp 
(1% of genome). 
The genome is genetically segregated into an early region and 
a late region. 	The early region is defined by three strong 
promoters for E.coli RNA polymerase between 1.25% and 1.88% and 
a transcriptional termination site for E.coli RNA polymerase at 18.89%. 
Nine genes, numbered from 0.3 to 1.3, have been mapped within this 
Fig. 1.5 	Simplified genetic map of the 17 genome. 
The major coding sequences in the "early" region are indicated 
by boxes, with the relevant gene number above each box. 	Trans- 
cription and protein products are indicated below the line. 	The 
transcriptional signals defining the "early" region (promoters 
A1, A2 and A3; terminator ted) are indicated above the line. 
The open arrow indicates the direction of transcription from 
Al l A2 and A3. 	The "late" region is also boxed. 	The collective 
function of each group of genes is recorded within the relevant 
box. 
AAA 	 ted
_ LATE TRANSCRIPTION (PHAGE RNA POLYMERASE) M 
RNaselltcteavage sites 
I 	 I 	 I 	 Major Early mAs 
'If 	 if 	 If 	if 
Anti-Host Protein 	RNA DNA 	Protein Prodicts 
Restriction Kinase POLYMERASE 	L IGASE 
Fig 15 
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region and are involved in early stages of infection (Studier et al, 
1979). 	The late region overlaps the early region somewhat and 	is 
transcribed by a 17 encoded RNA polymerase. 	It can be further 
sub-divided on the basis of the time-course of gene expression into 
the Class II genes, which generally specify proteins involved in 
DNA metabolism, and the Class III genes, which generally specify 
proteins involved in DNA maturation, and structural proteins of the 
phage particle (Studier, 1972). 
The nucleotide sequence of the phage genome has revealed a 
number of interesting features including: the structure of the 
three promoters for E.coli Rpol at the start of the early region 
(Siebenlist, 1979); the structure of the E.coli Rpol-terminator at 
the end of the early region (Dunn and Studier, 1980); the structure 
of ribonuclease III targets within the early region (Robertson 
et al, 1977; Rosenberg and Kramer, 1977; McConnell, 1979; Oakley 
and Coleman, 1977; Dunn and Studier, 1981); the structure of a 
number of promoters for the phage specified 17 Rpol (Rosa, 1979; 
Oakley and Coleman, 1977; Boothroyd and Hayward, 1979; Panayotatos 
and Wells, 1979; Dunn and Studier, 1981); and the structure of 
the primary origin of DNA replication (Saito et al, 1980). 	The 
lack of any real sequence homology between promoters for E.coli Rpol 
and 17 Rpol fits the observation that each polymerase recognises 
and interacts only with its own promoters. 	Despite the similar 
activities of the two proteins, the only similarity between the 
sites they recognise is a general A/I-richness upstream of the mRNA 
start site. 	Sequence information also reveals that 17 DNA is 
remarkably efficient as a carrier of coding information for proteins. 
The coding sequences are interrupted by only small stretches of 
untranslated nucleotides, many of which contain some other type of 
33. 
genetic signal. 	It is noteworthy that these regions include 
promoters for both polymerases, the early region terminator and the 
origin of replication. 	Perhaps translation of RNA from these 
regions would interfere with their activities. 	Where no such 
interruptions occur, junctions between genes are typically close; 
often the termination codon for one protein overlaps the initiation 
codon for the following protein or the coding sequences actually 
overlap by several nucleotides. 	However, extensive overlapping of 
genes in different reading frames has not been observed in 17. 
Class I gene expression 
These genes are located within the "early region", and are 
transcribed from about 0 to 8 minutes after infection at 30°C 
(McAllister and Wu, 1978). 	Their products are collectively 
involved in neutralising the host's defence system and in directing 
the cell's activities towards the expression of 17 genes. 
Purified E.coli Rpol initiates transcription of T7 DNA 
preferentially at three closely associated promoters, designated 
A19  A2 and A3, at map positions 1.25%, 1.576 and 1.8890' (Stahl and 
Chamberlin, 1977; Siebenlist, 1979; Dunn and Studier, 1981). With 
high Rpol:17 DNA ratios, polymerase molecules will also bind to 
four other sites on the genome (Stahl and Chamberlin, 1977; Koller 
et al, 1978; Delius et al, 1973). 	Designated minor promoters 
A0 or D (0.6%)9 B (3.76), C (7.70') and E (92.1%), transcription can 
be initiated at these sites under certain conditions in vitro (Stahl 
and Chamberlin, 1977; McConnell, 1979a). 	The physiological 
importance of these sites has yet to be established. 
Transcription proceeds from left to right using only the 
r-strand as template (except for A 
0 
 ) and terminates with up to 95% 
efficiency at the 18.89% terminator, designated ted (Millette 
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et al, 1970; Peters and Hayward, 1974; O'Hare, 1978). 	Termination 
is rho-independent and 
2/3 
 of the transcripts end with a C-residue, 
the remaining 
1/3 
 terminating at the subsequent G-residue (Dunn 
and Studier, 1980). 	McConnell has shown that, in the event of 
initiation at the C promoter in vitro, rho-independent termination 
can occur at two or more sites before the start of the gene I 
coding region (1979b). 	The resulting major polycistronic trans- 
cript can be cleaved by purified ribonuclease III, mimicking the 
in vivo situation, to yield five independent mRNAs and at least 
four short untranslated species (Rosenberg et al, 1974; Robertson 
et al. 1977). 	Both the independent mRNAs and the polycistronic 
transcript can be translated, with much the same efficiency, to 
yield 17 early proteins. 	The one exception to this is that 
translation of 0.3-coding region is much reduced in the unprocessed 
transcript. 	This could reflect secondary structural effects on 
initiation of translation due to the extra RNA in the message 
(Steitz and Bryan, 1977). 
Transcription in vivo is apparently very similar to that 
in vitro. 	Initiation occurs almost exclusively at the A promoters 
(Studier, 1972), although initiation within the "early region" has 
been reported (Minkley and Pribnow, 1973; Pfennig-Yeh et al, 1978), 
and proceeds from left to right. 	In a wild-type host, 50-75% of 
transcripts will terminate at a site between the 0.4 and 0.7 genes 
yielding excess of 0.3/0.4 gene mRNA after infection (Hercules et al, 
1976; Pfennig-Yeh et al, 1978). 	Of the transcripts that extend 
beyond here, a further 50% terminate at a site between genes 0.7 and 
1 (Hercules et al, 1976). 	The remaining transcription complexes 
proceed to the end of the operon and terminate at ted, after gene 
1.3 (Studier, 1972). 	The efficiency of termination at this site 
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is at least 75% (McAllister and Barrett, 1977). 	Rho mutations do 
not affect this (Kiefer et al, 1977). 
The only class I gene products essential for growth on a 
wild-type host are those of genes 0.3 and 1. 	The latter is a single 
polypeptide, T7-specific-Rpol which is responsible for transcription 
of the class II and class III genes. 	The 0.3 gene codes for a 
protein (MW 14,000) involved in overcoming the host's restriction 
system (Studier, 1975). 	The 0.7 gene codes for a protein kinase 
(MW © 36,000) which apparently phosphorylates the host Rpol (Zillig 
et al, 1975). 	Phenotypically, this gene is required for rapid 
shut-off of early gene expression (McAllister and Barrett, 1977b). 
However, shut-off does occur after some delay in T7 0.7 mutants, 
evidently as a result of gene 2 product activity (Hesselbach and 
Nakada, 1977). 	The mechanism of shut-off remains obscure but is 
presumably a phosphorylation of the E.coli Rpol and/or direct binding 
and inhibition of Rpol by the gene 2 product (Hesselbach and 
Nakada, 1977). 
The 1.3 gene codes for a non-essential DNA ligase which is 
probably involved in DNA synthesis and metabolism (Studier, 1972); 
17 1.3 strains are effectively complemented by the host. 	Not 
surprisingly, in view of its function it is expressed in class II 
as well as class I (Oakley and Coleman, 1977). 
Class II and Class III gene expression 
The class II gene products are responsible for T7 DNA metabolism 
and host DNA degradation (Studier, 1972). 	Transcription of these 
genes occurs from about 4 to 12 minutes after infection at 30°C 
(McAllister and Wu, 1978). 	The class III genes code for structural, 
assembly and DNA-maturation functions (Studier, 1972). 	These genes 
are transcribed from about 8 minutes after infection until the time 
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of lysis. 	The delay in their initiation is part of a general pattern 
almost certainly arising from a phased injection of the phage DNA. 
The known promoters for 17 Rpol can be divided into two classes, which 
correspond to the two classes of T7 late proteins. 	The nucleotide 
sequences around the RNA start sites for five class II and five 
class III proteins have been determined (Oakley and Coleman, 1977; 
Rosa, 1979; Panayotatos and Wells, 1979; Boothroyd and Hayward, 
1979). 	The five class III promoters exhibit a 23 base pair 
continuous homology that includes the RNA start site, plus other 
strong homologies. 	The sequences of the five class II promoters 
are highly homologous with the 23-base pair class III homology, but 
each diverges from it in at least 2 and as many as 5 positions. The 
switch from class II to class III gene expression is not understood 
but is presumably influenced by these sequence differences and is 
apparently dependent on the 3.5 gene product (McAllister and Wu, 1978), 
N-acetylmuramyl-L-alanine amidase known as 17 lysozyme (Inouye et al, 
1973). 	This product is not, however, required for ultimate lysis 
of the infected cell. 
Transcription of both classes of genes initiates at several 
promoters, that of class II terminating mostly at a site near 
position 6190' whilst that of class III proceeds to the right-hand 
end of the genome. 	The distribution of promoters is such that the 
region from gene 8 through gene 10 is expressed from both class II 
and class III promoters. 
The Present Study 
I will describe the cloning of a number of T7 fragments thought 
to contain transcription terminators including one which I have 
discovered (in leftward orientation) in the late region. 	Fusion of 
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these fragments in vitro to galK has permitted the measurement of 
their efficiencies in a defined system in vivo, for comparison 
with earlier estimates. 	The sequence of the new transcription 
terminator is also presented. 
These constructions should facilitate the future isolation 
and study of mutant terminator sequences generated in vitro 
in an attempt to clarify the termination event further. 
CHAPTER 2 - MATERIALS AND METHODS 
1. Growth Media 
L-broth contained, per litre: Difco Bacto Tryptone, lOg; 
Bacto Yeast Extract, 5g; NaCl, 5g; adjusted to pH 7.2. 
L-agar contained, in addition: NaCl, 5g; Difco agar, 15 g. 
BBL-agar contained, per litre: Baltimore Biological 
Laboratories trypticase, log; NaCl, 5g; Difco agar, 10 g. 
BBL top-layer is BBL-agar with only 6.5 g Difco agar per litre. 
Bacterial buffer contained, per litre: KH2PO4, 3 g; 
Na2HPO4, 7 g; NaC1, 4 g; MgSO4.7 H20, 0.2 g. 
Phage buffer contained, per litre: KH2PO4, 3 g; 
Na2HPO4, 7 g; N2C1, 5 g; 0.1 M MgSO4, 10 ml; 0.01 M CaCl2, 10 ml; 
1% (w/v) gelatin, 1 ml. 
Spizizen minimal medium contained, per litre: (NH4)2SO4, 2 g; 
K2HPO4, 14 g; KH2PO4, 6 g; Trisodium Citrate Dihydrate, 1 g; 
MgSO4.7 H20, 0.2 g; Final concentrations of supplements were: 
Sugars or glycerol, 0.2% (w/v); amino acids, 20 pg/mi; vitamin B1, 
2 pg/mi; acid casein hydrolysate, 0.1% (w/v). 	Spizizen minimal 
agar contain, in addition: Difco agar, 15 g. 
MacConkey agar contained, per litre: Bacto-Peptone, 17 g; 
Difco Protease Peptone, 3 g; 	Bacto Bile Salts No. 3, 1.5 g; 
NaCl, 5 g; Bacto-Agar, 13.5 g; Bacto Neutral Red, 0.03 g; 
Bacto Crystal Violet, 0.001 g; Carbohydrate source, 10 g. 
Galactose-Tetrazolium indicator plates contained, per litre: 
as for L-agar and in addition: Galactose, 0.8%; Tetrazolium, 0.02 g. 
Antibiotics were used at the following concentrations: 
Ampicillin 	 50 pg/mi 
Tetracycline 	 25 jig/ml 
Chloramphenicoi base 100 pg/mi 
TABLE 2.1 	Bacterial Strains 
Strain 	 Genotype 	 Donor 
C600 	 lac leu thi thr tonA supE 	N.E. Murray 
AA125 	 -uvrB) 6(lacZ)M15 (trpED)N.E. Murray 
102 lacI3 his tonA tsx 
MG1000 	 (araAB0IC-leu)7697 z(lacIZY) M. Casadaban 
X74 araD139 galU galK strA 
ED8654 	 metB galK2 galT1 lacY hsdM 	N.E. Murray 
hsclR supE supF 
Escherichia coli B 	Prototroph 	 F.W. Studier 
N100 	 galK2 recA13 	 K. McKenney 
JM1O1 	 (lac 	2) thi strA endA 	K. Murray 
sbcB115 supE/F'traD36 proAB 
lac I+ lacM15 
TABLE 2.2 	Phage Strains 
Strain 	 Genotype 	 Donor 
T7 	 wild type 	 F.W. Studier 
0 
NMx590 	 b538 irnm434 shn6 
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2. 	Phage Techniques (A and T7.) 
Plating cells: A fresh overnight bacterial culture was diluted 
20-fold in L-broth and grown with aeration at 370 C. 	When a 
concentration of 2-5 x i08 cells/ml was reached, the cells were 
pelleted and resuspended in an equal volume of 10 mM MgSO4. 	The 
suspension was stored for up to 7 days at 4 C. 
Titrations: Phage suspensions were serially diluted in phage 
buffer. 	0.1 ml of each dilution was mixed with either 0.2 ml of 
a suitable indicator strain (plating cell preparation) for A, or 
0.2 ml of a fresh overnight culture for 17. 	Each infection was 
mixed with 3 ml BBL Top-agar (at 46C) containing 10 mM MgSO4, not 
necessary for T7, and poured onto a BBL plate. 	Plaques were scored 
after 12-18 hours incubation at 37°C for A, or 4-8 hours for T7. 
Vortex-mixing was never used for infections or dilutions. 
Plate lysates: Single plaques were picked into 1 ml phage 
of 
/ 	 6 
buffer plus 1 drop/chloroform. 	For A, 10 pfu were mixed with 0.2 ml 
plating cells and 3 ml BBL Top-agar (at 46°C) containing 10 mM Mq504, 
and poured onto a fresh wet L plate. 	T7 was treated similarly but 
using 	pfu per 0.2 mis of a fresh overnight culture. 	Plates 
were incubated at 37°C until confluent lysis was achieved; 5 ml 
[-broth were then added and the plates refrigerated overnight. Aroth 
and top-layer were removed using a bent pasteur pipette, and shaken 
gently with a few drops of chloroform. 	The suspension was 
clarified in a bench top centrifuge at 5,000 rpm, 20°C for 10 mm, 
and finally titrated. 	Titres were in the range 5 x 10 
8_ 
 10  
11
pfu/ml. 
Liquid lysates: (Procedures are described for a 100 ml culture, 
but may easily be scaled up.) 	A fresh overnight culture was 
diluted 50-fold in L-broth supplemented with 10 mM MgSO4, and grown 
at 37°C, with aeration, to 00650  0.45 (2 x 108 cells/ml). 	Phage 
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were then added with a moi of 1, and the 0D650 followed until it 
reached a minimum. 	Chloroform (0.2 ml) and NaCl (3 g) were then 
added, shaking continued at 37°C for 10 min and the lysate stood at 
4°C for 60 mm. 	The lysate was then cleared at 5,000 g, 4°C, 15 mm, 
titrated, and stored at 4°C with 0.2 ml chloroform/ml. 	Concentration 
of phage, for DNA preparation, was achieved as described in 2e and 2f. 
Concentration of phage by Ultracentrifugation: Phage were 
harvested from clarified lysates by ultracentrifugation for 3 hours 
at 50,000 q, 4°C. 	The resulting pellets were resuspended in 
0.05 vols phage buffer by gentle rotary shaking overnight at 4°C. 
Residual debris was removed by a further clarification at 10,000 g, 
4°C, 15 min and the supernatant treated at 20°C for 1-3 hours 
with RNAase A and DNAase I (10 pg/ml of each). 	Nuclease treatment 
is not necessary for T7 preparations. 
CsC1 gradient centrifugation: Phage concentrated in the above 
way were further purified for DNA preparation by one of two 
procedures. If DNA was required for restriction analysis only, the 
phage sample (10h1  pfu) was overlaid onto a CsC1 step-gradient. 
The gradient was prepared in 14 ml polycarbonate centrifuge tubes 
using 1.5 ml steps of preclarified CsCl solutions of densities 1.3, 
1.5 and 1.7 g/ml. 	The least dense solution was added first and 
the denser solutions underlaid using a syringe and 21 gauge hypodermic 
needle. 	The gradients were run at 33,000 rpm for two hours at 
20°C in a 6 x 14 ml MSE Titanium swing-out rotor. 	Gradients 
typically showed three bluish bands, the middle of which contained 
intact phage. 	This was collected by side-puncture of the tube 
below the band with a 25 gauge needle. 	Phage required for storage 
were also prepared in this way and kept at 4°C. 	If DNA was 
required for cloning purposes, samples were further purified 
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subsequent to the above procedure by CsC1 equilibrium centrifugation. 
The collected band was mixed with 41.500' (w/w) preclarified CsC1 
solution. 	The gradients were run in 13 ml polyallomer "quick-seal" 
tubes (Beckman) using a Spinco 50Ti rotor (48 hours, 38,000 rpm, 
200C). 	The single phage band was recovered as above. 
Phenol extraction of phage DNA: 	Phage collected from CsC1 
step-gradients or equilibrium gradients were dialysed for 1 hour 
against TE buffer (10 mM Tris-HC1 (pH 7.8), 1 mM EDTA) at 4°C to 
remove CsC1. 	The dialysate was extracted four times with an equal 
volume of freshly-distilled phenol (pre-equilibrated against 
0.5 M Tris-HC1 (pH 8.0)) at 20°C. 	Phases were separated by 
lowspeed centrifugation and the upper DNA-phase removed, keeping 
well clear of the interface. 	Residual phenol was removed from 
the extracted material by extensive dialysis ( 60 hours) against 
8 changes of TE buffer at 4°C. 	The first buffer batch contained 
0.3 M NaCl., 	DNA. concentrations and purity were estimated by 
measuring the absorbance at 260 nM, 280 nM and 320 nM. 	Phage 
suspensions greater than 10 
13 
 pfu ml were diluted before phenol 
treatment, to avoid inefficient protein extraction. 
Preparation of X-phage DNA from plate lysates (Cameron et al, 1977): 
10  
pfu derived from a single plaque were mixed with 0.2 ml plating 
cells and 3 ml BBL-agarose (10 mM MgSO4) at 46°C, and poured onto 
a wet L-agarose plate (use of unpurified agar results in poor 
restriction). 	After incubation at 37°C until lysis was confluent 
(5-8 hours), 5 ml of 10 mM Tris-HCJ (pH 7.5), 10 mM EDTA were added 
and the plate left overnight at 4°C. 	To 4 ml of the supernatant 
were added 0.4 ml 0.5 M EDTA, 0.2 ml 2 M Tris base, 0.2 ml 10% (w/v) 
SDS, and 10 il Diethylpyrocarbonate (sigma). 	The mixture was 
heated at 65°C for 30 min in open tubes in the fume cupboard, and 
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then chilled on ice. 	1 ml 5 M potassium acetate (unbuffered) 
was added, and the solution left on ice for 1 hour before centri- 
fugation (27,000 g, 10 min,40C). 	The clear supernatant was 
decanted, mixed with 11 ml ethanol in a siliconised Corex tube, 
and left overnight at -20°C (or for 30 min at -700C). 	Nucleic 
acids were pelleted (12,000 g x, 30 mm, 4°C) washed with cold 80% 
ethanol, dried in a vacuum desicator, and finally dissolved in 
200 pl sterile TE buffer. 
3. 	Plasmid Techniques 
a) 	Small scale plasmid DNA preparations for screening purposes 
(Birnboim and Doly, 1979): 1.5 ml of an overnight culture in L-broth 
plus antibiotic were centrifuged (2 mm, 4°C) in a 1.5 ml "microfuge" 
snapcap tube using a Quickfit Micro-centrifuge. 	The cells were 
washed in 1 ml TE buffer, pelleted, and resuspended in 0.1 ml 
"Lysis" solution (2 mg/ml Lysozyme, 25 mM Tris-HC1 (pH 8.0), 
10 mM EDTA (pH 8.0), 50 mM Glucose). 	After 10 min on ice, 0.2 ml 
"Alkaline SDS" solution (0.2 M NaOH, 1% (w/v) SDS) was added and the 
mixture left on ice for a further 10 mm, with occasional inversion. 
A further 0.15 ml of "High Salt" solution (3 M CH3CODNa (pH 5.0)) 
was added, and the tube was thoroughly mixed by inversion and left 
on ice for a further 30 mm. 	The resulting heavy white precipitate 
was pelleted by centrifugation for 6 min at 4°C and the supernatant 
transferred to a new sterile microfuge tube together with 1 ml of 
ethanol. 	The tube was mixed by inversion and placed at -70°C for 
30 min to precipitate nucleic acids. 	These were then pelleted 
(3 mm, 4°C, Quickfit-Microcentrifuge), resuspended in 0.05 ml 
0.3 M CH3COONa (pH 5.0) and reprecipitated by the addition of 0.125 ml 
of ethanol and incubation at -70°C for a further 30 mm. 	Nucleic 
acids were once more pelleted, dried in a vacuum desicator,  and 
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redissolved in 0.05 ml of TE buffer. 	This method proved extremely 
useful when screening recombinants, as 24 samples can easily by 
analysed in one day using 10-30 p1 of final DNA solution per 
restriction endonuclease digest. 	Should it be necessary, RNA can 
be removed from this preparation by the addition of 1 p1 RNAase A 
(1 mg/ml, pre-treated for 15 min at 95°C) and incubation at 37°C 
for 30 mm. 
b) 	Large-scale preparation of plasmid DNA: 	A single colony was 
inoculated into 100 ml L-broth supplemented with selective anti- 
biotic, and incubated at 37°C with aeration for 16-18 hours. 	The 
cells were pelleted (000 g, 15 mm, 4°C) and washed with TE buffer. 
Unless otherwise stated, all the following treatments and additions 
were at 2-4°C. 	The cells were resuspended in 1.5 ml 2590' (w/v) 
sucrose solution and treated with 0.5 ml lysozyme solution (10 mg/ml). 
The mixture was left for 5 min prior to the addition of 0.5 ml 
0.5 M EDTA (pH 8.5) and 0.2 ml RNAase A (5 mg/ml, pretreated at 
95°C for 15 mm). 	A further 5 min interval preceded the addition 
of 2.5 ml "Triton" solution (per 100 ml: 1 ml 10% (w/v) Triton-X-100, 
12.5 ml 0.5 M EDTA (pH 8.5), 5 ml Tris-HC1 (pH 8.0)). 	The mixture 
was gently inverted for 10 min and then cleared by centrifugation 
(27,000 g, 20 mm). 	The resulting supernatant was made up to 9 ml 
with TE buffer and 9 g CsC1 plus 0.9 ml ethidium bromide (5 mg/ml) 
were added. 	The solution was then centrifuged (50Ti rotor, 90,000 g 
15°C, for 60 hours) and the tube viewed under long-wave UV. 
Typically, two fluorescent bands could be seen, the lower of which 
contained supercoiled plasrnid DNA. 	This was collected by side- 
puncture of the tube below the band using a syringe and 19 gauge 
needle. 	The preparation was dialysed against IC buffer to remove 
CsC1, and extracted twice with an equal volume of freshly-distilled 
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phenol (pre-equilibrated against 0.5 M Tris-HCl (pH 8.0)) at 20°C. 
Residual phenol was removed from the extracted material as for 
phage DNA preparations, and the DNA was collected by ethanol 
precipitation. 	DNA concentrations and purity were estimated by 
measuring the absorbance at 260 nM, 280 nM and 320 nM. 	This 
nthod gave yields of 1 to 7.5 mg/litre for Co1E1 derivatives, and 
a minimum of 0.5 mg/litre for lower-copy-number plasmids. 
4. 	DNA Techniques 
All DNA solutions were stored at 4°C. 
Ethanol precipitation: DNA was precipitated by the addition 
of 0.1 vol 3 M potassium acetate (pH 6) and 2-3 vol ethanol, 
followed by incubation at -20°C (12 hours) or -70°C (30 mm), in 
siliconised Corex tubes or plastic microfuge tubes. 	Nucleic acids 
were pelleted (12,000 g, 30 mm, 4°C, or 3 min in a Quickfit micro-
centrifuge, 41C), washed with 80% ethanol, dried in a vacuum 
desicator and redissolved in TE buffer. 
Restriction endonuclease digestions: 	Appropriate quantities 
of DNA, lOx reaction buffer, dH2O and restriction endonuclease 
were mixed thoroughly in plastic microfuge tubes and incubated at 
appropriate temperatures, typically for 1 hour. 	Reactions were 
stopped by the addition of excess EDTA and/or incubation at 70°C for 
10 mm. 	Table 2.3 lists the enzymes used and the reaction 
conditions for each. 
DNA fragment purification: 	Fragments were purified from agarose 
gels by passive elution. 	The required region of gel was excised 
and homogenised by passage through a 19 gauge needle into a siliconised 
Corex tube. 	After the addition of 5 ml PE buffer (50 mM Tris-HC1 
(pH 8.0), 100 mM NaCl, 10 mM EDTA), the suspension was shaken at 
37°C for 12-24 hours. 	Agarose fragments were removed by 
TABLE 2.3 RESTRICTION ENDONUCLEASES 
Endonuclease Bacterium of Origin Specificity 
Alul Arthrobacter luteus AG'CT 
AvaI Anabaer,a variabilis CPyCGPuG 
BamHI Bacillus amyloliquefaciens H G'GATCC 
EcoRI Escherichia coli RY13 GAATTC 
HaeIII Haemophilus aegyptius GGCC 
HindlIl Haemophilus influenzae Rd 
V 
GTPyPuAC 
Hindill Haemophilus influenzae Rd AAGCTT 
pi Haemophilus parainfluenzae GT1'AAC 
KpnI Kiebsiella pneumoniae 0K8 GGTAc!C 
Source Assay Conditions 
A Newman* 10 mM Tris-HCl 	(pH 7.6); 	7 mM MqC12; 
6 mM 2-mercaptoethanol 
J C Boothroyd* 6 mM Tris-HCl 	(pH 7.5); 	6 mM MqC].2; 
6 mM NaCl, 6 mM 2-mercaptoethanol 
BRL 20 mM Tris-HCl (pH 7.0); 	7 mM MgC19 ; 
100 mM NaCl; 	2 mM 2-mercaptoethanot 
BOEHRINGER 10 mM Tris-HC] 	(pH 7.5); 	10 mM MqCl2; 
50 mM NaCl; 6 mM 2-mercantoethanol 
NEB 6 mM Tris-HCl 	(pH 7.4); 	6.6 mM MqC12; 
6 mM NaCl; 6 mM 2-mercaptoethanol 
Mrs K Mileham* 6.6 mM Tris-HCl 	(pH 7.4); 	6.6 mM MaCi2; 
1 mM dithiothreitoj. 
NEB 7 mM Tris-HCl 	(pH 7.4); 	7 mM MqCi7 ; 
60 	NaCl; mM 	6 mM 2-mercaptoethanot 
I Garner 10 mM Tris-HCl (pH 7.4); 	10 mM MgCl 
2; 6 mM 2-mercaptoethanol 
BRL 6 mM Tris-HC] 	(pH 7.5); 	6 mM MgCl 
2; 
6 mM 2-mercaptoethanol 
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centrifugation and passage of the supernatant through siliconised 
glass wool. 	The suspension was passed twice through a 0.1 ml 
DEAE-cellulose (Whatman, DE52) column in a 1 ml plastic syringe 
at 5 ml hr. 	DNA bound to the column was eluted with 0.5 ml 
PEN buffer (50 mM Tris-HC1 (pH 8.0), 1 M NaCl, 10 mM EDTA) and 
concentrated by ethanol precipitation. 	The method gave good yields 
(50-9096) and its products were suitable for restriction, ligation 
and nick-translation. 
Recombination of DNA fragments in vitro: 	Restriction 
endonuclease digests containing DNA fragments possessing cohesive 
termini were diluted to 5-30 pg DNA/ml with 10 mM Tris-HC1 (pH 7.5), 
100 mM NaCl. 0.1 vol of lOx T4 ligase cocktail (660 mM Tris-Cl 
(pH 7.2), 10 mM EDTA, 100 mM MgC12, 100 mM Dithiothreitol, 1 mM ATP) 
were added together with 14 DNA ligase. 	Ligation was at 10°C for 
3-12 hours, after which samples were withdrawn for transfection/ 
transformation. 	Digests containing DNA fragments possessing 
flush termini were treated similarly but with the following 
differences: i) concentrations of 200-500 pg/ml DNA were used, 
ii) lOx ligation cocktail was 10 mM ATP, iii) 10-fold more T4 DNA ligase 
was used per reaction. 
Transfection/transformation: A fresh overnight culture was 
diluted 50-fold in L-broth and incubated at 37°C, with aeration, 
until an 0D650 of 0.5-0.6 was reached. 	The material was trans- 
ferred to an ice-bath for the remaining procedures. 	The cells 
were pelleted (000 g, 10 mm, 4°C), washed in 0.5 vol TE buffer, 
and resuspended in 0.5 vol 0.1 M MgCl2. 	The cells were then 
pelleted, resuspended in 0.5 vol 0.1 M CaCl2 and left at 2°C for 
20 mm. 	After a final pelleting, the cells were resuspended in 
0.05 vol 0.1 M CaCl2 and left for 1 hour before use. 	DNA was diluted 
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in 0.1 ml SSC:CaCl2 (3 vol lx SSC: 4 vol 0.1 M CaC12) and 0.2 ml 
competent cells were added. 	After 30 min the cells were heat- 
shocked at 42°C for 2 mm, and returned to ice for a further 30 mm. 
For transfections, the cells were then mixed with 3 ml BBL top-agar 
(461C), supplemented with 10 mM MgSO4, and plated out. 	For 
transformations, 1 ml [-broth was added and the mixture incubated 
at 37°C for 1 hour before plating on selective medium. 
f) 	Use of synthetic molecular recombination linkers: 	The method 
was essentially as described by Maniatis et al (1978). 	2 pg HindIll 
molecular recombination linker (dCCAAGCTTGG from Collaborative 
Research Inc.) were phosphorylated using T4 polynucleotide kinase 
(10 units/pi, 24 units total) in a total volume of 10 p1 PNK 
buffer (20 mM Tris-HCl (pH 7.5)9 10 mM MgCl 21 1 mM ATP, 10 mM 
-mercaptoethanol) for 1 hour at 37°C. 	The reaction mix was then 
added directly to 8 pg Alul digested T7 DNA (in 10 p1 PNK buffer) 
and 1 p1 T4 DNA ligase. 	The mixture was incubated at 10°C for 
4 hours, followed by 70°C for 10 mm, and returned to ice. 	The 
efficiencies of the phosphorylation/blunt-end ligation steps were 
monitored by running one-tenth of the mixture on a 3-10% poly-
acrylamide gradient gel and examining the ethidium-stained gel 
under UV (see 1/iv). 	A successful phosphorylation/ligation was 
evidenced by the presence of a ladder of linker oligomers (2 to 15-mers). 
The remaining mixture was digested with 40 units Hindill for 1 hour 
at 37°C. 	Linker fragments were then removed by passage through a 
Sephadex 0-75 (Pharmacia) column (8 cm x 0.5 cm). 	The column 
was eluted with TE buffer and 10 x 200 p1 fractions collected. 50 l 
samples were assayed for DNA fragments >50 bp long by gel electro- 
phoresis (3-10% polyacrylamide). 	Fractions containing such DNA 
were concentrated by ethanol precipitation and used in ligations 
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with Hindill digested A590 DNA. 	Following transfection, Alul 
fragments with synthetic Hindill cohesive termini were recovered in 
A-recombinants exhibiting a clear plaque morphology (due to the 
insertional inactivation of the imm434 repressor-gene). 
32P-labelling of DNA by nick translation (Rigby et al, 1977): 
10 uCi a 2-P-dCTP (400 Ci/mMole) was dried in a vacuum desicator, 
washed twice with 20 il dH2O, and resuspended in 20 ul of 50 mM 
Tris-HCl (pH 7.5), 5 mM MgCl2, 20 uM dAIP, 20 PM dCTP, 20 pM dTTP 
containing 1 pg of the appropriate DNA. 	The reaction was started 
by addition of 1 p1 DNAase I (10 	mg/ml) and 1 p1 E.coli DpolI 
(1 unit/pl) and incubated at 15°C. 	Incorporation of label was 
followed by monitoring TCA-precipitable counts bound to Whatman OF/C 
filters (2.4 cm). 	The reaction was stopped by the addition of 
0.2 ml TNE buffer (10 mM Tris-HCl (pH 8.0), 50 mM NaCl, 1 mM EDTA) 
when incorporation ceased. 	A drop of Orange-C marker dye was 
added, and unincorporated nucleotides removed by passage over a 
Sephadex 0-50 column (20 cm x 1 cm). 	1 ml fractions were eluted 
with TNE buffer until the Orange-C (which co-migrates with dNTPs) 
had reached the bottom of the column. 	Peak fractions were 
identified by Cerenkov counting, and stored at -20°C. 
Terminal labelling of nucleic acid molecules (Murray, 1973): 
DNA for labelling (1-5 ug) was first treated with 1 p1 Calf 
Intestinal Phosphatase (15 units/tl) in TE buffer or restriction 
buffer, for 30 min at 37°C. 	The reaction was stopped by the 
addition of one-tenth vol 0.5 M EDTA and incubation at 70°C for 
15 mm. 	The DNA was then ethanol-precipitated, washed in 80% ethanol, 
dried in a vacuum desicator, and resuspended in 10 pl 1.2 x PNK 
buffer (1 x PNK buffer was 20 mM Tris-HCl (pH 7.5), 10 mM MgCl 29 
10 mM 	-mercaptoethanol). 	Sufficient y-32P-ATP (3000 Ci/mMole) 
Liu 
for the labelling reaction was supplemented with cold ATP and 
dried in a vacuum desicator. 	(A final ATP concentration of 
1 pM is required to label single-stranded 5'-ends, whereas 10-20 pM 
is required to label blunt or recessed ends.) 	The DNA solution 
was used to reth 	
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ssovle the y- P-ATP, and 2 p1 14 polynucleotide 
kinase (10 units/pl) added to start the reaction. 	(When labelling 
blunt or recessed ends, the DNA should be denatured by incubation 
at 90°C for 2 min and quenching in ice, immediately before 
adding the ATP.) 	The mixture was incubated at 37°C for 1-2 hours, 
and the reaction terminated by incubation at 70°C for 15 mm. 	The 
mixture was phenol-extracted once, ethanol-precipitated twice, washed 
in 80% ethanol twice, and resuspended in TE buffer. 
i) 	Plaque detection by DNA:DNA hybridisation (Benton and Davis, 1977): 
A circular nitrocellulose filter (Millipore, 8 cm diameter) was 
placed carefully onto each plate carrying plaques, and left for 
2 mm. 	The filter was then carefully removed and placed on the 
following, plaque side uppermost: 	Whatman 3 MM paper saturated with: 
 0.5 M NaOH 	(5 mm) 
 0.1 M NaOH, 	1.5 M NaCl (5 mm) 
 0.5 M Tris-HC1 	(pH 7.5), 	1.5 M NaCl 	(5 mm) 
 0.5 M Tris-HC1 	(pH 7.5), 	1.5 M NaCl 	(5 mm) 
The filters were blotted dry, baked for 2 hours at 80°C in vacuo, 
and then prehybridised in hybridisation solution (0.02% (w/v) Ficoll 
400, 0.02% (w/v) polyvinylpyrrolidone, 0.02% (w/v) gelatin, 0.110' 
(w/v) SDS, 4x SSC, 50% formamide, 50 pg/ml denatured, sonicated 
Salomon sperm DNA) at 37°C for 2-4 hours. 	The filters were then 
transferred to a sealed polythene bag containing 10-20 ml Hybrid-
isation fluid and>5 x 10 cpm 32P-labelled probe DNA (previously 
denatured by incubation at 90°C for 10 mm). 	Filters were 
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hybridised in this solution for 12-18 hours at 37°C, then washed 
in 4 x 500 ml 2 x SSC, 0.5% (w/v) SDS, and dried at 37°C. Auto-
radiography was at -70°C using flash-sensitised X-ray film (DuPont, 
Cronex 4) and an intensifying screen (Ilford Fast Tungstate), 
usually for 12-48 hours. 
j) 	Colony Detection by DNA:DNA hybridisation (Grunstein and 
Hogness, 1975): 	Colonies of plasmid-containing bacteria were 
transferred by sterile toothpick, in an ordered array, to an L-agar 
plate containing selective antibiotic. 	A circular nitrocellulose 
filter (8 cm diameter, Millipore) was carefully placed on the 
surface of the plate, which was then incubated overnight at 37°C. 
The filter was removed and placed on the following, colony side 
uppermost: 	Whatman 3MM paper saturated with: 
1) 0.5 M NaOH (7 mm) 
1 M Tris-HC1 (pH 7.4) (2 mm) 
1 M Tris-HC1 (pH 7.4) (2 mm) 
0.5 M Tris-HC1 (pH 7.4)9 1.5 M NaCl (4 mm) 
The filter was blotted dry, baked for 2 hours at 80°C in vacuo, and 
subsequently treated as above (see 4/i). 
k) 	DNA fragment detection in agarose gels by DNA:DNA hybridisation 
(Southern, 1975): 	Agarose gels were stained with ethidium bromide 
and photographed to visualise DNA fragments. 	Regions of the gel 
of interest were immersed in the following: 
0.5 M NaOH, 1.5 M NaCl (40 mm) 
0.5 M Tris-HC1 (pH 7.4), 3 M NaCl (40 mm) 
Treated sections of gel were placed on 2 sheets of Whatman 3 MM paper 
(presoaked in 20 x SSC), supported over a reservoir of 20 xSSC. 	The 
edges of the paper dipped into the reservoir and functioned as wicks. 
An exact gel sized piece of nitrocellulose (Millipore), soaked 
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in 2 x SSC, was placed over the gel, followed by a similarly sized 
piece of Whatman 3 MM paper soaked in 2 x SSC. 	Throughout, air- 
bubbles were excluded at interfaces. 	A 10 cm stack of similarly 
sized dry Whatman 3 MM paper was placed on top, followed by a 
suitably sized glass-plate. 	The construction was covered with 
Vitafilm (Goodyear) and a weight (usually a 5 1 plastic container 
of Mineral oil) placed on top. 	Overnight, capillary action drew 
SSC from the reservoir, through the gel, through the nitrocellulose 
filter to the paper above. 	Denatured DNA carried with the SSC was 
retained on the nitrocellulose filter, which was then washed in 
2 x SSC, blotted dry and baked at 80°C for 2 hours in vacuo. 	The 
filter was subsequently treated as above (see 4/i) to highlight 
DNA fragments of interest. 
1) 	Gel electrophoresis: 
(i) 	Horizontal agarose mini-gels:— Gels were prepared by boiling 
0.2 g agarose in 25 ml TAE buffer (40 mM Tris-Acetate (pH 8.3), 33 mM 
sodium acetate, 1 mM EDTA) with vigorous stirring, on an electric 
hot-plate/magnetic stirrer for 30 sec. 	The agarose solution was 
pipetted onto a horizontal glass plate (7 cm x 7 cm x 0.2 cm) over 
which a seven-tooth slot-former was supported (1 mm clearance) with 
bulldog clips. 	The agarose solution, retained on the plate by 
surface-tension, set within 5 mm. 	The slot-former was removed, 
the plate supported over two reservoirs containing 400 ml TAE buffer, 
and pieces of ay--cloth hung from each end to make electrical contact 
with the reservoirs. 	DNA samples for analysis (10 p1) were mixed 
with 5 pl TAE loading buffer (0.5 x TAE, 0.125 M EDTA, 0.100' (w/v) 
bromophenol blue, 50% (w/v) glycerol) and loaded by micropipette. 
After applying 50V for 5 mm, the surface was wetted with TAE buffer 
and covered with Vitafilm, and the voltage increased to 125V for 30 mm. 
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DNA (0.1-0.5 g) was visualised by-staining with ethidium bromide 
(Sigma, 2pg/ml) for 10 mm, destaining in dH2O for 2 mm, and 
transillumination with long-wave UV (Ultraviolet Products Inc., 
Chromatovue C-62, 365 n. peak transmission ). 	Photography was 
with Ilford FP4 film using 20 sec exposure through a red filter. 
Horizontal agarose gels (McDonnell et 21, 1977):- Gels 
(1%-1.50,61 (w/v)) were prepared by boiling agarose in 200 ml TA[ 
buffer with vigorous stirring, on an electric hot plate/magnetic 
stirrer for 1 mm. 	The agarose solution was then cooled to 50°C 
and poured into a perspex mould (30 cm x 14 cm x 0.5 cm) sealed 
at each end with perspex spacers (retained by bulldog clips) and 
having a 13-tooth slot-former in place 5 cm from one end. 	After 
the agarose had set, the slot-former and end-spacers were removed, 
and the gel was prepared for electrophoresis as above. 	DNA 
samples for analysis (30 p1) were mixed with 5 V1 TAE loading buffer 
and loaded by micropipette. 	Gels were run at 50V for 15 mm, 
the surface wetted with TAE buffer and covered with Vitafilm, and 
the voltage increased to 100V for 16-20 hours. 	DNA (0.5-2 pg) 
was visualised as in 1/i, except ethidium bromide staining was for 
30 min and destaininq was for 45 mm. 
Vertical 5% polyacrylamide gels:- Stock solutions for these 
gels were: 30% acrylamide (29% (w/v) acrylamide, 1% (w/v) bisacrylamide) 
10 x TBE buffer (0.9 M Tris base, 0.89 M boric acid, 
25 mM EDTA, pH 8.3) 
100%) (w/v) ammonium persuiphate in dH2O (freshly prepared) 
A 40 ml solution containing 6.625 ml 30% acrylamide, 4 ml 10 x TBE, 
0.5 ml 10% ammonium persuiphate, and 28.88 ml dH2O was degassed 
(2 min swirling on a waterpump). 	25 pl TEMED (N,N,N',N'- 
tetramethylethylenediammne, Serva) were added and the solution poured 
52. 
into a glass sandwich (20 cm x 16 cm x 0.15 cm) with perspex spacers 
sealed with water-agar. 	The gel was overlaid with 2-butanol and 
allowed to polymerise (.1 hour). 	A stacking gel mixture containing 
1.67 ml 30% acrylamide, 2 ml 10 x TB[, 0.33 ml ammonium persulphate 
and 16 ml dH2O was prepared and degassed while the gel was setting. 
When polymerisation was complete, the 2-butanol was decanted and 
the surface of the gel rinsed in 1 x TBE buffer. 	Following the 
addition of 10 pl TEMED, the stacking gel was overlaid by pipette, 
a 13-tooth slot-former inserted, and the surface areas covered with 
2-butanol. 	After polymerisation, the slot-former and bottom spacer 
were removed and the gel attached to a perspex gel apparatus 
(Raven), with 400 ml. 1 x TBE buffer in each reservoir. 	DNA samples 
for analysis were ethanol-precipitated, dried in a vacuum desicator, 
and resuspended in 20 ul TE buffer. 	After the addition of 10 p1 
TBE loading buffer (0.5 x TBE, 0.125 M EDTA, 0.1% bromophenol blue, 
50% (v/v) glycerol), samples were dried to 10-15 p1 prior to loading 
with a Hamilton microsyringe. 	Gels were run at 300V for 1 hour 
and DNA (2-4 pg) was visualised as in 1/i. 
(iv) 	Vertical 3-101% gradient polyacrylamide gels (Maniatis et al, 
1975):— Stock solutions for these gels were as in 1/Hi. 	Two 
30 ml solutions containing 3 ml and 10 ml 30% acrylamide respectively, 
3 ml 10 x TBE, 0.25 ml 10% ammonium persulphate and dH2O to 30 ml, 
were degassed as before. 	After addition of 10 p1 TEMED to each, 
a 2-ch2mber linear gradient-maker was used to pour a 3-10% gradient 
into a glass sandwich (40 cm x 1 cm x 0.15 cm) with perspex spacers 
sealed with water-agar. 	The gradient was overlaid with 2-butanol 
and allowed to polymerise. 	A stacking gel mixture containing 1.67% 
acrylamide, 2 ml 10 x TBE, 0.33 ml ammonium persulphate and 16 ml 
dH2O was prepared and degassed while the lower gel was setting. 
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The 2-butanol was then decanted, the gel surface rinsed with 1 x TBE, 
10 p1 TEMED added to the stacking gel and the latter overlaid by 
pipette. 	A 13-tooth slot-former was then inserted and the surface 
areas covered with 2-butanol. 	After polymerisation, the gel was 
set up and samples applied as in l(iii), above. 	Electrophoresis 
was at 250V for 30 mm, followed by 120V for 15 hours. 	DNA (2-4 jig) 
was visualised by ethidium bromide staining (as in 1/i) and gels 
were photographed against a black background by overhead shortwave 
UV illumination (Mineralight C5, 254 nM peak transmission) using 
5-8 min exposure through a red filter, and Ilford FP4 film. 
m) 	Gel autoradiography: 	Gels were dried onto Whatman 3 MM paper 
(BIORAD Laboratories Gel Slab Drier) and autoradiographed at -70°C 
using flash-sensitised X-ray film (DuPont, Cronex 4) and an 
intensifying screen (Ilford Fast Tungstate), usually for 12-48 hours. 
were 
Sequencing gels, wrapped in Saranwrap, / autoradiographed wet at 
room temperature using X-ray film (DuPont, Cronex 4) for 12-48 hours. 
5. 	Enzyme assays: 	Assays of two enzymes were used. 
a) 	Assay of -galactosidase (Miller, 1972):— cultures were grown 
at 37°C on an orbital shaker at 200 rpm in Spizizen minimal medium 
containing ampicillin (50 pg/mi), acid casein hydrolysate (0.1% (w/v)), 
and glycerol (0.200' (w/v)) to avoid catabolite repression. 
-galactosidase levels were determined from samples taken at 0D650  
between 0.2-0.6. Each assay contained the following: 0.8 ml PM2 
reducing buffer (120 mM sodium phosphate (pH 7.0), 1 mM MgSO4, 0.2 mM 
MnSO4, 10 mM fl-mercaptoethanol); 0.2 ml 0.1% (w/v) CTAB; 0.01 ml 
1% (w/v) sodium deoxycholate; 1 ml of a suitable dilution of cells; 
and 0.6 ml 13.5 mM o-nitrophenyl -D-galactopyranoside (Sigma). 
Assays were incubated at 28°C and were stopped after sufficient 
colour had developed (usually 20-100 mm) by the addition of 1.3 ml 
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1 M Na2CO3. 	The A550 and A420 were measured using a Zeiss 
spectrophotometer and B-gaiactosidase units calculated as follows: 
Miller Units 	z 100 x 0D420 - (1.75 x 0D550) 
(per ml of culture 	 t x V x OD 600 
at 0D600 of 1.00 
where V is the volume of culture in sample (ml) 
t is the duration of 28°C incubation in minutes 
0D600 is the culture absorbance at time of sampling. 
b) 	Assay of galactokinase (McKenney et al, 1981):— Cultures 
were grown at 37°C on an orbital shaker at 200 rpm in Spizizen 
minimal medium containing ampicillin (50 pg/mi), acid casein 
hydrolysate (0.1% (w/v)) and fructose (0.200' (w/v)) to avoid catabolite 
repression. 	Galactokinase levels were determined from samples 
taken at 0D650 0.2. 	1 ml samples were treated with 40 p1 of lysis 
buffer (100 mM EDTA, 100 mM Dithiothreitol, 50 mM Tris-HC1 (pH 8.0)) 
and two drops of toluene. 	Lysates could be stored on ice for at 
least 60 min prior to the evaporation of toluene using an air-line 
(20°C) and assay. 	Each assay contained the following: 20 p1 5 mM 
Dithiothreitol/16 mM NaF, 50 pi 8 mM MgCl2/200 mM Tris-HCl (pH 7.9)/ 
3.2 mM ATP, 10 pl 10 mM D-galactose (containing 14C-galactose to 
give a final specific activity of 4.5 x 
10  
dpm/pmole; Amersham), 
and 20 pl lysed culture. 	Assays were incubated at 32°C for 10-30 mm 
and 50 pl aliquots removed to 2.5 cm discs of DE81 paper (Whatman). 
Filters were washed in dH2O (Hayward, 1980) together with two blank 
control filters. 	Total counts were determined by removing two 
random 25 pl aliquots to DE8I discs, these remaining unwashed. 
Filters were dried at 80°C, counted by scintillation in 0.4% 
butyl-PBD (GBA)/toluene (Packard TRI-CARB scintillation spectro-
photometer), and galactokinase units calculated as follows: 
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Galactokinase units 	z (cpm - B) x 2500 




phosphorylated per mm 
per 0D650) 
where 	U is the average count on unwashed filters 
B is the average count on blank filters 
t is the duration of 32°C incubation in minutes 
0D650 is the culture absorbance at time of sampling 
6. 	M13 sequencing: This method has been extensively discussed in 
the literature and will not be described here (Sanger et al, 1977; 
Sanger and Coulson, 1978; Smith, 1974; Schreier and Cortese, 1979; 
Anderson et al, 1980; Messing et al, 1981). 	However, the principle 
of the method will be discussed briefly later (see Fig. 5.1. ). 
56. 
CHAPTER 3 - ISOLATION OF T7 DNA FRAGMENTS 
3.1 Introduction 
The study of transcriptional terminators in their native envir- 
onment has three major disadvantages: simple screening procedures 
to monitor terminator efficiency are usually not available; directed 
mutagenesis specifically affecting terminator sequences is 
difficult to achieve using genomic DNA; isolation of mutant sequences 
for characterisation is relatively tedious. 	Moreover, if each 
regulatory site is studied in context, valid comparisons between 
their efficiencies and factor dependencies are impossible as there 
is no standard for comparison. 	The technique of gene fusion has 
proved extremely useful in overcoming some of these problems. Genetic 
fusions can place a monitor gene, whose function is readily assayed 
and is subject to powerful genetic selection techniques (e.g. lac, 
gal or trp genes), under the control of different regulatory elements. 
This allows comparative study of transcriptional signals in a single 
genetic environment. 	For example: in vitro recombination can he 
used to insert a transcriptional terminator between a given promoter 
and a suitable monitor gene. 	The vector should possess an 
independent, selectable marker and facilitate the assay of its monitor 
gene function in vivo. 	It is desirable that it should also allow: 
the transfer of mutant or wild-type fragments into other suitable 
vectors; the characterisation of terminators by in vitro techniques 
(e.g. DNA sequencing and transcription studies); the easy recovery 
of terminator fragments to permit specific mutagenesis in vitro; 
and the forced reconstruction of the original fusion using mutant 
DNA. 	It is, therefore, advantageous if the cloned fragments are 
determined by cohesive termini specified by one (or preferably two) 
of the more commonly used restriction endonucleases. 
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The ara-!-lac fusion (Casadaban, 1975) present on the ColEl-
derived piasmid vector, pMC81, allows the construction of recombin- 
ants of this type (Casadaban and Cohen, 1980). 	A derivative of 
this vector, pHR1, has lacZ expression dependent on transcription 
initiating at the constitutive promoters P[10 and P 
L11' 
 from the 
rp1KAJL gene cluster of [.coli (Newman, 1980). 	The derivative 
contains a single site for Hindlil, at which DNA fragments can be 
inserted between the ribosomal gene promoters and the lacZ structural 
gene (Fig. 3.1). The following work attempted to exploit pHR1 to 
study transcriptional terminators derived from the T7 genome; in 
particular, ted. 
3.2 Construction of T7 derived recombinants 
The construction of such recombinants poses special problems in 
the case of T7 DNA. 	The phage genome does not contain the DNA 
sequences recognised by the more commonly used restriction endo-
nucleases (e.g. EcoRI, Hindlil, PstI, BamHI, Sail) (Rosenbergetal, 
1979; Dunn and Studier, 1982). 	Presumably the lack of cleavage 
sites for these enzymes is due to their elimination by natural 
selection during phaqe infection of various hosts. 	Furthermore, 
the remaining suitable enzymes generate relatively large DNA fragments 
which present two disadvantages. 	Firstly, they are likely to 
contain a lethal element from the T7 genome such as a strong 
promoter or a lethal gene. 	Secondly, the presence of multiple 
transcriptional signals and/or translational properties which can 
distort transcription is a likely source of difficulties. 
The strategy adopted was, therefore, to fragment T7 DNA with 
restriction endonucleases that produce small fragments with 
flush-ends, one of which should contain tecl and little else. 	The 
Fig. 3.1 
The upper part shows the genetic organisation and physical map of pMC81, linearised at one of its 3 BamHI 
sites (Casadaban and Cohen, 1980). 	Transcription initiates in the araUl region, preceedinq leftwards 
into araC, and rightwards through araB', 'Mu', trp'CBA' into 'lacZ. 	The fusion of trpA' to 'lacZ creates 
a hybrid, functional protein that is noticeably temperature sensitive (Squires, 1982). 	The co-ordinates 
of restriction sites are marked in kilobase-pairs starting from the BamHI site lying between rep Co1E1 
and araC. 
The lower part shows, at an expanded scale the genetic organisation and physical map of the first 
11 kb of pHR1 (Newman, 1980). 	The total size of the vector is 27.4 kb. 	Transcription initiates 
in the rpo P
L11 P
[10 region and proceeds rightwards into 'lacZ throuqh trp'BA'. 	The co-ordinates of 
restriction sites are given in kilobase-pairs except for 4 PstI sites between the Kpnl and BqlII sites 
which have been omitted for clarity. 
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enzymes chosen were Alul, HpaI and Hindu; 	the former generates 
a 184 bp tecl fragment (T7 co-ordinates 18.68% to 19.1210'), and the 
latter two the same 446 bp tecl fragment (T7 co-ordinates 18.2710' 
to 19.40%). 	The resulting fragments wereprovided with Hindill 
cohesive termini by the addition of synthetic molecular linkers and 
digestion with Hindlil (Fig. 3.2). 	DNA treated in this way was 
ligated to Hindill-digested pHR1, and transformed into MC1000. 	The 
resulting colonies were screened by colony-hybridisation with a 
[32P]-3575 bp KpnI fragment (I D, 17 co-ordinates 14.04% to 
22.98%) for fragments originating from the region of the T7 genome 
in which tecl lies. 	Transformants carrying plasmids were selected 
on lactose-MacConkey agar containing ampicillin. 	This medium 
allowed the secondary screening of all colonies for a reduction in 
lacZ expression, as judged by their colour phenotype. 	However, 
this procedure failed to identify a pHR1 derivative carrying either 
tecl or any other fragment producing a reduction in lacZ expression. 
This prompted the use of phage xNM590, in which Hindill-
insertions inactivate immunity functions, as an initial vector 
(Murray et al, 1977). 	This has three major advantages over pHR1 
for the preliminary isolation of recombinants: (i) a high trans-
formation efficiency enables the recovery of many recombinants; 
(ii) the clear-plaque phenotype of recombinants simplifies their 
identification; (iii) plaque-hybridisation is more sensitive than 
colony-hybridisation as a means of identifying desired recombinants. 
T7 DNA was, therefore, treated as above with Alul and 
synthetic molecular linkers, but ligated to Hindill-digested XNM590 
(Fig. 3.2). 	Note that Alul gener2tes90 fragments from 17 DNA 
(Fig. 3.3). 	Following transfection into ED8654, recombinants were 
initially identified by their clear-plaque morphology, plaque-purified, 
Fig. 3.2 
Flow diagram summarising the final strategy adopted for cloning 
the 184 bp tecl Alul fragment. 	Further details can be found in 
sections 2.4.f and 3.2. 
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and transferred by cocktail stick in an ordered array onto a lawn 
of ED8654. 	Plaques containing phage carrying fragments of T7 DNA 
were identified by plaque-hybridisation of this array with a 
T7 DNA probe, radiolabelled by nick-translation. 	In this way, 93 
recombinant phage were identified, exhibiting a varying degree of 
homology with the 17 probe as judged by "spot" intensity after 
autoradiography. 	(This correlation can only be considered 
quantitative if we assume: equal distribution of 32P-label in 
the probe; similar concentrations of phage within plaques; 
efficient transfer of all phage DNA to nitrocellulose filters.) 
3.3 Screening of the T7 library for ted 
The array was next plaque-hybridised to a [ 
32 
 P]-3575 bp KpnI 
fragment D, as in previous colony-hybridisations, to identify phage 
carrying fragments originating from the region of the T7 genome in 
which tecl lies. 	Sequence data predicted that this probe should 
hybridise to 13 17 Alul fragments; among these the tecl fragment 
is 184 bp, and no others are close in size (Dunn and Studier, 1980). 
The desired clone should, therefore, have been easily identified 
if present. 	The probe highlighted 11 phage, which were purified 
on CsC1 step-gradients and phenol-extracted to yield DNA suitable 
for restriction analysis. 	Digestion with Hindlil and analysis on 
3-10% gradient polyacrylamide gels revealed that the majority of 
these phage carried multiple Hindlil-inserts of varying sizes 
(Table 3.1). 	Further characterisation by Alul digestion revealed 
that several of the larger Hindill fragments contained internal Alul 
sites (Table 3.1); these were presumably the products of the T7 
Alul-fragment ligation. 	It is unlikely that they arose from 
incomplete Alul digestion as digestions used in these experiments 
Table 3.1 
The recombinant phage hybridising to 17 KpnID are recorded. 	The 
table indicates the sizes of the Hindill inserts they contain 
(in bp) and whether or not they contain an internal Alul site 
or -). 	Larger fragments of limited interest were not tested 
(N.T.) as they probably arose from several T7 Alul fragments. 	The 
sizes of the products of Hindlil/Alul digestion are recorded where 
observed. 
TABLE 3.1 	Recombinant Phage Hybridising to T7 
AIG Size of insert/s Anternal Alul sites AluI Products 
9 BOO bp + not detected (n.d.) 
650 bp + (n.d.) 
10 720 bp + 655 bp and 65 bp 
600 bp - 
17 305 bp - 
220 bp + (n.d.) 
21 330 bp - 
36 1275 bp N.T. 
46 310 bp - 
260 bp - 
19B bp - 
74 600 bp + (n.d.) 
281 bp + 232 bp and 49 bp 
194 bp - 
174 bp - 
77 1375 bp N.T. 
1300 bp N.T. 
79 720 bp - 
188 bp - 
81 1150 bp + (n.d.) 
848 bp - 
340 bp - 
132 bp - 
85 910 bp + 837 bp 
270 bp - 
ri! 
were routinely checked for completeness prior to linkering. 	The 
smaller Hindlil-inserts showed only a small increase in mobility 
after Alul digestion and were presumed, therefore, to be derived 
from unique Alul fragments (Hindlil linker molecules contain Alul 
sites; therefore Alul digestion removes short terminal segments 
from linkered fragments). 	Only two phage, xIG46 and x1074 carried 
Hindlil-inserts approximating in size to 194 bp (184 bp T7 DNA and 
10 bp linker DNA). 	The tecl fragment should yield fragments of 
121 bp and 73 bp when digested with Alul together with HaeIII (the 
184 bp Alul fragment has a single HaeIII site 116 bp from its left 
end). 	However, double-digestion of X1C46 and X1G74 with AluI/HaeIII 
revealed that neither phage carried a Hindlil-insert with an 
internal HaeIII site (data not shown). 	These phage, therefore, 
did not contain inserts carrying T7 ted. 
3.4 Identification of a putative, unknown T7 transcriptional terminator 
It had been noted that the phage A1G5 carried an insert of 
192 bp which showed only a small increase in mobility after Alul 
digestion (Fig. 3.3) and contained a HaeIII site (data not shown). 
Although this phage had not hybridised significantly to the LpnI D 
probe, it was further examined in case it might prove to carry ted. 
Its DNA was digested with Hindill, PstI, BamHI and EcoRI (the latter 
three enzymes to "smash" the A vector and so minimise phage-infection 
problems arising on transformation). 	The products were then ligated 
to Hindill-digested pHR1, treated with Calf Intestinal Phosphatase. 
Following transformation into MC1000, plating on lactose-MadConkey 
agar containing ampicillin, and overnight incubation at 37°C, 
colonies were examined for a reduction in lacZ expression. 	On this 
medium, MC1000 harbouring plasmids expressing lacZ at 2 significantly 
Fig. 3.3 	3-10% Polyacrylamide Gel Electrophoresis 
Track DNA Restriction Digest 
1 Linker oliqomers - 
2 T7 Alul 
3 pBR322 Alul 
4 A590 Alul 
5 xIG5 Alul 
6 xIG5 Hindill 
7 pBR322 Alul 
8 xIG5 Hindill 
9 xIG5 HaeIII 
10 x590 HaeIII/HindIII 
11 x105 HaeIII/HindIII 
12 pBR322 HaeIII 
Note: The sizes of fragments are given in base pairs. 
The marker digests are pBR322/AluI and pBR322/HaeIII. The 
sizes of these fragments are predicted from sequence data 
(Sutcliffe, 1978). Note that the 659 bp pBR322/AluI 
fragment migrates as if it were 722 bp. 	The position of 
novel fragments in tracks 5 and 11 are designated 'a'. 














































lower level than pHR1 should display a paler phenotype than 
MC1000 (pHR1) (red). Such a reduction in lacZ expression should be 
produced by Hindlil-inserts carrying transcriptional terminators. 
This effect was observed: xIG5 yielded 10% white-colony derivatives 
of pHR1; the remainderwere red colonies. 
The former were initially characterised by mini plasmid DNA 
preparations and EcoRI digestion. 	Fragments of 13.4 Kbp, 7.9 Kbp 
and 6.1 Kbp are produced by EcoRI digestion of pHR1. 	Comparison 
with plasmids derived from six different white colonies revealed 
that all had lost the 6.1 Kbp EcoRI fragment, and gained a 6.3 Kbp 
fragment (Fig. 3.4). 	Since X1G5 contains a single Hindill-insert 
of 192 bp, and the 6.1 Kbp EcoRI fragment of pHR1 contains its 
Hindlil site, it was suspected that the white colonies contained 
pHR1 derivatives carrying the 192 bp Hindlil-insert from x105. 	This 
was confirmed by further restriction analysis of CsC1-pl2smid DNA 
preparations using Hindlil, each derivative yielding a novel 192 bp 
fragment. 
The position of the HaeIII site within the Hindlil-insert was 
investigated by restriction analysis of both X1G5 and pHR1 derived DNA 
(Figs. 3.3, 3.4). 	Double-digestion of A105 DNA with HaeIII/HindIII 
generated a fragment of 180 bp which was absent from the equivalent 
digest of xNM590. 	The smaller 12 bp segment of the X105 insert 
was undetectable on the gels used for analysis (3-10% polyacrylamide). 
Similarly, sequence data predict that pHR1 will yield a 900 bp 
fragment on digestion with HaeIII, which should be subdivided by 
Hindlil digestion into a 623 bp fragment and a 267 bp fragment 
(Post et al, 1979; Crawford et al, 1980). 	These predictions 
were verified by digestion of pHR1. 	Digestion of the plasmids 
derived from the six white colonies with HaeIII revealed, however, 
Fig. 3.4 	190' Agarose gel electrophoresis (tracks 1-9) and 
3-10% polyacrylamide gel electrophoresis (tracks 10 and 11) 
Track DNA Restriction digest 
1 Ac1857 EcoRI 
2 p(i) EcoRI 
3 p(ii) EcoRI 
4 p(iii) EcoRI 
5 pHR1 EcoRI 
6 p(iv) EcoRI 
7 p(v) EcoRI 
8 p(vi) EcoRI 
9 Xc1857 Hindill 
10 pHR1 HaeIII 
11 p10103 HaeIII 
Note: The sizes of fragments are given in base pairs. 	The 
marker tracks (1, 5, 9 and 10) are Ac1857 or pHR1. 
Tracks 2-8 contain "mini" plasmid-DNA preparations, hence 
the smeary background of E.coli chromosomal DNA. 	The 
























that the 900 bp fragment was no longer present. 	Instead, each 
derivative yielded two extra fragments whose sizes were approximately 
800 bp and 282 bp. 
These observations suggest: (i) that the six white colonies 
contained derivatives of pHR1 carrying the 192 bp Hindlil-insert 
from X1G5; (ii) that all six derivatives carried the insert in 
the same orientation; (iii) that the insert has a HaeIII site 
approximately 180 bp from one end; (iv) that the insert reduces 
lacZ expression sufficiently to cause a colour-phenotype change in 
one orientation only (Fig. 3.4); (v) that the insert did not carry 
ted. 	One of these plasmids was designated pII103. 
3.5 Expression of lacZ by pIG103 
To confirm that a reduction in lacZ expression is produced by 
the 192 bp 17-DNA insert, samples of MC1000 strains harbouring pHR1 and pIG10 
were taken between 0D600  0.2 and 0.6 and assayed for -galactosidase 
activity (Table 3.2). 	Each result is the mean of 3 or more 
independent determinations on separate cultures. 
The results indicate that MC1000(pIG103)does indeed exhibit a 
lower level of -galactosidase activity than MC1000 (pHR1). It must 
be concluded that the presence of the 192 bp insert between P L10L11 
and lacZ results in a 78% reduction of lacZ expression. 	It is most 
unlikely that this is due to plasmid copy number effects, as plasmid 
DNA preparations revealed no major differences in yield. 	However, 
caution is still needed when interpreting these results as accurate 
assessment of plasmid copy number is difficult, and artifactual 
polar effects of fusions can have a strong influence on lacZ 
expression by pMC81. 	The results, therefore, merely suggest the 
possibility that the cutdown of lacZ expression is due to the 
insertion of 2 transcriptional terminator in pHR1. 
TABLE 3.2 
Expression of -ga1actosidase by MC1000 (pIG103). 	The activities 
of -ga1actosidase in MC1000 (pHR1) and MC1000 (p16103) (expressed 
in Miller units) are indicated at various stages of growth. 
TABLE 3.2 
A600 Miller units in Miller units in Termination MC1000 (pHR1) MC1000 (pIG103) 
0.2 783.2 (±10) 172.5 (±6) 77.9 
0.3 760.7 (±12) 151.8  80.0 
0.4 755.6 (±16) 166.2 (±10) 78.0 
0.5 741.8 (±15) 164.7  77.8 
0.6 765.1 (±10) 179.4  76.6 
63. 
3.6 Suitable fragments carrying tecl and tec2 
During the course of this work, restriction fragments carrying 
tecl and a second transcriptional terminator from T7, tec2 (Minkley 
and Pribnow, 1973; Peters and Hayward, 1974a), became available 
from another group (Studier and Rosenberg, 1981). 	These fragments 
had been isolated by a similar approach to that described above, 
but using BamHI synthetic linker molecules. 	Two fragments 
containing tecl had been isolated. 	The first of these was a 
446 bp HpaI fragment (T7co-ordinates 18.27% to 19.40%) cloned in 
the BamHI site of pBR322 to produce pAR48, using the following 
linkers: dCCGGATCCGC. 	The second was a 142 bp Fnu4HI fragment 
(17 co-ordinates 18.77% to 19.12%) cloned in the BamHI site of 
pBR322 to produce pAR1085, using the following linkers: 
dGGATCCAGATCCGG (after "filling-in" of the cohesive ends of the 
Fnu4HI fragment). 	Finally, the tec2 transcriptional terminator has 
been isolated on a 632 bp AvaII-HaeIII fragment (T7 co-ordinates 
26.70% to 28.28%) cloned in pBR322 to produce pAR410, using the 
following linkers: dCCGGATCCGG: (Avail cohesive end "filled-in"). 
It should, however, be noted that the existence of tec2 in this 
region has not been demonstrated but is strongly implicated from 
sequence homology between this fragment and tecl and current 
information concerning the position of tec2 in the T7 qenome. 
These plasmids were kindly donated by Dr F. W.Studier, and prevented 
any further attempts on my part to isolate ted. 	However, their 
inserts could not be studied by subcloning into pMC81, as appropriate 
cloning sites are not available in this plasmid. 	The cloning of 




It was disconcerting to find that many of the X590 derivatives 
isolated contained more than one inserted Hindlil fragment, and 
that some of these inserts included more than one Alul fragment of 
T7 DNA. 	The reasons for this are probably two fold: an insufficient 
concentration of Hindill linker molecules in the first (blunt- ended) 
ligation reaction; and an insufficient concentration of Hindill-cut 
vector DNA in the final ligation. 	A factor which must have 
aggravated the first problem is revealed by recent information 
concerning the nucleotide sequence of the 17 genome (Dunn and 
Studier, 1982). 	I initially estimated, by extrapolation from the 
known Alul map to the left end of T7 DNA, that digestion of the 
whole genome with Alul should generate some 60 fragments. 	The 
complete nucleotide sequence, however, indicates that there are 
at least 90 fragments. 	Furthermore, the phosphorylation of the 
linker molecules may have been inefficient, reducing still further 
the efficient ratio of linker to T7/AluI fragments. 	This would 
favour ligation of T7 Alul to Alul fragments. 	Poor phosphorylation 
of linker was in fact indicated, in some preliminary cloning attempts, 
by an absence of linker oligomers among the products of ligation. 
The cloning attempt which gave rise to the recombinants described 
here appeared to be satisfactory, by the latter criterion. 	However, 
it might be wiser to monitor the phosphorylation reaction, using 
'r-32P-ATP, to ensure a high yield and/or known concentration of 
functional linker molecules. 
Underestimation of the number of fragments produced upon 
digestion of T7 DNA with Alul must also have reduced my chances of 
recovering a tecl recombinant from the 93 derivatives of X590 
actually isolated. 	Owing to the availability of suitable fragments 
65. 
cloned by other workers, further cloning attempts guided by the 
above experience were judged to be redundant. 
The observed reduction in expression of lacZ by pIG103, as 
compared with pHR1, must be interpreted with caution. 	Polarity 
effects beyond the site of insertion in trpB can certainly influence 
lacZ expression strongly in this system. 	The structure of pMC81 
(and therefore of pHR1) is such that lacZ is fused in phase with 
trpA (C.L.Squires, pers. comm.). 	Efficient expression of lacZ 
therefore requires efficient initiation of trpA translation. 
However, the latter is strongly dependent on efficient translation 
of trpB as trpB and trpA are translationally coupled (c.f. trp[ and 
trpD: Oppenheim and Yanofsky, 1980). 	In pHR1, the same situation 
should arise: in this case ribosomes should read from rplJ into 
trpB in phase (producing a hybrid protein). 	Insertion of a DNA 
fragment disrupting trpB translation will therefore have a marked 
effect on lacZ expression. 	The likely maximum degree of this 
effect has been demonstrated by the insertion of a 567 bp 165 rDNA 
fragment (containing nonsense codons in every reading frame) at the 
trpB Hindlil site in pMC81 (Barry et ml, 1979). 	The result was a 
10-fold decrease in arabinose-induced lacZ expression. 	The 
insertion of the tec3 fragment at this site in pHR1 might have 
similar translational effects, thus reducing lacZ expression even if 
the insert contains no transcriptional terminator. 	We could only 
exclude this possibility if the nucleotide sequence of tec3 were known 
and we could predict that translation of trpB would not be disrupted 
in pIG1O3. 
Similarly, other possible mechanisms not involving transcriptional 
termination within the insert cannot be eliminated without further 
work. 	For example, the inserted fragment may contain an RNA 
EM 
processing site, generating 'T7- trpB-trpA:lacZ mRNA lacking the 
5'-end of trp. 	This might preclude lacZ translation and/or lead 
to accelerated degradation of the message. 	Alternatively, the 
insert might contain a promoter allowing initiation of transcription 
"backwards" through trpB into rpl]. 	Convergent transcription 
would disrupt expression of lacZ in this instance. 
The observation that the drug rifampicin stimulates lacZ 
expression by pIG103, a phenomenon otherwise observed only with 
fusions (to lacZ or galK) containing known transcription terminators, 
suggests that the insert in pIG103 probably does lead to trans-
criptional termination (Howe et al, 1982; Newman et al, 1982). 
However, this could either be a secondary result of premature trans-
lational termination, leading to exposure of a normally cryptic 
transcriptional terminator downstream of the insert (recall the 
proposed mechanism for the polar effects of nonsense mutations: 
Adhya and Gottesman, 1978); or could reflect the presence of a 
true transcriptional terminator within the insert. 	To clarify these 
questions, I wished to study the tec3 fragment in a fusion system 
less liable to polarity effects downstream of the cloning site. 	In 
the next chapter, I shall describe the insertion and study of 
ted, tec2 and tec3 fragments in galK fusion plasmids designed by 
McKenney et al (1981) to minimise polarity effects. 
67. 
CHARTER 4 - CONSTRUCTION OF galK FUSION STRAINS 
4.1 Introduction 
The inherent disadvantages of the pMC81 vector system, and 
the availability of BamHI restriction fragments carrying T7 ted 
and T7 tec2, prompted the use of a second vector system. 	The pKO 
system developed by McKenney et al (1981) combines the concept of 
gene fusion with recombinant DNA technology to facilitate precise 
study of transcriptional signals. 	The approach involves defined 
fusion of DNA fragments in vitro to plasmid and A-phaqe vectors 
carrying the galactokinase gene (galK). 	The influence of cloned 
fragments on galK expression allows identification of those 
carrying promoter or terminator sequences and determination of 
their signal strengths. 	These can then be studied in a multi-copy 
mode, using plasmid vectors, or a single-copy mode, using X-phage 
vectors. 
The basic plasmid of the system is a promoter-monitoring vector, 
pKOl (Fig. 4.1). 	This pBR322 derivative possesses the ampicillin 
resistance gene as an independent selectable marker; the galK 
coding sequence; and unique restriction sites for the enzymes EcoRI, 
Hindill and Smal upstream of galK. 	The entire nucleotide sequence is known 
apart from approximately 700 bp internal to the galK gene. 	This 
allows the precise cloning of suitable DNA fragments containing 
known or potential promoter sequences upstream of galK. 	Derivatives 
can be screened for promoter activity by colour-phenotype on 
indicator plates. 	For example, a galK strain carrying pKOl is 
white when grown on MacConkey-gallactose plates, and red when grown 
on Tetrazolium-galactose plates because galI< is barely expressed. 
The same strain carrying derivatives of pKOl containing a correctly 
orientated promoter-bearinq fragment expresses galK more strongly, 
Pig, 4.1 	Promoter monitoring plasmids of the pKO system. 
The basic plasid, pKOl, is shown together with a number of its 
derivatives (McKenney et al, 1981). 
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and therefore tends to red on MacConkey-galactose plates and white 
on Tetrazolium-galactose plates. 	Furthermore, the efficiency of 
galK expression can be more accurately determined by assaying the 
level of galactokinase activity in each strain produced. 	The 
assay used is relatively simple, sensitive and linear, detecting 
between 5 and 200,000 molecules of enzyme per cell. 
A further benefit of the choice of galK as monitor gene is its 
comparative insensitivity to translational polarity. 	Translation 
of the galK gene normally initiates independently in an intercistronic 
region upstream of galK. 	McKenney et al reasoned that if this 
region were left intact in the vector, then galK translation might 
be relatively independent of the RNA structure occurring upstream 
of the galK gene. 	Results from experiments in which galK was 
genetically fused at different distances from the P 
L 
 promoter of 
phage-A support this contention by demonstrating that galK 
expression remains proportional to the level of transcription 
initiated from P L (Adhya et al, 1976). 	Accordingly, McKenney et al 
included gal DNA upstream of galK (168 bp) when constructing the 
vector. 
As a further precaution, they ensured the presence of trans-
lation stop codons in all three phases between the cloning sites 
and the galK AUG. 	Translation initiating within or upstream of an 
insert could, in principle, exert differential effects on qalK 
translational efficiency. 	The above three stop codons are located 
at least 72 bp upstream of the galK coding sequence, ensuring that 
there is always a lengthy untranslated leader region. 
The properties of the galK gene also permit selection for either 
positive or negative effects of inserts on gene expression. 
Activation of the plasmid-encoded galK gene by cloned fragments can 
ri 
be recognised by restoration of a Gal+  phenotype to a galK mutant 
host. 	Thus, selection by growth on media containinq galactose 
as sole carbon source, or screening on suitable indicator media 
allows isolation of promoters, promoter "up" mutations and terminator 
"down" mutations. 	Similarly, expression of galK in a cell defective 
in all three gal operon gene functions (ETK) leads to the 
accumulation of the toxic intermediate g2lactose-1-phosphate, and 
cell death. 	This can be exploited to isolate terminators, 
terminator "up" mutations, and promoter "down" mutations. 
However, the plasmid vector system has several limitations, 
most of which are due to copy number effects. 	For example: if the 
transcription signal is affected by ancillary factors, these may 
become limiting in the cell; the cell may respond abnormally to 
the presence of many copies of the regulatory site; and if plasmid 
copy number varies for different constructions, then it is not 
possible to make valid comparisons of promoter or terminator strengths 
between them. 	These problems can be alleviated by transferring 
the regulatory site-galK fusion to a single gene copy. 	The complete 
pKO system allows for this by permitting the transfer of plasmid 
fusions to a single genomic copy, via a X-phage intermediate. 
Despite the potential benefits of the phage system, the present 
study utilises exclusively plasmid vectors as the requisite phages 
were unavailable until very recently. (It is not clear that high 
copy number has, in fact, generated any problems in the present case.) 
The vectors used here are all derivatives of p1<01, and were 
constructed in our laboratory by K. Howe. 	The unique restriction 
sites upstream of galK in pKOl have been manipulated by McKenney and 
others to generate several different promoter-monitoring vectors 
(Fig. 4.1). 	McKenney et al have also constructed a terminator- 
Fig. 4.2. 	Construction of pHR1800 and pHR9. 
The EcoRl/Hindlil fragment carrying P-qal  was derived from pKG1800. 
This was cloned in pKDl and pK04 by K. Howe to produce pHR1800 
and pHR9 respectively (see section 4.1). 	The sizes of these 
plasmids are shown in kilobase-pairs. 
Note: The pK03 vector fragment of pKC1800 was restricted with 
PstI to minimise recovery of pK03 derivatives. 	Any pK03 molecules 
surviving this treatment were detected by HaeII digestion as pKOl 
has one less HaeII site than pK03. 	This difference arises from 
the construction of pKOl from pK03 by the deletion of 2 bp (at a 
HaeII site) to produce a vector with all three translation frames 
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monitoring plasmid, pKG1800, in which galK expression is dependent 
on transcription initiated at the P.9al promoter. 	However, this 
vector differs from pKOl in that the stop codon in one translation 
phase is separated from the AUG start codon of galK by only 3 bp. 
It is likely that upstream translation terminating at this stop 
codon would strongly affect initiation of galK translation. 	For 
this reason, K. Howe, in our laboratory, constructed vectors analogous 
to pKG1800 but derived from pKOl (Fig. 4.2). 	Translation of the 
galK leader region would, therefore, terminate at least 72 bp 
upstream of the galK coding sequence. 	The first of these vectors, 
pHR1800, is derived from pKQl and pKG1800. 	The 1.09 kb EcoRl/Hindlil 
fragment carrying P.9alwas subcloned from pKG1800 into pKOl, replacinq 
the latter's 0.19 kb EcoRl/Hindill fragment. 	pHR1800 carries 
unique restriction sites for Hindlil and Smal between P1 and galK 
at which restriction fragments produced by these enzymes (or any 
enzymes generating flush-ends) can be cloned. 	The second vector, 
pHR9, is derived from pKG1800 and pK04, a promoter-monitoring vector 
analogous to pKOl. 	pK04 had been derived from pKOl by the insertion 
Of a BamHI linker at its Smal site. 	K. Howe transferred the P.921- 
containing EcoRl/Hindlil fragment from pKG1800 into pK04 to produce 
pHR9, a terminator-monitoring vector suitable for studying Hindlil 
and/or BamHI generated fragments. 
The use of the above vectors should alleviate problems 
encountered when using pMC81 and allow the study of the ted, tec2 
and tec3 fragments in a single system. 	It should, however, be 
noted that, as discussed in detail later, the study of terminators 
even in the pKO system is complicated owing to the lack of control 
over translation in the region immediately upstream of the trans- 
criptional terminator. 	I shall describe the construction of the 
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desired fusions in numerical rather than historical order 
(i.e. ted, tec2, tec3). 
4.2 	Construction of fusions carrying tecl fragments 
Initial attempts to subclone the BamHI-inserts from pAR48 and 
pAR1085 into pHR9 were unsuccessful. 	Donor DNA was digested with 
BamHI, EcoRI, Hindlil and PstI (the latter three enzymes to "smash" 
the pBR322 vector) and ligated to BamHIdigested pHR9 DNA treated 
with calf intestinal phosphatase. 	Following transformation into 
Nba, plating on galactose-MacConkey agar containing ampicillin, 
and overnight incubation at 37°C, the resulting colonies were either 
red or white. 	The red colonies had the same phenotype as N100 (pHR9). 
They could well have been re-created N100(pHR9), but might also have 
included N100 harbouring pHR9/tecl recombinants if these produced 
enough galactokinase to develop the red colony phenotype. 	The white 
colonies could similarly have represented NiDO transformed with two 
kinds of plasmids: pBR322 (or pBR322/tecl); or pHR9/tecl 
recombinants if these produced insufficient galactokinase to allow 
the red colour to develop. 	Restriction analysis of mini plasmid 
DNA preparations from 20 red and 20 white colonies derived from each 
ligation suggested that the red colonies were all N100(pHR9) and 
the white colonies were N100(pBR322), N100(pAR48) and N100(pAR1085) 
(data not shown). 	This conclusion was supported by the observation 
that some white derivatives were also tetracycline resistant. 
Two other subeloning strategies, aimed at minimising recovery 
of the pBR322 vector, were considered. 	The tecl fragments could 
either be purified and used in ligations to pHR9, or an intermediate 
vector could be used to allow selection against donor vector molecules. 
Since further subolonings might be necessary in future, I reasoned 
that the second strategy was more attractive. 	I therefore subcloned 
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each tecl fragment into the plasmid pACYC184. 	This is a 3.97 kb 
plasmid conferring chloramphenicol and tetracycline resistance on 
its hosts (Chang and Cohen, 1978). 	Within this plasmid, insertions 
at a unique EcoRI restriction site disrupt the chloramphenicol 
resistance gene, while insertions at the unique Hindlil, BamHI or 
Sall restriction sites disrupt the tetracycline gene. 	pAR48 and 
pAR1085 DNA were digested with BamHI and ligated separately to 
BamHI-digested pACYC184. 	Following transformation into ED8654, 
plating on L-agar containing chloramphenicol, and incubation over-
night at 37°C, colonies were transferred, by cocktail stick, in an 
ordered array to L-agar containing chloramphenicol, tetracycline or 
ampicillin. 	After overnight incubation at 37°C, 10% of picked 
colonies exhibited a ChlR  Tet5 Amp  phenotype, as expected for 
ED8654 strains harbouring pACYC184 derivatives containing, at their 
BamHI sites, inserts which do not include the amp DNA of pBR322. 
The tetracycline resistance gene of pACYC184 is derived from 
the same source as that in pBR322, and should, therefore, possess 
the same nucleotide sequence. 	Accordingly, pACYC184 should carry 
a 104 bp HaeIII fragment which can be subdivided with BamHI into 
80 bp and 24 bp (Sutcliffe, 1978). 	These predictions were verified 
by digestion of pACYC184. 	The physical structure of plasmid DNA 
from Chl 
R 
 Tet S Amp 
S
colonies derived from both ligations was then 
investigated using mini plasmid DNA preparations. 	Digestion with 
EcoRI, to linearise each plasmid, revealed that, as expected, the 
putative pACYC184/pAR48 recombinants were about 4.6 kb, and the 
putative pACYC184/pAR1085 recombinants were about 4.15 kb. 	Digestion 
with HaeIII revealed that they had all lost the 104 bp fragment and 
gained new fragments of the expected sizes (data not shown). 	One 
plasmid derived from the pACYC184/pAR48 ligation was designated 
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p10124, and one derived from the pACYC184/pAR1085 ligation was 
named p10132. 	ED8654 strains harbouring these plasmids were used 
to prepare plasmid DNA by CsC1-gradient-centrifugation. 
p10124 DNA was digested with BamHI and ligated with BamHI - 
digested pHR9 DNA treated with calf intestinal phosphatase. 
Following transformation into N100, plating on galactose-MacConkey 
agar containing ampicillin, and overnight incubation at 37°C, only 
red colonies were observed (the same phenotype as N100(pHR9)). 
100 colonies were tested for chloramphenicol resistance by picking 
to L-agar containing this antibiotic. 	It was noted that 6 colonies 
were "sickly" on galactose-MacConkey agar containing ampicillin. 
These alone proved to be ChlR,  and could have arisen by double trans-
formation with pHR9 and pACYC184 or by transformation with a 
pHR9/pACYC184 hybrid. 	The colonies were screened further by 
hybridisation with a [ 
32 
 P1-17 DNA probe. 	24 colonies responded 
positively. 	10 of these were analysed by restriction of mini 
plasmid DNA preparations. 	These results suggested that all were 
pHR9 derivatives carrying the 456 bp BamHI tecl fragment. 	Two 
restriction patterns were observed, suggesting that the fragment 
had been cloned in both orientations. 	The plasmid containing the 
fragment in the 'e'-orientation (transcribed in the same direction 
as in 17) was designated p10125. 	The plasmid containing the 
fragment in the 's'-orientation (inverted) was designated p10126. 
Restriction analysis of CsC1-gradient plasmid DNA preparations from 
N100 strains harbouring these plasmids confirmed that their structures 
were as expected (Fig. 4.3, Table 4.1 and Fig. 4.4). 	Note that both 
plasmids have lost the 930 bp, HaeIII fragment of pHR9, which should 
be subdivided by BamHI digestion to yield fragments of 651 bp and 
279 bp (running as 650 bp and 280 bp in my gels). 	Note also that 
Fig. 4.3 
Proposed structures of the constructed galK fusions. 
Restriction sites are represented as follows: HaeIII, S ; Hindill, 
BanHI, t . 	The distances between restriction sites are given 
in base-pairs. 	The sizes of the 190 bp HindIII/HaeIII fragment of 
pHR1800 and the 279 bp BamHI/HaeIII fragment of pHR9 are predicted 
from sequence data (McKenney et al, 1981). 	Similarly, the sizes 
of 17 DNA fragments expected from p16125, p16126, p16134, p16135, 
p16138 and p16139 are also predicted by sequence data (Dunn and 
Studier, 1981). 	The sizes of the 630 bp HaeIII/HindIII fragment 
of pHR1800, the 651 bp HaeIII/BamHI fragment of pHR9 and the T7 
DNA fragments expected from pi6115, p16116 and p16117 are derived 
from restriction analyses reported in the text (sections 4.4 and 
3.4). 	The latter are in good agreement with a more precise 
determination of these distances by DNA sequencing (Chapter 5). 
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TABLE 4.1 
Observed Sizes of 
Plasmid Restriction New Restriction Fragments 
not present in vector (bp) 
p16115 HaeIII 650 and 450 
HaeITI7HindIII 180 
p16116 HaeIII 820 and 305 
HaeITI7HindIII 180 
p10117 HaeIII 820, 	305 and 190 
HaeITT7HindIII 180 
p10125 HaeIII 730, 447 and 215 
HaeIT!7BamHI 215, 	180 and 65 
p10126 HaeIII 850, 	347 and 215 
HaeITi7BamHI 215, 180 and 65 
p10134 HaeIII 1282 and 288 
p10135 HaeIII 900 and 665 
p10138 HaeIII 706, 370 and 170 
p10139 HaeIII 722 and 344 
Expected Sizes of 
New Restriction Fragments 
662 and 470 
180 
831 and 302 
180 
831, 302 and 192 
180 
714, 459 and 213 
213, 180 and 63 
831, 342 and 213 
213, 180 and 63 
1288 and 284 
916 and 656 
720, 375 and 165 
747 and 348 
A summary of the restriction analyses of the galK fusions constructed. 	The estimated sizes of novel 
fragments, not observed on diqestion of vector DNA, are given. 	Sequence data for T7 (Dunn and Studier, 1981) 
and the observed position of the HaeIII site in the 192 bp Hindlil-insert from X105, allow calculation of the 
expected sizes of novel fragments for comparison with my actual estimates (see also Fig. 4.3). 	The 920 bp 
HaeIII fragment containing the Hindill site of pHR1800 was not present in p10115, p10116 or p10117. 
Similarly, the 930 hp HaeIII fragment containinq the BamHI site of pHR9 was not present in p10125, p10126, 
p10135, p10138 and p10139. 
Fig. 4.4 	3-10% Polyacrylamide Gel 
Track DNA Restriction Digest 
1 pBR322 H2eIII 
2 p16125 BamHI 
3 pHR9 HaeIII/BamHI 
4 pHR9 !!11I 
5 p16126 HaeIII 
6 p16125 HaeIII 
7 pHR9 HaeIII/BamHI 
B pIG126 HaeIII/BamHI 
9 p16125 HaeIII/BamHI 
10 pBR322 HaeIII 
Note: 	Sizes of fragments are given in base pairs. 
The marker tracks are pBR322/HaeIII. 	The 930 bp/HaeIII 
fragment of pHR9 is shown intact, and subdivided by Barrtil 
digestion to yield fragments of 651 bp and 279 bp. 	The 
sizes of novel fragments in tracks 5, 6, B and 9 are 
shown. 



















the phenotypes of N100(pIG125) and N100(pIG126)were in the reverse 
order to that expected in simple terms; reduction of galK levels 
had been hoped for in the former but not the latter strain. 
However, cutdown was detected by galK assays in both cases (Table 4.2), 
but only the p10126 derivative showed a noticeably altered colour 
phenotype. 
p10132 DNA was treated similarly, again giving rise only to 
red colonies; 5 of these were "sickly" and ChiR. 	Hybridisation 
with [32P]-T7 DNA revealed that 32% of these colonies contained DNA 
homologous to the probe. 	Restriction analysis of mini plasmid DNA 
preparations from 10 of these suggested that they were pHR9 
derivatives carrying the 164 bp BamHI tecl fragment. 	The two 
restriction patterns observed suggested that this fragment had 
been cloned both in the 'e'-orientation and as two tandem copies in 
the 's'-orientation. 	A plasmid containing a single-copy of this 
fragment in the 's'-orientation has not yet been recovered. 	The 
corresponding plasmids were designated p10139 and p10138 respectively. 
Restriction analysis of CsC1-gradient plasmid DNA preparations from 
N100 strains harbouring pIG138 and p10139 confirmed that their 
structures were as expected (Fig. 4.3, Table 4.1 and Fig. 4.5). 
Note the interruption of the 930 bp HaeIII fragment of pHR9. 
4.3 	Construction of fusions carrying the tec2 fragment 
pAR410 DNA was treated similarly, by cloning the insert first 
into pACYC184 and subsequently into pHR9. 	Ligation of BamHI-digested 
pAR410 with BamHI-digested pACYC184 gave rise to 25% ChiR  Tet5  AmpS. 
Restriction analysis of mini plasmid DNA preparations from 10 of 
these suggested that they were pACYC184 derivatives carrying the 
642 bp BamHI tecl fragment. 	One of these plasmids was designated 
pIG129 and its DNA was purified by the CsC1-gradient method. 	It 
Fig. 4.5 	3-10% Polyacrylamide Gel Electrophoresis 
Track DNA Restriction Digest 
1 pBR322 tt111 
2 pIG134 BamHI 
3 pIG139 BamHI 
4 p16134 HaeIII 
5 pIGl3S HaeIII 
6 pHR9 HaeIII 
7 p16138 tt111 
8 p16139 HaeIII 
The sizes of fragments are given in base pairs. 
The marker track is pBR322/HaeIII. 	The sizes of novel fragments 
in tracks 4, 5, 7 and 8 are shown. 	The 930 bp/HaeIII fragment 






























was then digested with BamHI, and ligated to BamHl-digested pHR9 
treated with calf intestinal phosphatase. Transformation into 
N100 again gave rise only to red colonies. Hybridisation of 100 
of these to a [32P]-T7 DNA probe revealed that 22 of them had 
homology to T7 DNA. 	Restriction analysis of mini plasmid DNA 
preparations suggested that they were pHR9 derivatives carrying the 
642 bp BamHI tec2 fragment. 	The two restriction patterns observed 
indicated that the fragment had been cloned (in single-copy) in both 
orientations. 	The plasmid carrying the fragment in the 'e'- 
orientation was designated pIG134, whereas the plasmid carrying the 
fragment in the 's'-orientation was named pIG135. 	Restriction 
analysis of CsC1-gradient-purified plasmid from strains harbouring 
these plasmids confirmed their expected structures (Fig. 4.3, 
Table 4.1 and Fig. 4.5). 	Note that they lack the 930 bp HaeIII 
fragment characteristic of pHR9. 
4.4 	Construction of fusions carrying the tec3 fragment 
x1G5 DNA was digested with Hindill and EcoRI (the latter enzyme 
to "smash" the X-vector and so prevent transfection during trans-
formation) and ligated to Hindlil-digested pHR1800 DNA treated with 
calf intestinal phosphatase. 	Transformation gave rise to two colony 
phenotypes: 97% red colonies and 3% white colonies. 	This was the 
first subcloning attempted in the pKO system, and it was suspected 
that the white colonies would harbour pHR1800-derivatives containing 
the tec3-insert in the same orientation as in pIG103 (Chapter 3) 
and therefore yielding less galactokinase than pHR1800. 	For this 
reason, these colonies were not screened by hybridisation but 
directly by restriction analysis of mini plasmid DNA preparations 
from 4 white colonies and 18 red colonies (the latter to search for 
tec3 inserted in the inverse orientation). 	Unexpectedly, the 
Fig. 4.6 	3-10% Polyacrylamide Gel Electrophoresis 
Track DNA Restriction Digests 
1 pHR1800 Alul 
2 pBR322 HaeIII 
3 pIG116 Alul 
4 pIG116 Hindill 
5 pHR1800 HaeIII 
6 pBR322 HaeIII 
7 pIG117 HaeIII 
8 pIG116 HaeIII 
9 pIGll5 HaelII 
10 pHR1800 HaeIII/HindIII 
11 pIG116 HaeIII/HindIII 
The sizes of fragments are given in base pairs. 
The marker tracks are pBR322/HaeIII. 	The sizes of novel fragments 
in tracks 3, 7, 8, 9 and 11 are shown. 	The 920 bp/HaeIII fragment 
of pHR1800 is shown intact (track 5) and subdivided with the 















































results indicated that: the 4 white derivatives contained plasmids 
carrying two tandem copies of the tec3-fragment in the 'e'-orientation 
(i.e. the same transcriptional orientation as in p10103); 6 red 
derivatives contained plasmids with single inserts in either the 
or the 's'-orientation; 1 red derivative contained a pHR1800/X 
recombinant; and 9 red derivatives contained pHR1800 itself. It 
was these findings, together with the results of the galK assays on 
these strains (Table 4.2) and the phenotype of colonies derived 
from attempts to subclone tecl and tec2 fragments ,which prompted 
the introduction of the colony-hybridisation step in the screening 
procedure for tecl and tec2 clones (already described). 
One plasmid containing the tec3 fragment in the 'e'-orientation 
was designated p10116 and one with the 's'-orientation was named 
pIG115. 	One plasmid containing two tandem copies in the 
'e'-orientation was designated p10117. 	Restriction analysis of 
C5C1-gradient plasmid DNA preparations from strains harbouring 
these plasmids confirmed their structure (Fig. 4.3, Table 4.1 and 
Fig. 4.6). 	Note the absence of the 920 bp HaeIII fragment of 
pHR1800, which is subdivided by Hindill digestion into 630 bp and 
290 bp. 
4.5 Expression of galK by the novel fusions 
N100 strains harbouring the above fusions were assayed for 
galactokinase activity. 	Comparison with galactokinase levels in 
N100(pHR1800), N100(pHR9) and N100(pKO1) revealed that some of these 
strains did indeed exhibit a reduced expression of galK (Table 4.2). 
N100(pIG125) shows a 78% reduction in galK levels when compared to 
N100(pHR9). 	Similarly, N100(p10136) shows a 98% reduction in galK 
levels. 	The latter strong cutdown was unexpected. 	A priori it 
might be due to the inverted tecl terminator per se, or the 
TABLE 4.2 
The results of 	K assays on N100 strains harbouring ted, tec2 and tec3-g2lK fusions. Each result is 
derived from assays on three separate cultures. 	galK units are expressed in nanomoles of qalactose 
phosphorylated per minute per A650. 	The percentage termination is given where relevant. 	The colony 
colour phenotype of each strain on either qalactose-MacConkey-ampicillin agar (22-26 hour incubation) 

































q.alK Units 	% Termination 
570 (±21) - 
544 (±16) 5 
30 (±4) 95 
0 100 
11  - 
1029 (±50) - 
226 (±8) 78 
20 (±3) 98 
243 (±10) 76 
178 (±7) 83 
1124 (±60) 0 






























coincidental features of the inverted 456 bp DNA insert. 	The 
galactokinase levels observed in the N100 strains harbouring p10139 
and p10138 indicate that the latter explanation may be true. 
N100(p10139) shows a 76% reduction in galK levels, in good agreement 
with N100(p10125). 	N100(p10138), however, shows only an 83% 
reduction in galK levels despite containing two copies of tecl in 
the same orientation as in p10126. 	This suggests that each 164 hp 
(inverted ted) fragment is responsible for an approximate 60% 
reduction of galK expression in p10138. 	Whether this effect is due 
to the inverted tecl terminator itself and/or to other sequences 
in the fragment, the results suggest that the 98% reduction in galK 
seen in N100(p16126) is not exclusively due to the inverted ted 
sequence. 	Other sequences within the 456 bp insert in p10126, or 
at its fusion junctions must play a role. 	In view of the properties 
of the pKO system, these effects are probably transcriptional 
rather than translational. 
N100(p10134) shows a somewhat surprising result in that no 
reduction in galK levels is observed. 	Two possibilities exist to 
explain this: (i) transcriptional termination does not occur; 
(ii) the fusion possesses a promoter of similar strength to 
downstream of the terminator sequence. 	The latter explanation 
would allow transcriptional termination to occur, without it being 
detectable by galactokinase assay. 	This alternative was easily 
tested by subcloning the 642 bp BamHI fragment from p10129 into 
pKO4. 	Transformation and plating on galactose-MacConkey agar 
containing ampicillin gave rise only to white colonies (as N10[1(pKO4)). 
Should such a promoter exist on this fragment, recombinants carrying 
it in the correct orientation would give rise to red colonies (as 
N100(pHR9)). 	It therefore seems unlikely that the observed galK 
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levels in N100(p16134) are due to the existence of tec2 and a 
promoter on the 642 bp fragment. 	N100(pIG135) shows another 
unexpected result: a 99% reduction in galK levels. 	Again, this 
could be due to the inverted (putative) tec2 sequence, or to other 
sequences within or at the junctions of the insert. 
The results obtained with tec3-glJ{ fusions support the hypothesis 
that the reduction in lacL expression produced by the same insert 
in pMC81 (generating p16103) was due to transcriptional termination 
at the putative "tec3" site. 	N100(p16116), with tec3 in the same 
orientation as in p16103, shows a 95% reduction in galK levels. 
N100(pIG117), with two copies of the fragment in the 'e'-orientation, 
shows no expression of galK. 	I infer that the tec3 fragment causes 
termination of transcription (with 95% efficiency) in this orient- 
ation in the pKO system. 	N100(pIG115), with tec3 in the 's'- 
orientation, shows only a 5% reduction in galK levels (which is a 
negligible effect in the standard errors of the results). 
It was surprising that the colour phenotypes of the strains 
isolated were not more distinct from those of strains carrying the 
vector plasmids. 	After overnight incubations (i.e. 14-16 hours) on 
galactose-MacConkey agar containing ampicillin at 37°C, it was 
impossible to distinguish strains producing as few as 20 galK units 
from those with up to 1000 galK units. 	In an attempt to improve 
the sensitivity of this test, strains were streaked on the same 
medium and growth observed at regular intervals from 0 to 30 hours. 
In this way, it was found that distinctions could be made between 
strains harbouring the vectors (pHR1800 or pHR9; 570 and 1029 units 
respectively) and those showing 	95% termination (R 30 units). 
Similarly, strains were grown on galactose-Tetrazolium agar containing 
ampicillin where the colour phenotype of Gal and Gal strains is 
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reversed (Table 4.2). 	This screening proved less demanding in 
terms of incubation times, but again could distinguish between 0 and 
95% termination, but not between 0 and 83%. 	On the MacConkey 
medium, an incubation of 22-26 hours was required for these 
distinctions to be made, whereas the Tetrazolium medium required 
only a 14-16 hour incubation. 	Furthermore, the distinctions on 
Tetrazolium plates became more obvious after further incubation at 
37°C or 20°C. 
The observed difference in q2lK activity between N100(pHR1800) 
and N100(pHR9) is probably due to a plasmid copy number effect. 
N100(pHR9) routinely gives higher plasmid yields than N100/pHR1800 
(2-4 fold). 	This variation is mysterious, as pHR9 differs from 
pHR1800 by only 10 bp; it is as yet unexplained. 	However, the 
derivatives of each vector give DNA yields similar to their parents, 
so that valid comparisons of galactokinase levels are possible. 
Finally, it was surprising to find a reduction in galK levels 
by several "inverted" terminator fragments. 	Consideration of the 
sequences transcribed in each fusion is necessary for interpretation 
of these results. 
4.6 Discussion 
It should be noted, that in the following discussion I assume 
that all observed effects are transcriptional. 	This is likely in 
view of the properties of the galK system, but not definite. 	Other 
effects, e.g. RNA processing, may be involved and cannot be discounted 
until the completion of in vitro transcription studies on these fusions. 
The observed reduction in galactokinase expression caused by 
the inserts in pIG125 and pIG139 suggests an efficiency of term-
ination for tecl in vivo which is in good agreement with the estimate 
1iJ 
of about 7590' made, for 17 itself, by McAllister and Barrett (1977). 
However, this efficiency is somewhat lower than that observed 
in vitro by Millette et al (1970) and Peters and Hayward (1974), 
i.e, 90-95%. 	This discrepancy may reflect an imperfect reconstruc- 
tion in vitro of the intracellular situation due, for example, to 
the omission of an as yet undefined cofactor(s) involved in the 
termination event at ted. 	We can, therefore, speculate on the 
in vivo situation, in the light of the new information that short 
ted-bearing fragments, when cloned in the pIG plasmids, mimic the 
behaviour of tecl in T7 itself. 	Assuming that one or more protein 
factors are missing, they are unlikely to be required for the first 
steps of termination at ted, as in their absence in vitro, these 
first steps occur with an efficiency of at least 95%. 	However, the 
results of O'Hare and Hayward (1981) suggest that the termination 
process is not efficiently completed under these conditions. 	Thus, 
it is possible that the factor(s) shift a termination intermediate 
(formed with 9590' efficiency in vitro) into a new conformation, from 
which 75% of complexes rapidly proceed to complete termination,- 
while 25% proceed to readthrough. 	The first intermediate referred 
to might, for example, be a "paused" complex (termination in vitro 
may follow an alternative non-physiological pathway to completion). 
The alternative possibility is that the cofactor(s) stimulate(s) 
readthrough of ted. 	Assuming a protein:protein interaction for 
antitermination, we have at least four possible ways to explain the 
observed results: (i) the factor(s) may interact with Rpol shortly 
after transcriptional initiation, and associate with it during 
elongation. 	If the initial "loading" is only 25% efficient then 
75% of Rpol molecules will terminate transcription at ted; 
(ii) in the same situation, if the initial "loading" were stoichiometric, 
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a 7590'-efficient "unloading" event upstream of tecl would prevent 
stoichiometric readthrough of the terminator; (iii) the factor(s) 
may interact with Rpol as it approaches ted, affecting only 25% of 
transcribing Rpol molecules as above; (iv) loading may be stoichio-
metric but the factor(s) may be only 25% efficient in catalysis of 
readthrough. 	In any case, we can predict the occurrence of sequences 
analogous to the nut sites of X (Chapter 1) appropriately situated 
in the 17 genome. 	Moreover, these features must be retained or 
mimicked in the pIG plasmids. 
Ponta et al (1974) suggested that the 0.7 gene product is 
required for efficient termination at tecl in vivo. 	If this were 
the case, we would expect less efficient termination in vivo when 
tecl is studied in isolation from gene 0.7, i.e. in N100 (pIG125) 
and N100 (pIG139). 	The observation that tecl stimulates 76-78% 
termination in the pKO system, as in T7 itself, suggest that the 
0.7 gene product is not required for efficient termination at ted. 
However, we cannot exclude the inelegant alternative hypothesis that 
17 infection alters the termination properties of E.coli such that 
gene 0.7 is needed to restore the status quo (at least in respect 
of ted). 
Inversion of the tecl fragments produces somewhat surprising 
results in that we might expect the inverted tecl DNA sequence to 
function much less efficiently as a terminator than tecl itself. 
Calculations based on the "rules" of Tinoco et al (1973) indicate 
that the stem-loop component should have a free energy of -14.4 Kcal 
in its normal orientation, but only -12.4 Kcal when inverted (due to 
the presence of a disruptive C-A mismatch in the inverted structure). 
There is precedent for supposing that this is significant: introduction 
of C-A mismatches in the stems of trp3:4) and XtR1  reduces the free 
energy of these structures (admittedly more markedly than for ted) 
and greatly increases transcriptional readthrough in both cases 
(Stauffer et al, 1978; Zurawski and Yanofsky, 1980; McDermit et al, 
1976). 	Even supposing that the weakened stem-loop of the inverted 
tecl sequence is sufficiently strong to allow termination, termination 
at this site would further require that translation does not prevent 
formation of the RNA stem-loop structure, and that appropriate "tail" 
sequences occur downstream of this structure. 	Examination of the 
p10126 sequence (Fig. 4.8) reveals that translation should terminate 
30 nucleotides upstream of the inverted tecl stem-loop thus allowing 
it to form. 	However, the downstream sequence has only four, 
dispersed T residues out of 11 and also bears no resemblance to 
known rho-dependent terminator "tails". 	Hence, it seems unlikely 
that the tecl sequence per se could produce strong transcriptional 
termination in the inverse orientation. 
In reality, termination is observed both in N100 (p10126) and 
N100 (p10138). 	However, the 9890' termination observed in the former 
plasmid cannot be due exclusively to the inverted tecl sequence, 
because the shorter inverted ted-containing fragment present in 
p10138 causes only 84% termination, despite being present in tandem 
copies. 	(We can estimate that this fragment would cause 60% 
termination in single copy.) 	Termination at the inverted tecl site 
should be immune to translational interference as translation of 
both p10126 and p10138 should stop 30 nucleotides upstream of the 
first inverted tecl stem-loop encountered. 	Hence, we must consider 
the possibility that other sequences within (or at the boundary of) 
the fragment cloned in p10126 may be causing additional transcriptional 
termination. 	Before doing so, a digression to consider the present 
difficulty of recognising potential terminators in a known sequence 
is called for. 
A nucleotide sequence can be scanned by computer to predict 
regions of homology capable of forming stem-loop structures. 	This 
usually reveals a wide variety of relatively stable structures. 
Whether or not these should be considered putative transcriptional 
terminators depends on at least two further factors: (i) there 
should be no translation through the corresponding segment; (ii) 
there should be a suitable downstream sequence (T-rich, or resembling 
the CAATCAA consensus). 	Unfortunately, even with these criteria, 
it is difficult to predict with confidence that the putative 
terminator will actually function. 	Moreover, all available computer 
programmes, to my knowledge, depend upon initial identification of 
inverted-repeat sequences; yet the 12t' terminator does not possess 
such a feature. 	(Indeed, none of the 	features which make this 
a terminator are at all clear.) 	Terminators similar to ipt' will 
therefore, be missed by the computer. 	Finally, prediction of the 
stability of possible stem-loops is achieved using rules derived 
from those of Tinoco et al (1973). 	Recent evidence confirms a 
long standing suspicion that these rules leave something to be 
desired, essentially because they are based on studies of an 
insufficient range of different synthetic oligonucleotides. 	One 
obvious defect of "Tinoco's rules" is that they ascribe essentially 
no stabilising influence to the G:U base pair. 	The existence of 
G:U base pairs, first suggested by Crick (1966) to explain the 
degeneracy of the genetic code, has now become an accepted feature 
of RNA secondary structure. 	The confirmed existence of the G4-U69 
base pair in tRNAPhe  (Quigley et al, 1975; Ladner et al, 1975) 
supported the hypothesis of Lomant and Fresco (1975) that G:U and 
G:T base pairs could occur in helical structures containing 
predominantly Watson-Crick base pairs. 	However, unequivocal proof 
of G:U base pair formation required the discovery of hydrogen-bonded 
imino-ring proton resonances in the 1HNMR spectra of tRNA (Johnston 
and Redfield, 1978, 1981; Robillard et al, 1976). 	Further support 
came from NMR- and ethidium bromide binding-studies of poly 
[d(GpTp)], which found that the polymer formed a stable double-helix 
(Early et al, 1978). 	Finally, the existence of G:U base pairs in 
the double-helical regions of tRNA was firmly established by NMR- and 
nuclear Overhauser effect-studies (Reid et al, 1979; Hurd and 
Reid, 1979; Johnston and Redfield, 1978, 1981). 
What degree of stabilisation does a G:U base pair provide to 
an RNA double-helix? 	This appears to depend on adjacent sequences. 
Uhlenbeck et al found that terminal G:U base pairs were as stable 
as terminal A:U base pairs. 	Clarke (1977) suggested that internal 
G:U base pairs could be accommodated in an RNA double-helix without 
causing gross helical distortion. 	He suggested, however, that such 
a base pair is a centre of potential weakness, as it requires a 
certain accommodation of the helix backbone if two H-bonds are to 
be made. 	Two lines of evidence provide a more direct insight into 
the influence of internal G:U base pairs on RNA secondary structure. 
An NMR-study of a short RNA duplex (CpApUpUpGp:CpApGpUpGp) indicated 
that such a base pair did not stabilise the duplex, and was in fact 
a distinct centre of instability (Romaniuk et al, 1979). 	An 
extension of this work studied the RNA duplex ApGpCpCpUp:ApGpUpCpUp, 
where the G:U base pair is flanked not by A:U but by G:C base pairs 
(Alkema et al, 1982). 	G:C base pairs are considerably stronger 
than A:U base pairs, and were expected to allow less conformational 
perturbation of the helix backbone. 	Here, the G:U base pair was 
found to contribute an increase of duplex stability, comparable with 
that found for an internal A:U base pair. 	Hence, it seems clear 
that G:U base pairs can stabilise RNA secondary structure in 
some sequences. 
Recent studies confirm that the influence of all non-bonded 
base oppositions is, as suggested by Tinoco et al (1973), disruptive. 
However, the severity of the effect depends on the bases involved, 
as does the possibility that more exotic secondary conformations 
may be formed. 	Some authors suggest that A.A, C.A and C.0 base 
oppositions can be accommodated within a standard RNA duplex without 
looping out (Alkema et 21, 1982; Lomant and Fresco, 1975). 	It 
is generally accepted, however, that all other mismatches take up 
an extra-helical conformation (for review see Lomant and Fresco, 
1975). 	Tinoco et al considered that all unpaired base oppositions 
would affect the stability of an RNA structure equally, and so 
assigned to them all a penalty of +2 Kcal when calculating the free 
energy of potential structures. 	Clearly, this may not be justified 
if A.A, C.A and C.0 base oppositions are indeed able to stack in an 
RNA double-helix without appreciable backbone distortion. 	The 
true penalties in these cases may be negligible, even if they 
contribute no extra stability. 
The rules of Tinoco et al have undoubtedly been of value in RNA 
secondary structure studies. 	However, it is now evident that 
predictions based on them may be inaccurate and in some cases 
midleading. 	Further research is required before accurate estimates 
of the stability of potential RNA secondary structures can be made. 
I have, in practice, found the current computer approach to 
prediction of terminators unhelpful and shall not discuss it further 
in the present context. 	Rather, I will identify sequences (without 
calculating free energies) which are similar to other known terminators, 
allowing both G:U pairing and single, non-bonded base oppositions. 
Viewed in this way, p10125 (Fig. 4.7) possesses three reasonably 
stable "hairpins", one of which is the known tecl stem-loop (309-316 
and 321-328). 	Termination here is known to be rho-independent. 
Two-thirds of the in vitro transcripts end in a C (position 335) 
and the remaining one-third end in the following 0 (position 336) 
(Dunn and Studier, 1980). 	Termination occurs in a U-rich region 
(7/11), although there are no more than 3 consecutive U-residues. 
As might be expected, this sequence shows no homology to the CAATCAA 
consensus (i.e. the rho-dependent terminators, Xt R11 tRNATYr and 
AtRo). 	Upstream of ted, another possible hairpin with a 5 bp 
stem and a 6 nucleotide loop lies within the cloned fragment (117-121 
and 128-132). 	However, the sequence following this stem has only 
5/11 1-residues, and shows no homology with other known terminators 
suggesting that it may not have termination potential. 	The third 
possible hairpin overlaps the right-hand BamHI site and has a stem 
of 6 bp with a loop of 2 nucleotides (500-505 and 508 and 513). 
Following this, the sequence CAATAA bears some resemblance to the 
CAATCAA consensus. 	However, the smaller tecl fragment in p10139 
possesses only the tecl sequence, yet N100 strains harbouring p10125 
and p10139 exhibit similar efficiencies of termination. 	It, there- 
fore, seems likely that the termination observed in these strains 
is due solely to the tecl sequence (although we cannot formally 
exclude other sequences present in the p10139 insert). 	The other 
two hairpins present in the pIG125 insert are probably inactive. 
Consideration of the predicted translational properties of the 
cloned sequences casts further light on the situation. 	In pIG125, 
ribosomes should enter the mRNA corresponding to the cloned fragment 
out of phase and terminate translation 218 nucleotides upstream of 
the normal T7 gene 1.3 stop codon. 	In pIG13,  however, translation 
Fig. 4.7 
The predicted nucleotide sequence around the insert in pIG125 
is shown. 	The symmetries noted in the text are underlined with 
arrows. Translation entering the insert is marked by " 	" and 
is termed phase 1. 	Translation stop codons are underlined and their 
phase is recorded in brackets. 
Fig. 4.7 	T7 tecl in pHR9 	-4 
1 	 50 
I 	 I 
GATCAGCCCAAAATTCCATACGTTGAAAGCTTACTCCCCATCCCCCCGGA 
	
(1) 	 100 

















I 	 I 	 I 	 I 
TGACGCTTGCGTATATTCTTGCGGTATACCCTCAAGTAGCACTAGTAGTA 
500 





The predicted nucleotide sequence around the insert in pIG126 
is shown. 	Details are marked as in Fig. 4.7. 
Fig. 4.8 	T7 tecl in pHR9 	4- 
1 	 50 
I 	 I 	 I 	 I 	 I 	 I 
CATCACCCCAAAATTCCATACCTTCAAACCTTACTCCCCATCCCCCCGGA 
(1) 	 100 
TG AAC TA TAC IC CAC ACGC A ACCA CAC ACT CCCGCT AAG TAA CAAGC — 
	
(2) 	() 	150 
CCCAACTACTACTAGTGCTACTTGAGGGTATACCGCAAQAATATACGCAA 
(3) 	 200 
GCGTCAGGATAGC TGCCAAAGCCGCAAGGAATTTACCAAICTTCTTAAAC 
250 
I 	 I 	 I 
ATAAACTGTCTCCTTATAAACGCAGAAAGGCCCACCCGAAGGTGArccAG ) 
300 
I 	 I 
TCTGATTACATTTTCTCTTGAGGGTTGTCCTCGGTGCCACGGAACATTAC > < 
350 
I 	 I 
C AAC GATG CC TGC CC CA AAC AG CCATC AGG TGTTTCC TCC ATCT AGCT AA 
4.00 
I 	 I 
TTTGACACGCCCACCCATCGTAAGGCTTAATAGTACAAGCATCGTTGTCG 
4.50 
I 	 I 	 I 
CCAATACCGTATGGCCTAAACAATCCCCATTGACTTAGCGTGGCCTCTTT 
500 
I 	 I 	 I 
TACTGTCTCAGTGAACTCATCCATTAAGCCGCGAGAGATATTCGTGGCGT 
T CCC GATCCC CCC CC AA I AA > < 
Fig. 4.9 
The predicted nucleotide sequences around the inserts in pIC139(a) 
and pIG138(b) are shown. 	Details are recorded as in Fiq. 4.7. 







ACCCTCAAGACAAAATGTAATCACACTGGC ICACCI TCGGGTCGCCCTTT 
> 	K 
(1) 	




N.B. Stops at same translation stop as 17 in vivo. 
(b) 	17 ted (142 bp) fragment in pHR9 	c 
1 so I 
GATCAGCCCAAAATTCCATACGTTGAAAGC TTACTCCCCATCCCCCCGGA 
(1) 	 100 
TAGATCCGCGCAACGAATTTACCAAC ITCTIAAACATAAAGTGTCT 
(1) 	(1) 	150 
CCTTATAAACCCAGAAAGCCCCACCCGAAGGTGAGCCAGTGTGATTACAT 
(1) 	 200 
I TIC TCT TGACGG TTGT CC I CCGTG CCACG C AACAT I ACG A ACCAT CCCI 
250 
I 	 I 
GCCCCCCATCTCCATCCAGATCCGCCGCAACGAATTTACCAACCTTCTTA 
300 
AACA TAAAG T CTC TCCT TAT AAACGC AG AA AGGCCC ACC CC AACC IC AC 
:1 
350 
I 	 I 	 I 
CAGTGTCATTACATTTTCTCTTGAGGCTIGTCCTCGCTGCCACCGAACAT ) 
I 	 400 
TACGAACGATCGGTGCCCCdGATCTGGATCGGGGGCAAAAGCGCTGCA 
CGCGCACTITTATC 
N.B. Three stops before inverted tecl stem. 
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should enter the insert in phase, and therefore terminate at the 
normal place (1.3 gene stop). 	My results indicate that this 
difference has little or no effect on the efficiency of termination, 
suggesting that the final position of upstream ribosomes on the 
transcript does not influence termination at tecl significantly. 
Note that translation is unlikely to reinitiate upstream of tecl on 
the pIG125 mRNA. 	However, ribosomes may well initiate at the 
putative gene 1.4 start (nucleotide 355: Boothroyd and Hayward, 1979) 
in the mRNA derived from both plasmids. 	This may explain why the 
potential terminator downstream of tecl in pIG125 is apparently not 
functional. 
Four potential hairpins arise from the pIG126 insertion, only 
one of which shows downstream sequence homology with known terminators. 
The first has a 7 bp stem (including a C.0 mismatch) and an B nucleo- 
tide loop (83-89 and 98-104). 	The second is the inverted ted 
sequence with its internal C.A mismatch (229-236 and 241-248). 	The 
third has a 7 bp stem and a 3 nucleotide loop (268-272 and 278-284). 
The fourth is identical in sequence to the third in pIf125 (500-505 
and 508-513) and is followed by CAATAA which resembles the CAATCAA 
consensus. 	The first structure is in a translated region, and will 
therefore probably not function as a terminator. 	Translation will 
stop 56 nucleotides upstream of the inverted tecl sequence. 	Assuming 
that translation does not restart the remaining three structures 
might all contribute to transcriptional termination. 	The 98% 
termination observed in NiDO (pIG126) must be due to the presence of 
more than one region, as in NiOD (pIG138) we see only an estimated 
609('] termination per fragment. 	The insert in this case includes only 
the second and third possible hairpins. 	Thus it seems possible that 
the fourth hairpin of pIG126 is responsible for efficient transcriptional 
Fig. 4.10 
The predicted nucleotide sequence around the insert in pIG134 
is shown. 	Details are marked as in Fig. 4.7. 
	
Fig. 4.10 	17 tec2 in pHR9 —* 






I 	 10 
CTCGTGTACAGTTTAAACAACGTGAATCTACTGACGCAATCTTTGTTCAC 
200 
























termination (just beyond the end of the inserted sequence). Although 
an identical sequence seemed not to function in p10125, we have seen 
that this could reflect translational interference in that case. 
Finally, the results for p10138 indicate that weak termination of 
transcription (totalling 60%) may be generated by one or both of 
the other potential hairpin structures (the second and third noted 
above for p10125) despite their lack of convincing downstream 
"terminator-tails". 
The most surprising observation in this chapter was the failure 
of the insert in p10134 to cause any reduction of galactokinase 
expression. 	There is evidence that transcription by E.coli Rpol 
terminates near position 28% on the 17 qenome, as well as at ted 
(Minkley and Probnow, 1973; Peters and Hayward, 1974). 	The BamHI 
fragment contained in p10134 is thought to originate from the region 
which should contain this termination site (Dunn and Studier, 1981, 
1982). 	However, some doubt exists as to whether the fragment has 
been correctly identified. 	According to Studier and colleagues,it 
should also encode an RNAse III target located just ahead of gene 
3.8. 	Nevertheless, they have been unable to demonstrate cleavage 
by this enzyme of RNA transcribed from the plasmid containing the 
fragment (Dunn and Studier, 1982). 	However, my restriction data 
are consistent with predictions from the sequence they have deter- 
mined for this fragment. 	I must, therefore, assume that it has been 
correctly identified. 	The fragment (Fig. 4.10) contains twelve 
regions of significant inverted-symmetry, the strongest of which is 
that suggested by Hayward (1981) as a potential tec2 site (567-578 
and 584-595). 	It lies in an intercistronic region (between genes 
and 
3.5 and 3.8), shows stem-loop/3'-sequence homoloqy to the tecl sequence 
(including 2 similar distribution of U-residues: 7/12) and has a 
go 
sequence GCA appropriately positioned (in comparison to ted) to 
allow termination. 	Termination here would be expected to be 
mainly at a C preceding an A, thus explaining the dinucleotide 
sequence result of Peters and Hayward (1974). 	Other symmetries 
occur at: 152-157 and 161-166; 197-199 and 203-205; 331-333 and 
338-340; 336-340 and 346-350; 445-449 and 458-462; 477-479 and 
483-485; 531-535 and 540-544; 679-681 and 686-688; and lastly, 
688-691 and 694-697. 	Despite the abundance of inverted-symmetries 
in this fusion, termination was not observed. 	It was expected that 
the fragment should contain the tec2 termination site and that this 
at least, would cause some reduction in galactokinase expression. 
Translation should be unable to interfere with operation of the 
proposed tec2 terminator (even with an aberrant "restart" trans-
lation upstream) because there are stop codons in all 3 reading frames 
immediately before tec2 (540-542; 550-552; 554-6; and 558-560). 
Perhaps 567-595 is not the genuine tec2 stem-loop. If so, it seems 
unlikely that this terminator exists on the fragment cloned'; the 
nucleotides up to number 94 are part of T7 gene 3; 97 to 549 
constitute gene 3.5; and gene 3.8 starts at 616 and continues beyond 
the end of the cloned fragment (Dunn and Studier, 1981). 	Thus 
567-595 has the only plausible stem-loop potential (in the cloned 
DNA) which lies in an untranslated region of the original genome. 
Perhaps tec2 requires additional sequences not present in this insert, 
and/or a particular Rpol-cofactor interaction, for efficient 
termination. 	Finally, it is possible that the tec2 sequence is not 
located on this fragment at all, but in a region adjacent to it in 
the 17 genome. 
A further surprising result is that this fragment in the inverse 
orientation (p10135) reduces galactokinase expression by 99%. The 
Fig. 4.11 
The predicted nucleotide sequence around the insert in 
pIG135 is shown. 	Details are recorded as in Fig. 4.7. 
Fig. 4.11 17 tec2 in pHR9 
1 	 50 
GATCAGCCCAAAATTCCATACGTTGAAAGC TIACTCCCCATCCCCCCGGA 





(3) 	 200 
AGGGAAACCGCTG1GGTCTCCTTTAGTGAGTTCAATTAATTATCCACGG -- 
(1) 	(1) 



























C AAT AAGGCC TGC AC GCGC ACTTT I AT C 
1ip 
fusion (Fig. 4.11) contains twelve inverted-symmetries, and one 
A/T rich region (similar to !t')  with 28 A:T in 40 bp (640-680). 
The symmetries are in the following regions: 46-49 and 52-55; 
62-64 and 66-68; 149-159 and 165-175; 248-253 and 259-264; 253-255 
and 258-260; 264-266 and 267-269; 280-285 and 294-299; 360-364 
and 372-376; 403-405 and 411-413; 537-541 and 543-547; 573-579 
and 584-590; and lastly, 687-691 and 694-698. 	Translation from 
the galE region of mRNA would be expected to stop at position 177, 
where two tandem stop codons occur. 	This would probably prevent 
the formation of the first three potential mRNA stem-loops. 	There 
is no obvious restart sequence for translation downstream, so the 
remaining stem-loops may well form. 	Termination is presumably 
arising from one or more of these inverted-repeats, and/or the A/T 
rich region noted earlier. 
Concluding this consideration of nucleotide sequence, it is 
evident that I have only been able to speculate on the sequences 
involved in any observed reduction of galactokinase expression 
(presumably through transcriptional termination). 	Those terminators 
suggested must be viewed as tentative. 	Note, however, that the 
majority of the inverted-repeats discussed lack 3'-sequence homology 
with other known terminators. 	Furthermore, many would be present 
on the untranscribed strand of T7, and would therefore not be 
expected to function during phage infection. 	Should future in vitro 
experiments succeed in defining the 3'-ends of transcripts derived 
from these plasmids, they may provide useful information regarding 
"novel" termination signals. 
The observed 95% reduction in galactokinase levels arising from 
the insert in pIG116 suggests that the reduced lacZ expression 
characteristic of pIG103 does indeed reflect transcriptional termination. 
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Why then should we see a greater termination efficiency in N100 
(p10116) than in MC1000 (p10103) (98% versus 78%)? 	This may reflect 
translational interference with the termination event in MC1000 
(p10103). 	On the other hand, insertion of a fragment in pHR1 
could relieve polarity inherent in the vector, partially cancelling 
the effect of the newly introduced terminator. 	These possibilities 
serve to stress the inadequacies of the pMC81 system when compared 
to the pKO system. 	Only the latter will be considered from here on. 
It should, however, be noted that the difference in promoters 
between p10116 and p10103 could be relevant for terminator efficiency 
(c.f. Howe et al, 1982). 
Inversion of the tec3 fragment results in normal levels of 
galactokinase, suggesting that termination does not occur in this 
orientation. 	In light of other results, this is unusual. 	Most 
fragments show some degree of termination in both orientations. The 
special properties of the tec3 fragment may become understandable 
when we consider the nucleotide sequence of the insert and its flanking 
regions (Chapter 5). 
Footnote: 	A "nusA box" has recently been identified as a consensus 
sequence with which pnusA is presumed to interact (D. Friedman, 
pers. comm.). 	The sequence COCTCTTA occurs just upstream of phaqe 
lambda's N protein targets (xnutL and XnutR) and (with slight 
variations) at 021nutR and P22nutL. Closely related sequences are 
observed near trpt (COCAGTTAA, also OOCATTTTAA near the point of 
termination); !t'  (TGC0CTTAA) and the rrnB "attenuator" (TOCTCTTTAA). 
Examination of the T7 DNA sequence (Dunn and Studier, 1981) and the 
sequencpresented here reveals the following: a possible "nusA box" 
at 812-821 nucleotides in the T7 genome (COCTCTTTAA) just downstream 
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of E.coli Rpol promoters A1, A2 and A3; two possible "nusA boxes" 
near the tecl sequence, one just upstream of it, at nucleotides 74-83 
in Fig. 4.7 (CGCGCCTTAA) and one overlapping the point of termination, 
nucleotides 332-340 in Fig. 4.7 (TGCGTTTA); and one possible "nusA 
box" within the A/I rich region noted in pIG135 (Fig. 4.11) (GCCATTA). 
We can, therefore, reconsider the questions raised at the start of 
this discussion concerning termination at ted. 	It seems plausible 
that pnusA associates with E.coli Rpol, near the A-promoters of 17, 
and accompanies it during its transcription through the extensive 
"early" region (see Greenblatt and Li, 1981, for the current model 
of nusA protein function). 	Should this be the case, the sequences 
near tecl may favour termination by acting as auxiliary "loading/ 
reloading" sites, or conceivably as "recognition sites". Such 
sequences might be required if the efficiency of termination is 
controlled passively by detachment of pnusA from some transcribing 
complexes, or actively by interaction of pnusA with the "nusA box" 
such as to cause a conformational change in the attached Rpol, 
stimulating termination. 	It should be noted that there is a lack 
of nonsense polarity in the 17 early operon. 	In view of this, an 
antitermination action (possibly via pnusA) seems highly plausible 
and therefore an "unloading" or a "conversion to termination factor" 
site might well be required near ted. 	However, the first potential 
"nusA box" is not present in pIG139, yet the inserts in pIG125 and 
pIG139 produce a similar termination efficiency. 	It remains 
plausible that the potential "nusA box" overlapping the termination 
site is required for termination by one of the means discussed 
above. 	These observations also suggest 
93. 
another possible reason for the failure of the putative tec2 
terminator to function in NiOD (pIG134). 	Perhaps pnusA interactions 
well upstream of this terminator at targets not included in pIG134 
are necessary for termination at tec2? 	It should be noted that a 
potential "nusA box" (ACCGAATTA) occurs early in P4 initiated 
mRNA (Merril eta]., 1981). 
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CHAPTER 5 - DETERMINATION OF THE LOCATION OF tec3 IN THE T7 CENOME 
AND OF ITS DNA SEQUENCE 
5.1 Introduction 
The fact that the tec3 fragment appears to cause termination of 
E.coli Rpol-mediated transcription in p10103 and p10116 raises two 
questions: 
I) From what part of the 17 genome does this fragment originate? 
ii) What is its nucleotide sequence? 
The former question is important as the tec3 fragment is not 
predicted by the known nucleotide sequence of the first 12,000 bp 
of the 17 genome (Dunn and Studier, 1981) which includes all regions 
of the genome normally transcribed by E.coli Rpol. 	Mapping of the 
tec3 fragment might therefore suggest other interactions of E.coli 
Rpol with the phage DNA, apart from its transcriptional activities 
in the 'early' region. 	Furthermore, the nucleotide sequence of the 
tec3 fragment may suggest the region in which termination is 
occurring and should allow comparison of this sequence with known 
terminator sequences. 	In this chapter, I shall describe the 
determination of: (i) the nucleotide sequence of the tec3 fragment; 
(ii) its map position; and (iii) its orientation. 
5.2 Determination of the nucleotide sequence of the tec3 fragment 
Of the nucleotide sequencing methods that have been developed 
so far, one of the most simple, rapid and accurate is the "M13 dideoxy" 
method developed by Sanger. 	This technique has been discussed at 
length in the literature, and will simply be outlined here. 	It 
makes use of the ability of E.coli DNA polymerase to copy a single-
stranded DNA template faithfully, using a short DNA fragment as primer; 
and it exploits the E.coli,ma].e-specific, single-stranded,filamentous 
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DNA phage M13. 	Foreign DNA can be cloned into the double-stranded 
Replicative Form (RF) of one of the genetically engineered vector 
phages available. 	The insertion inactivates a segment of the 
-galactosidase gene contained in each vector. 	This segment allows 
the development of a Lac+  phenotype in lacZ hosts containing an 
F-prime carrying a second, complementary segment of the -galactosidase 
gene. 	Strains containing vector molecules produce blue plaques on 
XG/IPTG plates, whereas those containing recombinant phage give rise 
to colourless plaques. 
After infection, a single-stranded form of the phage (always the 
positive strand) is extruded without cell lysis. 	This is easily 
purified and, using a single, small DNA primer (suitable for all 
inserts) can be used to make radioactivecomplementary copies of 
the inserted DNA segment. 	The large fragment of DNA polymerase I 
("Klenow enzyme"), which lacks the 5"43' exonuclease activity of the 
intact molecule, is used to make these copies. 	DNA synthesis is 
carried out in four separate reactions in the presence of all four 
deoxyribonucleoside triphosphates (one or more of which is 32  P_ 
labelled) but with only one of the four dideoxyribonucleoside 
triphosphates in each reaction. 	Once the analogue is incorporated, 
the 3'-end is no longer a substrate for chain elongation and the 
growing chain is terminated. 	Hence, each reaction provides a 
population of partially synthesised, radioactive DNA molecules each 
having a common 5'-sequence and 3'-termin2l base but each varying 
in length. 	Parallel size fractionation of the four reaction products 
on a denaturing polyacrylamide gel and autoradiography allows 
visualisation of the various DNA chains. 	The DNA sequence can be 
read as a ladder representing the shortest chains (5'-end) at the 
base of the gel to the longest chains (3'-end) at the top of the gel. 
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The resolution of the gel determines the length of the DNA sequence 
that can be discerned. 	The technique is summarised in Fig. 5.1. 
Accordingly, pIC116 DNA was digested with Hindlil and ligated 
to Hindill digested M13mp2/HindIII DNA (a Hindill or EcoRI vector). 
Following transformation into JM101, potential recombinants were 
identified by their colourless plaque phenotype. 	These were 
purified, picked in an ordered array to a lawn of .JM101 and probed 
by hybridisation to [32P]-T7 DNA. 	A possible source of confusion 
is that M13 preparations generate deletions upon self-ligation, 
giving rise to colourless phenotypes. 	Screening by plaque 
hybridisation ensures that only true recombinants will be selected 
for sequencing. 	Single-stranded template DNA purified from 36 
recombinant phage was used in 'T-screen' reactions to search for 
clones containing the insert in both orientations. 	This entailed 
using each template in a single base-specific reaction (in this 
case with ddTTP). 	Size fractionation of the products on a poly- 
acrylamide gel, followed by autoradiography, allows visualisation 
of a pattern characteristic of each template, representing the 
position of every 'P in the sequence. 	Two patterns should be 
found,representing phage containing the tec3 insert in the two 
possible orientations. 	However, of the 36 templates screened, all 
gave the same characteristic pattern; all must have their inserts 
in the same orientation. 	Further attempts to find the opposite 
orientation were not made as I reasoned that the failure to find 
this among 36 isolates must imply that there is a strong selection 
against it. 	Although the reason for this remains obscure, it is a 
fairly common problem in M3-cloning. 	It was therefore only 
possible to sequence the insert using one strand as template, 
without confirmation from the opposing strand. 	The determined 
Fig. 5.1. 	Flow diagram summarising the M13 dideoxy sequencing 
technique. 
Fragments can be cloned at the EcoRI or Hindlil sites in M13 mp2/ 
Hindill; the sequence around these sites is shown. 	Following 
single-stranded template preparation from recombinant phage, a 
short DNA primer is annealed to the recombinant so as to allow DNA 
synthesis through the cloning sites. 	The 3'-termini of the 26 bp 
'universal' primer is shown. 	The primed template is used in four 
DNA synthesis reactions containing the four dNTPs (one of which 
32 
is alpha-labelled with 	P), Klenow polymerase, and one of the 
four ddNTPs. 	The partially synthesised, labelled DNA chains 
(each having a common 5'-terminus) are separated on a denaturing 
polyacrylamide gel. 	The smallest DNA chains migrate to the 
bottom of the gel whilst the longer chains migrate through the gel 
in proportion to their size. 	The sequence is read as a ladder 
from the base to the top of the gel. 
M13mp2/ Hind ffl 	EcoRI 	Hifldfll 	[ç.QRI 
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Fig. 5.2 
A typical sequencing gel.. 	The position of the tentative HaeIII 
site is shown. 	The sequence of the T7 Alul fragment in p16115-117 
reads as follows: 






Note N/M  are possible bases where N is the likelier. 	In both cases, 
the sequence of Dunn and Studier (1982) verifies the likelier base. 
The only difference between my sequence and that of Dunn and Studier 
(as mentioned in Chapter 5, discussion) is that I assign a T-residue 
at position 133 whereas they assign a C-residue at this position. 
Tracks 1-5 define the position of the HaeIII site within the 
Hindlil insert. 
Track DNA Restriction Digest 
1 plC115 HaeIII 
2 p16115 HaeIII/!I 
3 pBR322 HaeIII 
4 p16115 jI/HindIII 
5 pHR1800 HaeIII 
The marker digests are pBR322 and pHR1800, fragment sizes being 
recorded in base pairs. 	The sizes of novel fragments in p16115 
digests are shown. 	This data is consistent with the HpaI site 
being centred 155 bp from the HaeIII site. 
Fig 5-2 























sequence predicts that the Hindill fragment is 189 bp and the Alul 
fragment 179 bp, with an internal HaeIII site centred 11 bp from 
the middle of the Hindill site at one end of the fragment. 	It 
also predicts an internal HpaI site, 155 bp from the HaeIII target. 
The HaeIII site was tentative as C-C rich sequences are often 
difficult to read in M13 sequencing. 	Its position was verified 
by jpI/HaeIII digestion of pIG115 (Fig. 5.2), and proved useful 
in determining the orientation of the fragment. 
5.3 Determination of the location of tec3 in the 17 aenome 
This was achieved by hybridisation of a [32P]-pIGll6 DNA probe 
to various restriction digests of T7. DNA. 	The enzymes HpaI, 
Aval, HindII and HaeII produce a wide size range of 17 fragments 
(Rosenberg et al, 1979; Boothroyd, 1979). 	Digests of T7 DNA 
generated by these enzymes were fractionated by 1% agarose gel 
electrophoresis and transferred to a nitrocellulose filter by the 
procedure of Southern (1975). 	Hybridisation of a [32P]-pICll6 
DNA probe to this filter revealed that the plasmid had homology with 
HpaI "C", KpnI "A", Aval "F", Hindu "D21'and HaeII "D" (Fig. 5.3). 
The control hybridisation of [ 32P]-pHR1800 DNA to an equivalent 
filter showed that the vector molecule did not hybridise to any 17 
DNA fragments. 
These results strongly suggest that the tec3 fragment contained 
in pIC116 originates from a region of approximately 675 bp internal 
to the T7 gene 15 (T7 co-ordinates 72.4% to 74.09%). 	This was 
somewhat surprising in that the fragment appears to lie within the 
coding sequence of a coat core protein, in a region transcribed by 
T7 Rpol. 	Furthermore, the occurrence of an internal HpaI site 155 bp 
from the HaeIII site and the fragment's observed homology with T7 
HpaI "E" suggests that this fragment overlaps the Hpal site at the 
Fig. 5.3 	1% Agarose Gel Electrophoresis 
The T7 digests hybridised to [32P]-pIGll6 DNA are shown (tracks 1-6). 
Tracks 7-12 show the resulting autoradiograph revealing fragments 
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right end of Hpal "E", and lies mostly within HpaI "E". 	If so, 
the fragment in pIG103 and pI1116 has a transcriptional orientation 
opposite to that in 17. 
5.4 Determination of the orientation of the tec3 fragment in the 
T7 genome 
To test the conclusion that the HaeIII site in the tec3 fragment 
lies within JE1 "E", I investigated the position of the HaeIII 
sites around the Hpal site at 74.09% (Fig. 5.4). 	Restriction data 
from this region predict that an Aval site occurs approximately 497 bp 
downstream of the HpaI target (i.e. in HpaI "P"). 	This Ava I site 
is at the right-end of Aval 	which I purified from a 1% agarose 
gel following electrophoresis. 	The 5'-termini of the fragment 
were labelled with 
32 
 P using polynucleotide kinase, and the 
fragment was digested with HaeII to separate the labelled ends. 
The left-hand heterospecific fragment is about 880 bp, and the 
right-hand one is about 1160 bp. 	These were separated by electro- 
phoresis on a 5% polyacrylamide gel and the larger labelled fragment 
was purified by passive elution. 	This heterospecific fragment, 
with label at one end, was then partially digested with HaeIII. 
Following electrophoresis on a 3-10% polyacrylamide gel, and 
autoradiography, two labelled sub-fragments were observed, one of 
about 1160 bp and one of about 638 bp. 	This suggests that there 
is only one HaeIII site in the 1160 bp heterospecific HaeII-AvaI 
fragment from the right-hand end of Aval U[H 	Furthermore, the 
HpaI site (at 74.09%) is approximately 497 bp and the HaeIII site 
approximately 638 bp to the left of the labelled Aval site. 	This 
places the HaeIII site nearest to HpaI - 74.09% about 141 bp to its 
left, and confirms the suspected orientation of the tec3 fragment 
Fig. 5.4 	3-10% Acrylamide Gel Electrophoresis 
Partial HaeIII digestion of the labelled, right-hand, hetero- 
specific fragment produced on 	HaeII digestion of 5'-labelled 
T7 Aval "E". 	The marker track is pBR322. 	The sizes of fragments 
are recorded in base pairs. 
12345 
116O . 
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in the T7 genome, i.e. opposite to its transcriptional orientation 
in p10103 and p10116. 
Finally, it should be noted that the conclusions from sections 
5.3 and 5.4, and the sequence determined in section 5.2, are all 
supported by sequence data received recently from Dr ].Dunn, who 
has just completed the nucleotide sequence of the whole T7 genome. 
The few differences between our sequence data are recorded in Fig. 5.2. 
5.5 Discussion 
The data presented in this chapter unequivocally map the tec3 
fragment within the T7 genome to the region of the Hp2I target at 
74.09%. 	The sequence determined for the fragment (Fig. 5.5) can be 
examined for plausible termination sites, as in Chapter 4. 	Three 
inverted-repeats are evident in pIG115: 51-56 and 61-66; 71-74 and 
79-82; and 138-144 and 150-156. 	None of these shows good homology 
to known transcriptional terminators on their 3'-flanks. Furthermore, 
ribosomes entering the mRNA corresponding to the insert, from galE', 
are predicted to continue all the way through the T7 sequence. It is 
therefore not surprising that galactokinase levels in NiOD (p10115) 
suggest no termination of transcription by the insert. 	Even if any 
of the inverted-repeats were a potential terminator, translation could 
inactivate it by preventing hairpin formation by the nascent RNA. 
Studies of the transcription of p10115 in vitro, in the absence of 
ribosomes, might clarify this issue. 
In p10116, five inverted-repeats are evident: 134-140 and 
146-1.52; 173-179 and 184-190; 208-211 and 216-219; 222-224 and 
227-229; and 227-229 and 234-236. 	Only the first two symmetries 
are flanked on the 3'-side by sequenchomologous to known terminators; 
both have 3'-sequences rich in T-residues (6/11 and 7/11 respectively). 
Fig 5.5 
The nucleotide sequences around the inserts in pIG115(a) and 
pIG116(b) are shown. 	Details are recorded as in Fig. 4.7. 
Fig. 5.5 	T7 tec3 in pHR1800 
(a), 	 so I  
AGCTCCTCCGCCACCGTTTATGGCGATCAGCCCAAAATTCCATACGTJGAAAG 
I 	 1 	
190 
C TT GGCT C AG CC CA AGGCTCT CC ACGATTCCAT C AAG TC AATGAA C AAAC 
4 -, 4- 
150 
I 	 I 	 I 	 I 
TTGACGTAATCGACAAGCAATTCCAGAAGCGAATCAACGTTGAGTCGGTC 
-,----- 
(2) 	 290 
T CAACGGAT T TT AAGGAT ATGC C AGTC AACG AG AAC AT ICC T GAG TTCAA 
I 	 250 
GC AT AGCGAT ATGG TT A AC TACG C CAA TAAG A AGCC AAGCTT ACT CCCCA 
(3) 	(• 	 3Q0 
TCCCCGGGCAATAAGGGCTGCACGCGCACTTTTATCCGCCICIGCIGCGC 
(1) 
(b)1 	T7 tec3 in pHR1800 	9 	 50 
AGCTCCTCCGCCACCGTTTATGCGATCAGCCAAAATICCATACGIJGAAAG 
Jj) 	 I 	 iqo 
CTGGCTTCTTATTGGCGTAGTTAACCATATCGCTATGCTTGAACTCACC 
AATGTTCTCGTTGACTGGCATATCCTT AAAATCCGTTGAGACCCACTCA 
• 	i 	• 	r200 
CCI TGAT TCG CT TC TGG AATTGCT TG T CC ATT AfGT CAAG IT TGT TCAT 
20 
GACTTCATGGAATCGTCCAGACCCTTGGCCTGAGCCAAGCTTACICCCCA 




Furthermore, the first symmetry has CO positioned similarly to that 
of tecl and the second a CA at the same point as in the putative 
tec2 sequence. 	Translation of the mRNA corresponding to the insert 
should terminate at nucleotides 72-75 and would, therefore, probably 
not interfere with hairpin formation by any of the five symmetries. 
In particular, restarting of translation before the first two sites 
seems unlikely. 	The observed 95% reduction in galactokinase 
expression ascribable to the insert in p10116 could be due to trans- 
criptional termination at one or more of these sites. 	The best 
are the first two symmetries, in view of their 3'-flanking sequences. 
Future experiments, designed to define the 3'-terminus of transcripts 
derived from these plasmids in vitro, should resolve this uncertainty. 
They may also reveal termination within the p10115 insert in the 
absence of translation as discussed previously. 
The mapping of this fragment reveals that the observed termin-
ation is the result of yet another signal so orientated as to affect 
leftward transcription of T7 DNA by the host Rpol if this actually 
ever occurs. 	Terminators seem quite common in this orientation. 
It should be noted that my sequence differs at only one point 
from that determined by Dunn and Studier (1982). 	I assign an 
A-residue at position 102, where they propose a 0-residue. 	This 
may reflect a genuine mutation, which would place an isoleucine 
instead of a threonine at the corresponding position in p15. 	This 
could well be a "silent" mutation. 
The nucleotide sequence also confirms my earlier restriction 
data. 	The HaeIII cut is located 11 bp from the centre of the 
nearest Hindill site, and the Lpal site is centred 155 bp from the 
HaeIII cut. 	My estimates of 12 bp and 155 bp are, thus, in good 
agreement with the sequence data. 
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CHAPTER 6 	- FINAL DISCUSSION 
A major problem in interpreting the data presented here has 
been the lack of information concerning the stop-sites of terminated 
transcripts. 	Elucidation of these in vitro and in vivo will 
clarify the situation considerably. 	In view of the many putative 
terminators observed, Si-treatment of RNA:DNA hybrids would be my 
method of choice to achieve this. 	This method recommends itself 
in situations where there may well be multiple termination sites 
and locates the regions in which termination occurs. 
My estimates of ted's termination efficiency in the pKO system 
are in good agreement with that of Millette et al for T7 itself 
(1970). 	Thus, termination at this site appears to he 76-78% 
efficient when measured in isolation from the rest of the T7 genome. 
This observation contradicts the claim of Ponta et al (1974) that 
the T7 0.7 product is required for efficient termination at this site 
during phage infection. 	However, the "inelegant alternative" 
discussed earlier (Chapter 4) remains possible. 
The failure to demonstrate termination activity in NiOO (p10134) 
was surprising in that other authors have observed termination 
in vitro in this general region. 	The reasons for this failure are 
open to speculation. 	Perhaps other sequences not present on the 
tec2 fragment are necessary for an efficient termination at this 
site in vivo? 	Should my suggestion that a cofactor involvement is 
necessary for termination at tecl be true, we may need to mimic this 
situation when observing tec2 in the pKO system. 	The observed 
potential "nusA boxes" in T7 (shortly after the promoters Al,  A2  
and A3, and in the region of ted) suggest that pnusA may influence 
transcription of the early region. 	Should this be the case, we 
might need to imitate the relevant pnusA/Rpol interactions typical 
102. 
of T7 transcription to observe tec2 stimulated termination in the 
pKO system. 	Cloning the tec2 fragment downstream of the ted 
insert (in p10125 or p10139) may achieve this. 	Alternatively, 
translation may inhibit termination t this site as the previous 
demonstrations of termination in this general region were achieved 
in its absence in vitro. 	Translation of RNA transcripts from T7 
and p10134 may prevent termination at tec2. 	It should be noted 
that the insert contained in p10134 contains the complete 3.5 
gene (nucleotides 97-550, Fig. 4.10). 	Translation of RNA encoding 
the 3.5 gene product may inhibit the termination observed in vitro. 
This possibility would be more plausible should tec2 lie not in 
the region suggested by Hayward, but within the 3.5 gene. 	A 
further possibility is that tec2 lies in an adjacent region to this 
insert. 	To resolve this, we require to identify the termination 
site more precisely, perhaps by studying T7 mutants which lack the 
tecl sequence (e.g. T7 L637) in vitro and in vivo. 
The identification of a new transcription terminator, tec3, 
(even if it is non-physiological) provides new working material to 
investigate termination. 	Its nucleotide sequence reveals potential 
sites for termination, two of which are similar to tecl in that they 
have T-rich 3'-sequences. 	However, identification of the 3'-terminus 
of the terminated RNA is essential to identify the termination signal. 
Further study of termination here (and in the other fusions 
constructed) may provide insight into termination at "novel" termin-
ators as most of the putative termination sites noted have inverted 
dyad-symmetries but lack 3'-sequence homology with known terminators. 
Perhaps the most interesting region noted will be the A/T rich region 
noted in p10135. 	This is similar to 	t' in that its A/T content 
is 70% (63% for !t')  and both contain a potential "nusA box". 
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Should termination occur here, it will be only the second known 
example of a terminator sequence of this type. 
In considering which of the putative terminators are likely to 
function, it may be enlightening to compare them with mutant and 
synthetic terminator sequences. 	Let us first consider the structure 
of the inverted repeat. 	The strength of the stem appears to be 
positively correlated with terminator efficiency. 	For example: in 
mutations exist that increase (cm) or decrease (cnc) the 
stability of the stem. 	The efficiency of termination at these 
mutant sites increases (cm) or decreases (cnc) depending on the 
mutation involved. 	Similarly, in trp att, mutations that increase 
or decrease .!E operon expression have been isolated. 	Their 
properties support the importance of the stable formation of stern- 
loop 3:4 for termination. 	Increased trp operon expression results 
from a reduced stability of the 3:4 stern-loop. 	Decreased jjtrp operon 
expression results from an enhancement of its formation by abolition 
of translation or of stem-loop 2:3 formation. 	The synthetic 
terminators tMC (RI) and tLELC (Barn) (Christie and Platt, 1980; 
Christie et al, 1982) also show a positive correlation between stem- 
strength and termination efficiency. 	The former has a stem of 6 bp 
(5 G:C), a loop of 4 nucleotides, and encodes a "tail" of 4 U-residues. 
The latter is identical in these respects but has a stem of 7 bp 
(6 C:C). 	Termination in vitro (15%) is only observed in the latter 
sequence (using wild-type Rpol). 	Hence the strength of the stem 
appears to affect termination efficiency. 	Moreover, the authors 
suggest that a stem of 8 bp is the maximum useful length. 
What then of "tail" 3'-sequences? 	Most rho-independent termin- 
ators produce transcripts ending in a run of U-residues. 	A notable 
exception is T7 tecl which produces transcripts ending at a C- or 
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0-residue in a U-rich region (7/11). 	Terminator mutants that have 
a reduced number of U-residues following the stem-loop show a 
reduced efficiency of termination. 	For example: the flp.  att mutant 
!a 1419 has only four U-residues in this region (4/11) compared 
to eight (8/11) in the wild-type sequence. 	The altered attenuator 
is only partially functional in vivo and no termination is detectable 
in vitro (Bertrand et 21, 1977; Platt, 1981). Clearly, the presence 
of U-residues distal to a stem-loop is important for efficient 
termination. 	But is a long run of U-residues more important than 
a general U-richrtess? 	Many terminator sequences (having long runs 
of U-residues) and the particular instability of polyrU.dA (Martin 
and Tinoco, 1980) suggest the former. 	However, Hayward (pers. comm.) 
has suggested that, in view of such sequences as T7 tecl and rpoBC 
att, the latter may sometimes be just as effective. 	Should this be 
the case, the putative terminator sites with this structurewhich I 
have proposed above, may indeed be functional. 	Moreover, a tendency 
towards U-richness following stem-loops would, of necessity, produce 
long runs of U-residues. 
With these thoughts in mind, few of the putative sites are 
predicted to be actual sites of transcriptional termination. 	The 
efficient termination observed with the inverted tecl and tec2 frag- 
ments is, therefore, of potential interest. 	Identification of the 
point(s) of termination in these fusions may identify novel 
terminator tail sequences, or further examples of the unique trptl 
class. 	Clearly, in vitro experiments with these fusions is necessary 
to resolve these speculations. 	It is, however, evident that nucleo- 
tide sequence, with or without free energy calculations, is 
insufficient in the present state of knowledge to identify trans-
criptional terminators. 
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Should the reduction in galactokinase levels observed in N100 
(p10126), NiOD (p10138), N100 (p10135) and N100 (p10116) be due to 
transcriptional terminators, how can we explain their occurrence in 
such an orientation in T7 that they would not affect natural trans- 
cription? 	The established transcription of T7 DNA during infection 
is confined to the rightward direction (using the r-strand as 
template), with the possible exception of that initiated at the A 
promoter. 	However, Rpol does bind to the 1-str2nd in vitro when 
Rpol:DNA ratios are high. 	Furthermore, promoters for E.coli Rpol 
that could allow initiation of leftward transcription have been 
isolated (Dunn and Studier, 1982). 	It is, therefore, possible that 
transcription initiates on the 1-strand to some degree during 
infection. 	This would result in convergent transcription between 
Rpol molecules transcribing left to right and those transcribing 
right to left. 	Ward and Murray (1979) investigated this situation 
using Xtrp transducing phages. 	Here, transcripts initiated at the 
..tia promoter and XP L  converged and were shown to be mutually impaired. 
Should this situation occur during T7 infection, it would hinder gene 
expression. 	The presence of transcription terminators in the genome 
that prevent appreciable leftward transcription may help to alleviate 
such a problem. 	The competition between opposing transcription 
complexes is a "dynamic process" (as indicated by Ward and Murray). 
Prompt termination of leftward transcription may help rightward 
transcription complexes to displace the opposing complexes. 
On the other hand, the presence of these sequence may be 
fortuitous. 	As seen in Chapter 4, inverted-symmetries are relatively 
common in a large nucleotide sequence. 	These may be present by 
chance, or for a "purpose": for example, they may promote hairpin 
formation in transcripts so as to regulate the rate of transcription 
and/or the spacial 
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relationship between the polymerase and a following ribosome 
(recall the "pause" site in the trp leader region, Chapter 1); or 
they may be protein recognition sequences. 	The further occurrence 
of "fortuitous" sequences downstream of the stem-loops could "create" 
functional transcriptional terminators. 
The pKO system can be exploited to investigate termination in 
a number of ways. 	It is not yet clear whether the position at 
which ribosomes halt upstream of a transcriptional terminator will 
influence termination andif so, whether terminators differ in this 
respect. 	This can be investigated by the construction of similar 
fusions to those described above but with translation terminating 
at different sites upstream. 	To achieve this, it may be necessary 
to construct new vectors derived from the existing pKO vectors. 
Moreover, the assumed inactivation of transcriptional terminators by 
ribosomes translating through them has yet to be demonstrated. This 
prediction can be tested by constructing a pKO fusion containing a 
terminator upstream of galK such that translation would 'extend through 
the inserted fragment. 	The effect of translational readthrough on 
rho-dependent and rho-independent terminators could be tested in this 
way. 	Terminator-containing fragments suitable for constructing 
these fusions are available: McKenney et al (1981) possess a Xt81  
fragment suitable for the rho-dependent situation; and the 142 hp 
tecl fragment described above is suitable for the rho-independent 
situation. 
The pKO system can also be used to study mutant terminator sites. 
Site-specific mutagenesis1using cloned terminator fragments,will 
enable the reconstruction of defined pKO fusions containing mutant 
terminators. 	Comparison of galactokinase expression by these fusions 
with that of a fusion containing the wild-type terminator will enable 
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the influence of each mutation on transcription readthrough to be 
monitored. 	Moreover, the presence of each mutant terminator on a 
small cloned fragment will allow the easy characterisation of each 
mutation by DNA sequencing. 	However, as noted earlier (Chapter 4), 
the screening of resulting clones for mutant-terminators using 
colour-phenotype may prove difficult. 	Should tecl be used in this 
approach, terminator "up" mutations would reduce galactokinase 
expression and perhaps produce levels sufficient to cause a notice- 
able colour-change. 	It may, nevertheless, be necessary to utilise 
a weaker promoter than Pl to achieve the range of galactokinase 
expression suitable for mutant-terminator screening. 	This would 
undoubtedly be necessary when screening for tecl terminator "down" 
mutations. 
The present studies and considerations suggest a number of 
avenues by which the investigation of termination could continue: 
1) as noted above, in vitro mutagenesis should be used to isolate 
terminator specific mutants in the pKO system; 2) the present fusions 
should be transferred to a single-copy when the relevant pKO vectors 
become available; 3) the point(s) of termination in each fusion 
described above should be determined in vitro and in vivo; 4) the 
way in which Rpoi interacts with sequences around the termination 
site should be studied (the tec3 fragment has been sent to 
Dr S.Beychok, Columbia University, New York, who intends to investigate 
terminators in this way; 5) the possible function of these termin-
ators in the T7 genorne should be studied by using these fragments 
(in single-stranded form) as probes for RNA produced during infection; 
6) the possible involvement of pnusA in events at ted, tec2 and 
tec3 should be investigated in N100 nusA strains. 
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